https://revespquimioterapia.com/ 2026-08-04 https://revespquimioterapia.com/aboutmagazine 2026-08-04 https://revespquimioterapia.com/editorialboard 2026-08-04 https://revespquimioterapia.com/authorsrules 2026-08-04 https://revespquimioterapia.com/editorialprocess 2026-08-04 https://revespquimioterapia.com/editorialpolicies 2026-08-04 https://revespquimioterapia.com/openaccess 2026-08-04 https://revespquimioterapia.com/financing 2026-08-04 https://revespquimioterapia.com/publishingCosts 2026-08-04 https://revespquimioterapia.com/legalnotice 2026-08-04 https://revespquimioterapia.com/privacyPolicy 2026-08-04 https://revespquimioterapia.com/contact 2026-08-04 https://revespquimioterapia.com/copyright 2026-08-04 https://revespquimioterapia.com/contact 2026-08-04 https://revespquimioterapia.com/contact 2026-08-04 https://revespquimioterapia.com/articulo/peritonitis-por-clostridium-innocuum-asociada-a-di-87ad6155 2026-03-26 https://revespquimioterapia.com/articulo/a-comparison-of-the-efficacy-of-piperacillin-tazob-af29303b 2026-03-26 https://revespquimioterapia.com/articulo/rotura-esplenica-como-complicacion-de-una-tubercul-5aa0abd9 2026-03-26 https://revespquimioterapia.com/articulo/primer-caso-descrito-en-espana-de-infeccion-por-wo-fc7aeb25 2026-03-26 https://revespquimioterapia.com/articulo/multidrug-resistant-acinetobacter-baumannii-a-ther-983116a6 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-y-analisis-filogenetico-de-chlamydia-t-0306e906 2026-03-26 https://revespquimioterapia.com/articulo/episodios-de-salmonelosis-no-tifoidea-en-pacientes-4a17cf5b 2026-03-26 https://revespquimioterapia.com/articulo/experiencia-con-colistina-nebulizada-en-pacientes--fe3931eb 2026-03-26 https://revespquimioterapia.com/articulo/utility-of-lateral-flow-tests-in-sars-cov-2-infect-ce4c2168 2026-03-26 https://revespquimioterapia.com/articulo/enfermedad-periodontal-odontopatogenos-y-perfil-de-f7bf10a0 2026-03-26 https://revespquimioterapia.com/articulo/prevalence-of-mutations-associated-with-macrolide--5ce3cba9 2026-03-26 https://revespquimioterapia.com/articulo/etiology-of-bloodstream-infections-at-a-population-a5031ab6 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-economica-de-la-implantacion-del-autoan-2decd069 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-6-342-344-36e5406e 2026-03-26 https://revespquimioterapia.com/articulo/son-utiles-los-antimicrobianos-utilizados-en-infec-b122ab06 2026-03-26 https://revespquimioterapia.com/articulo/efficacy-of-cefditoren-in-the-treatment-of-upper-r-5abe1a7b 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-delafloxacino-frente-a-aisla-7e219e3e 2026-03-26 https://revespquimioterapia.com/articulo/fatal-sepsis-months-after-bladder-instillations-wi-7e011292 2026-03-26 https://revespquimioterapia.com/articulo/rectorragia-y-microabscesos-en-paciente-no-inmunid-6fb907ff 2026-03-26 https://revespquimioterapia.com/articulo/is-it-in-their-eyes-correlation-between-microorgan-0852215d 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-antibioticos-en-pacientes-neutropeni-5663c45d 2026-03-26 https://revespquimioterapia.com/articulo/respiratory-consequences-after-covid-19-outcome-an-d0144f05 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-ampicilina-sulbactam-frente-a-haemoph-3966f14a 2026-03-26 https://revespquimioterapia.com/articulo/meningitis-postquirurgica-por-gemella-haemolysans-811cf2fd 2026-03-26 https://revespquimioterapia.com/articulo/erratic-enteric-absorption-of-dolutegravir-in-a-cr-c6316757 2026-03-26 https://revespquimioterapia.com/articulo/nocardia-and-mucoral-co-infection-in-heart-transpl-71c952e1 2026-03-26 https://revespquimioterapia.com/articulo/invasive-group-a-streptococcus-infection-streptoco-4494a835 2026-03-26 https://revespquimioterapia.com/articulo/documento-de-consenso-sobre-el-tratamiento-antimic-7813743f 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-antimicrobiano-de-la-epoc-en-el-ancian-81dc1b41 2026-03-26 https://revespquimioterapia.com/articulo/la-prueba-b-carba-r-puede-determinar-de-forma-rapi-f254ff7b 2026-03-26 https://revespquimioterapia.com/articulo/top-ten-papers-in-fungal-infection-8f9c1b6f 2026-03-26 https://revespquimioterapia.com/articulo/las-claves-de-una-epoca-wright-y-fleming-0289ed99 2026-03-26 https://revespquimioterapia.com/articulo/efectividad-de-nirsevimab-en-la-prevencion-de-los--9c2879cf 2026-03-26 https://revespquimioterapia.com/articulo/impacto-en-la-poblacion-adulta-de-la-inmunizacion--5f2822d0 2026-03-26 https://revespquimioterapia.com/articulo/futuro-en-el-desarrollo-de-vacunas-b098d247 2026-03-26 https://revespquimioterapia.com/articulo/evolution-of-salmonella-spp-isolated-compared-to-t-e00b3872 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-in-vitro-de-citomegalovirus-al-gancic-1bcad654 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-de-resistencia-a-agentes-antibacterianos-22185737 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-en-urgencias-de-infeccion-por-vih-en-pac-00a9f19b 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-de-la-resistencia-antibiotica-de-pseudom-c8bc869a 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-urinaria-por-actinobaculum-schaalii-en-u-07d2d893 2026-03-26 https://revespquimioterapia.com/articulo/staphylococcus-aureus-resistente-a-meticilina-sens-31c44d5e 2026-03-26 https://revespquimioterapia.com/articulo/analisis-de-los-tipos-y-subtipos-gripales-en-funci-19fe04dc 2026-03-26 https://revespquimioterapia.com/articulo/los-aminoglucosidos-en-la-nueva-decada-su-uso-en-l-994036d3 2026-03-26 https://revespquimioterapia.com/articulo/mechanism-of-action-of-cefiderocol-e8616fd9 2026-03-26 https://revespquimioterapia.com/articulo/recommendations-for-antibiotic-selection-for-sever-db1188ca 2026-03-26 https://revespquimioterapia.com/articulo/mastoiditis-aguda-aumento-de-su-incidencia-y-contr-6d12ed79 2026-03-26 https://revespquimioterapia.com/articulo/mejora-en-la-rentabilidad-e-indicaciones-de-la-ext-8de6bd5d 2026-03-26 https://revespquimioterapia.com/articulo/valoracion-de-escalas-de-gravedad-en-pacientes-inc-dc7dc4b8 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-del-vih-1-a-los-inhibidores-de-la-inte-1dd01878 2026-03-26 https://revespquimioterapia.com/articulo/celulitis-por-neisseria-weaveri-tras-mordedura-de--ac334129 2026-03-26 https://revespquimioterapia.com/articulo/introduction-to-xii-updating-course-of-antimicrobi-a1469565 2026-03-26 https://revespquimioterapia.com/articulo/assessment-of-latent-infections-in-patients-receiv-065a32c6 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-de-los-biomarcadores-para-predecir-bacter-dac15a05 2026-03-26 https://revespquimioterapia.com/articulo/siguen-los-medicos-de-atencion-primaria-las-recome-15ccc11c 2026-03-26 https://revespquimioterapia.com/articulo/influencia-de-farmacos-inhibidores-de-bombas-de-io-d9cac522 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-inmunomodulador-con-interferon-beta-en-93fcff95 2026-03-26 https://revespquimioterapia.com/articulo/optimizacion-de-estrategias-en-la-prevencion-de-la-f83ea447 2026-03-26 https://revespquimioterapia.com/articulo/a-rare-case-of-meleney-s-ulcer-after-partial-chemi-fb553936 2026-03-26 https://revespquimioterapia.com/articulo/covid-19-some-unresolved-issues-2eb7e929 2026-03-26 https://revespquimioterapia.com/articulo/persistence-and-viability-of-sars-cov-2-in-primary-a257910a 2026-03-26 https://revespquimioterapia.com/articulo/un-dia-en-la-microbiologia-espanola-estudio-descri-e655f1fa 2026-03-26 https://revespquimioterapia.com/articulo/repeticion-de-las-pruebas-microbiologicas-en-la-so-43257396 2026-03-26 https://revespquimioterapia.com/articulo/analisis-de-1-250-episodios-de-infeccion-de-piel-y-6951f259 2026-03-26 https://revespquimioterapia.com/articulo/rapid-detection-of-clarithromycin-resistant-helico-43bec740 2026-03-26 https://revespquimioterapia.com/articulo/influence-of-cmo-pharmaceutical-care-model-based-i-b6f44d80 2026-03-26 https://revespquimioterapia.com/articulo/vacunacion-anti-covid-19-la-realidad-tras-los-ensa-c1c49dce 2026-03-26 https://revespquimioterapia.com/articulo/comparacion-del-metodo-de-microdilucion-pasco-con--d789169f 2026-03-26 https://revespquimioterapia.com/articulo/estudio-epidemiologico-de-portadores-nasales-de-st-3929953a 2026-03-26 https://revespquimioterapia.com/articulo/es-necesaria-la-prevencion-de-la-reactivacion-del--35710a00 2026-03-26 https://revespquimioterapia.com/articulo/comparacion-de-dos-metodos-para-el-estudio-de-la-s-e1859289 2026-03-26 https://revespquimioterapia.com/articulo/antiparasitarios-92b43db3 2026-03-26 https://revespquimioterapia.com/articulo/aislamiento-de-salmonella-enterica-serovar-typhi-e-a9093796 2026-03-26 https://revespquimioterapia.com/articulo/del-conocimiento-de-la-etiologia-bacteriana-al-tra-253e5efd 2026-03-26 https://revespquimioterapia.com/articulo/tinidazol-un-anaerobicida-clasico-con-multiples-us-ff1810c8 2026-03-26 https://revespquimioterapia.com/articulo/post-cart-t-cell-infection-etiology-pathogenesis-a-11640920 2026-03-26 https://revespquimioterapia.com/articulo/bahng-score-predictive-model-for-detection-of-subj-e112a47c 2026-03-26 https://revespquimioterapia.com/articulo/estrategias-para-la-mejora-de-la-prescripcion-del--80627cb7 2026-03-26 https://revespquimioterapia.com/articulo/neoscytalidium-dimidiatum-a-rare-locally-acquired-deep-cutaneous-infection-in-a-renal-transplant-recipient 2026-03-26 https://revespquimioterapia.com/articulo/chronic-lung-infection-by-achromobacter-xylosoxidans-in-a-patient-with-cystic-fibrosis-successfully-treated-with-cefiderocol-as-a-pre-and-post-lung-transplant-regimen 2026-03-26 https://revespquimioterapia.com/articulo/de-la-rinolicuorrea-al-16s-meningitis-por-streptococcus-salivarius 2026-03-26 https://revespquimioterapia.com/articulo/meningitis-neumococica-en-un-hospital-de-alta-complejidad-caracteristicas-clinicas-distribucion-de-serotipos-y-estado-vacunal 2026-03-26 https://revespquimioterapia.com/articulo/endocarditis-due-to-coxiella-burnetii-in-congenital-heart-disease-patients-a-clinical-case-series-and-diagnostic-considerations 2026-03-26 https://revespquimioterapia.com/articulo/un-ano-sin-el-profesor-dr-albert-pahissa 2026-03-26 https://revespquimioterapia.com/articulo/resistance-to-beta-lactams-in-gram-negative-bacill-9085a569 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-en-varones-de-la-poblacion-general-de--6b404459 2026-03-26 https://revespquimioterapia.com/articulo/respiratory-infections-in-coronavirus-disease-2019-995b56e5 2026-03-26 https://revespquimioterapia.com/articulo/diagnostic-and-therapeutic-approach-to-fungal-pneu-2e8bf091 2026-03-26 https://revespquimioterapia.com/articulo/value-of-syndromic-panels-in-the-management-of-sev-78025c5d 2026-03-26 https://revespquimioterapia.com/articulo/adecuacion-de-la-prescripcion-de-antibioticos-anti-6a043c47 2026-03-26 https://revespquimioterapia.com/articulo/do-face-masks-increase-the-rate-of-the-staphylococ-cc43dfec 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-del-agente-antimalarico-enpirol-e9d127b5 2026-03-26 https://revespquimioterapia.com/articulo/vitek-ms-matrix-assisted-laser-desorption-ionizati-c57156c2 2026-03-26 https://revespquimioterapia.com/articulo/telemedicina-centros-penitenciarios-y-enfermedad-p-dcfeddb8 2026-03-26 https://revespquimioterapia.com/articulo/new-evidence-on-the-use-of-fosfomycin-for-bacterem-b9f81b4d 2026-03-26 https://revespquimioterapia.com/articulo/etiology-diagnosis-and-management-of-pneumonia-in--6cc18d19 2026-03-26 https://revespquimioterapia.com/articulo/la-enfermedad-de-noma-cancrum-oris-una-enfermedad--bd6f00cd 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-antibiotico-empirico-inicial-de-la-neu-c749bce8 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-sensibilidad-de-salmonella-spp-no-typhi-4686723e 2026-03-26 https://revespquimioterapia.com/articulo/concordancia-entre-el-genexpert-y-el-life-real-det-23a225ee 2026-03-26 https://revespquimioterapia.com/articulo/cefiderocol-23727b59 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-antimicrobianos-de-los-aislamientos-2da5a050 2026-03-26 https://revespquimioterapia.com/articulo/endocarditis-por-candida-sp-experiencia-en-un-hosp-0f86718d 2026-03-26 https://revespquimioterapia.com/articulo/top-ten-papers-in-pneumonia-2020-2021-9c241398 2026-03-26 https://revespquimioterapia.com/articulo/vascular-catheter-related-infections-an-endemic-di-1c098d85 2026-03-26 https://revespquimioterapia.com/articulo/ceftolozane-tazobactam-in-nosocomial-pneumonia-5bb78e5d 2026-03-26 https://revespquimioterapia.com/articulo/combinaciones-de-antibioticos-nuevas-perspectivas--593bb527 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-fosfomicina-frente-a-enterob-5ac64500 2026-03-26 https://revespquimioterapia.com/articulo/levofloxacino-en-pacientes-ingresados-en-uci-facto-0831bb2e 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-virico-alternativo-en-las-sospechas-de-b33709ab 2026-03-26 https://revespquimioterapia.com/articulo/uso-de-antimicrobianos-en-la-exacerbacion-de-la-en-291930f3 2026-03-26 https://revespquimioterapia.com/articulo/micafungin-as-antifungal-prophylaxis-in-non-transp-33b12af1 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-la-sensibilidad-in-vitro-de-hongos-leva-fe7a1dc3 2026-03-26 https://revespquimioterapia.com/articulo/factores-predictores-de-bacteriemia-en-los-pacient-77c91857 2026-03-26 https://revespquimioterapia.com/articulo/conclusiones-da3125de 2026-03-26 https://revespquimioterapia.com/articulo/mechanical-ventilation-associated-pneumonia-during-3bde2dcd 2026-03-26 https://revespquimioterapia.com/articulo/distribucion-geografica-y-caracteristicas-de-la-ev-456fe4d4 2026-03-26 https://revespquimioterapia.com/articulo/aparicion-de-ld1-minicromosomas-de-leishmania-y-re-528e805c 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-los-antimicrobianos-de-aislamientos-d9c98143 2026-03-26 https://revespquimioterapia.com/articulo/betalactamasas-de-espectro-extendido-son-un-serio--e08674c3 2026-03-26 https://revespquimioterapia.com/articulo/use-of-tigecycline-in-critically-ill-patients-with-03c9e343 2026-03-26 https://revespquimioterapia.com/articulo/ceftobiprole-for-the-treatment-of-pneumonia-5e695b75 2026-03-26 https://revespquimioterapia.com/articulo/immune-treatment-in-covid-19-1ab0fc81 2026-03-26 https://revespquimioterapia.com/articulo/comparacion-del-efecto-in-vitro-e-in-vivo-de-merop-d7130363 2026-03-26 https://revespquimioterapia.com/articulo/meropenem-aspectos-farmacocineticos-farmacodinamic-497dd8a2 2026-03-26 https://revespquimioterapia.com/articulo/resistencias-de-escherichia-coli-a-las-quinolonas--60d02068 2026-03-26 https://revespquimioterapia.com/articulo/fungal-biofilms-from-bench-to-bedside-2cbd3563 2026-03-26 https://revespquimioterapia.com/articulo/aneurisma-micotico-por-salmonella-enteritidis-desc-73fc6134 2026-03-26 https://revespquimioterapia.com/articulo/la-penicilina-llega-a-espana-10-de-marzo-de-1944-u-096be91a 2026-03-26 https://revespquimioterapia.com/articulo/infection-control-in-long-term-care-institutions-f-33805e7e 2026-03-26 https://revespquimioterapia.com/articulo/ponencias-afecta-la-vacunacion-a-la-prescripcion-d-5b30b87e 2026-03-26 https://revespquimioterapia.com/articulo/fenotipos-de-resistencia-a-macrolidos-lincosamidas-16424535 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-ca-1-8-m-1-18-un-peptido-sin-ee8d5bef 2026-03-26 https://revespquimioterapia.com/articulo/daptomicina-revitalizando-un-antiguo-farmaco-ante--f9457242 2026-03-26 https://revespquimioterapia.com/articulo/endoftalmitis-por-abiotrophia-defectiva-tratada-co-9cc4e096 2026-03-26 https://revespquimioterapia.com/articulo/pseudoaneurisma-femoral-por-streptococcus-pneumoni-b83d0e07 2026-03-26 https://revespquimioterapia.com/articulo/el-analisis-multivariante-en-la-investigacion-con--d978682b 2026-03-26 https://revespquimioterapia.com/articulo/potentially-inappropriate-medications-according-to-ba326a23 2026-03-26 https://revespquimioterapia.com/articulo/farmacologia-de-antimicrobianos-utilizados-en-el-t-dceb89c9 2026-03-26 https://revespquimioterapia.com/articulo/quinolonas-y-streptococcus-pneumoniae-mecanismo-de-c268b528 2026-03-26 https://revespquimioterapia.com/articulo/activity-of-vancomycin-ciprofloxacin-daptomycin-an-edfaba13 2026-03-26 https://revespquimioterapia.com/articulo/nebulized-medication-is-not-associated-with-nosoco-816e4649 2026-03-26 https://revespquimioterapia.com/articulo/sars-cov-2-screening-of-asymptomatic-women-admitte-9c47b1b4 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-fluconazol-de-levaduras-de-interes--99e30536 2026-03-26 https://revespquimioterapia.com/articulo/nuevos-antifungicos-presente-y-futuro-7cdc28bb 2026-03-26 https://revespquimioterapia.com/articulo/tedizolid-new-data-and-experiences-for-clinical-pr-254c4409 2026-03-26 https://revespquimioterapia.com/articulo/profilaxis-y-tratamiento-de-las-infecciones-respir-aa18298e 2026-03-26 https://revespquimioterapia.com/articulo/a-comprehensive-approach-for-the-patient-with-clos-ca74948c 2026-03-26 https://revespquimioterapia.com/articulo/variabilidad-del-virus-de-la-hepatitis-c-e-inhibic-1247fbb5 2026-03-26 https://revespquimioterapia.com/articulo/seguridad-de-las-fluoroquinolonas-diez-anos-despue-f3a78d6e 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-del-metodo-e-test-para-determinar-la-ac-8f61b300 2026-03-26 https://revespquimioterapia.com/articulo/biofilm-modelo-de-comunicacion-bacteriana-y-resist-7671a355 2026-03-26 https://revespquimioterapia.com/articulo/segundo-documento-de-consenso-sobre-uso-de-antimic-f0d75129 2026-03-26 https://revespquimioterapia.com/articulo/influencia-de-las-infecciones-graves-por-gramnegat-623f9fc2 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-del-manejo-de-la-infeccion-por-clostrid-bec2b406 2026-03-26 https://revespquimioterapia.com/articulo/emergencia-de-b-lactamasas-ampc-plasmidicas-pampc--a1cdfc4d 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-farmacoeconomica-de-daptomicina-como-te-0d0f2c37 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-piperacilina-tazobactam-en-a-29e0b0d9 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-farmacocinetica-y-farmacodinamica-del-t-2829b632 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-the-covid-19-pandemic-on-the-diagnosis-a-9a86e7b2 2026-03-26 https://revespquimioterapia.com/articulo/cinco-anos-de-evolucion-del-consumo-extrahospitala-fee8c13f 2026-03-26 https://revespquimioterapia.com/articulo/dalbavancin-aee82358 2026-03-26 https://revespquimioterapia.com/articulo/highlights-from-22nd-international-aids-conference-03169403 2026-03-26 https://revespquimioterapia.com/articulo/caracterizacion-de-la-expresion-de-genes-asociados-402a9c87 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-azitromicina-frente-a-aislam-2298166f 2026-03-26 https://revespquimioterapia.com/articulo/effectiveness-safety-and-patient-reported-outcomes-f5dc57bf 2026-03-26 https://revespquimioterapia.com/articulo/criterios-de-sepsis-y-ensayos-clinicos-4c33377f 2026-03-26 https://revespquimioterapia.com/articulo/inmunoprofilaxis-y-quimioprofilaxis-frente-a-la-me-a6d86017 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-antimicrobiana-de-bacterias-anaerobia-08cc252c 2026-03-26 https://revespquimioterapia.com/articulo/group-a-streptococcus-invasive-infection-in-childr-111195a9 2026-03-26 https://revespquimioterapia.com/articulo/actividad-bacteriostatica-y-bactericida-de-la-rani-b2f35f58 2026-03-26 https://revespquimioterapia.com/articulo/presentacion-3807ea11 2026-03-26 https://revespquimioterapia.com/articulo/el-microbiologo-y-la-infeccion-asociada-a-cateter-c97ab03e 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-posaconazol-frente-a-levadur-10d57823 2026-03-26 https://revespquimioterapia.com/articulo/absceso-retroperitoneal-en-paciente-con-antecedent-82cd28df 2026-03-26 https://revespquimioterapia.com/articulo/covid-19-and-fungal-infections-etiopathogenesis-an-ccbb4d9b 2026-03-26 https://revespquimioterapia.com/articulo/pharmaecology-d807fe7f 2026-03-26 https://revespquimioterapia.com/articulo/edp-938-un-nuevo-antiviral-con-actividad-inhibidor-0059e354 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-urinaria-por-escherichia-coli-y-klebsiel-4f6c5337 2026-03-26 https://revespquimioterapia.com/articulo/guia-de-tratamiento-de-la-infeccion-producida-por--69787e0d 2026-03-26 https://revespquimioterapia.com/articulo/severe-bacterial-non-aids-infections-in-hiv-women-2dfe8d9a 2026-03-26 https://revespquimioterapia.com/articulo/introduction-to-xi-updating-course-of-antimicrobia-e12064da 2026-03-26 https://revespquimioterapia.com/articulo/seroprevalencia-de-sarampion-rubeola-paperas-y-var-692ce254 2026-03-26 https://revespquimioterapia.com/articulo/what-happened-to-infectious-diseases-and-anti-infe-ffd84644 2026-03-26 https://revespquimioterapia.com/articulo/froin-s-syndrome-secondary-to-epidural-abscess-8d70af27 2026-03-26 https://revespquimioterapia.com/articulo/manejo-de-afectacion-cutanea-y-sistemica-por-candi-7af9b42f 2026-03-26 https://revespquimioterapia.com/articulo/respiratory-co-and-superinfections-in-covid-19-5dd28182 2026-03-26 https://revespquimioterapia.com/articulo/bioinformatics-approaches-to-the-study-of-antimicr-f2822b3b 2026-03-26 https://revespquimioterapia.com/articulo/risk-factors-for-methicillin-resistant-staphylococ-a168b252 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-fluconazol-sobre-candida-alb-b7c952c6 2026-03-26 https://revespquimioterapia.com/articulo/conocimiento-actitud-y-experiencia-de-la-poblacion-d3555983 2026-03-26 https://revespquimioterapia.com/articulo/rifaximina-bf4c5605 2026-03-26 https://revespquimioterapia.com/articulo/quinolonas-breve-panorama-de-sus-efectos-adversos-1503e8a6 2026-03-26 https://revespquimioterapia.com/articulo/mapa-de-la-situacion-actual-de-la-atencion-a-la-se-aa21d01b 2026-03-26 https://revespquimioterapia.com/articulo/microscopia-vs-biologia-molecular-en-el-diagnostic-6eb52e41 2026-03-26 https://revespquimioterapia.com/articulo/dispondremos-de-antimicrobianos-adecuados-frente-a-ee702ffe 2026-03-26 https://revespquimioterapia.com/articulo/report-of-sexually-transmitted-infections-prevalen-f91e63d4 2026-03-26 https://revespquimioterapia.com/articulo/glecaprevir-pibrentasvir-en-combinacion-con-ribavi-366da52a 2026-03-26 https://revespquimioterapia.com/articulo/otros-daa345eb 2026-03-26 https://revespquimioterapia.com/articulo/peptidos-de-origen-eucariotico-con-actividad-antim-2568cb94 2026-03-26 https://revespquimioterapia.com/articulo/evaluation-of-three-immunochromatographic-assays-f-6ad3f3b1 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemias-por-anaerobios-estrictos-e17c121c 2026-03-26 https://revespquimioterapia.com/articulo/symposium-9-diagnostico-y-tratamiento-de-la-infecc-49e620f8 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-de-resistencia-a-claritromicina-en-aisla-77ac8fe6 2026-03-26 https://revespquimioterapia.com/articulo/mycoplasma-pneumoniae-y-resistencias-a-macrolidos--7b141c77 2026-03-26 https://revespquimioterapia.com/articulo/symposium-6-nuevos-avances-en-el-tratamiento-de-la-495c2590 2026-03-26 https://revespquimioterapia.com/articulo/ceftaroline-50b1a7ef 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-seis-fluoroquinolonas-y-peni-cbb5b810 2026-03-26 https://revespquimioterapia.com/articulo/enterococcus-spp-and-streptococcus-spp-bloodstream-0bfbdf2b 2026-03-26 https://revespquimioterapia.com/articulo/highlights-at-the-asm-microbe-2018-atlanta-usa-bce365ff 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-la-infeccion-por-helicobacter-pylor-6c444b40 2026-03-26 https://revespquimioterapia.com/articulo/resistencias-del-vih-1-y-el-laboratorio-clinico-f5c8eb2f 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-urinaria-en-curieterapia-eb5546c5 2026-03-26 https://revespquimioterapia.com/articulo/antiviral-therapy-and-immunotherapy-of-covid-19-43b7c990 2026-03-26 https://revespquimioterapia.com/articulo/profilaxis-post-exposicion-frente-vih-utilizamos-a-9ac72493 2026-03-26 https://revespquimioterapia.com/articulo/invasive-fungal-infections-in-onco-haematology-a-s-4f1cdb5f 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-de-mutaciones-asociadas-a-la-resistencia-8a77afa5 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-shigella-flexneri-en-un-adulto-y-r-74d85d6d 2026-03-26 https://revespquimioterapia.com/articulo/es-necesario-conocer-que-trabajadores-son-portador-06c36257 2026-03-26 https://revespquimioterapia.com/articulo/nifurtimox-chemotherapy-collateral-effects-in-trea-2bfe56c9 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-a-antibioticos-en-aislamientos-clinico-9e379242 2026-03-26 https://revespquimioterapia.com/articulo/fungemia-por-rhodotorula-mucilaginosa-presentacion-e3fe44f6 2026-03-26 https://revespquimioterapia.com/articulo/is-propionimicrobium-lymphophilum-a-new-urinary-tr-c00b8156 2026-03-26 https://revespquimioterapia.com/articulo/aspectos-epidemiologicos-de-las-micosis-en-el-paci-2322a541 2026-03-26 https://revespquimioterapia.com/articulo/prediccion-precoz-de-no-respuesta-durante-el-trata-535b04cc 2026-03-26 https://revespquimioterapia.com/articulo/20-anos-sin-manolo-gomis-infectologo-humanista-y-a-89bc95aa 2026-03-26 https://revespquimioterapia.com/articulo/influencia-de-la-protocolizacion-razonada-y-consen-f9e12607 2026-03-26 https://revespquimioterapia.com/articulo/estudio-epidemiologico-y-efecto-sobre-la-utilizaci-5e2fc55d 2026-03-26 https://revespquimioterapia.com/articulo/influencia-del-desplazamiento-de-la-union-a-protei-e849ff95 2026-03-26 https://revespquimioterapia.com/articulo/cefepima-en-el-tratamiento-de-la-osteomielitis-por-f44d9282 2026-03-26 https://revespquimioterapia.com/articulo/conferencia-inaugura-l-afd67ea4 2026-03-26 https://revespquimioterapia.com/articulo/faringoamigdalitis-en-el-adulto-2655a533 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-de-origen-comunitario-c023ddcd 2026-03-26 https://revespquimioterapia.com/articulo/optimizacion-farmacodinamica-de-la-administracion--c1b01d4d 2026-03-26 https://revespquimioterapia.com/articulo/microbiologos-espanoles-en-los-ultimos-60-anos-5532ddd7 2026-03-26 https://revespquimioterapia.com/articulo/actualizacion-sobre-el-tratamiento-de-las-infeccio-ffebdb10 2026-03-26 https://revespquimioterapia.com/articulo/actividad-comparada-in-vitro-de-la-josamicina-sobr-917b2687 2026-03-26 https://revespquimioterapia.com/articulo/hpv-genotype-distribution-among-women-with-normal--891869fb 2026-03-26 https://revespquimioterapia.com/articulo/current-approach-to-skin-and-soft-tissue-infection-93f035a4 2026-03-26 https://revespquimioterapia.com/articulo/resistencias-del-vih-1-a-los-antirretrovirales-en--5f8bf699 2026-03-26 https://revespquimioterapia.com/articulo/situacion-actual-del-tratamiento-farmacologico-fre-a339f8e2 2026-03-26 https://revespquimioterapia.com/articulo/absceso-esplenico-relacionado-con-bacteriemia-por--1f835bad 2026-03-26 https://revespquimioterapia.com/articulo/streptococcus-pneumoniae-resistente-570a2ccb 2026-03-26 https://revespquimioterapia.com/articulo/relacion-entre-sensibilidad-antibiotica-y-factores-4dddf661 2026-03-26 https://revespquimioterapia.com/articulo/sepsis-por-capnocytophaga-canimorsus-en-un-pacient-46eb5ae5 2026-03-26 https://revespquimioterapia.com/articulo/real-life-experience-of-hepatitis-c-treatment-in-a-1f42f3d3 2026-03-26 https://revespquimioterapia.com/articulo/resultados-de-la-implantacion-de-un-programa-de-op-252fd6e7 2026-03-26 https://revespquimioterapia.com/articulo/turicella-otitidis-aportaciones-a-su-posible-papel-3190b5e6 2026-03-26 https://revespquimioterapia.com/articulo/daptomycin-eosinophilic-pneumonia-an-adverse-effec-1e8cf2d2 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-de-la-pcr-multiple-filmarray-blood-cultur-1d9bf9f4 2026-03-26 https://revespquimioterapia.com/articulo/monkeypox-in-humans-a-new-outbreak-27595f67 2026-03-26 https://revespquimioterapia.com/articulo/retrospective-diagnosis-of-lymphatic-tuberculosis--a9a8a817 2026-03-26 https://revespquimioterapia.com/articulo/covid-in-pediatric-age-an-opinion-paper-2d0d4b3c 2026-03-26 https://revespquimioterapia.com/articulo/grangrena-de-fournier-secundaria-a-un-absceso-ingu-b08482d1 2026-03-26 https://revespquimioterapia.com/articulo/identificacion-rapida-en-cultivos-liquidos-del-com-164baefc 2026-03-26 https://revespquimioterapia.com/articulo/dispensacion-y-coste-de-antimicrobianos-en-espana--fe5f9522 2026-03-26 https://revespquimioterapia.com/articulo/poder-diagnostico-de-infeccion-bacteriana-de-liais-b6197ec3 2026-03-26 https://revespquimioterapia.com/articulo/recomendaciones-del-grupo-mensura-para-la-seleccio-c8b32706 2026-03-26 https://revespquimioterapia.com/articulo/primer-caso-de-reinfeccion-confirmada-por-sars-cov-8652d00a 2026-03-26 https://revespquimioterapia.com/articulo/prostatitis-bacteriana-cronica-con-diagnostico-mic-f1ec43cb 2026-03-26 https://revespquimioterapia.com/articulo/parto-prematuro-y-colonizacion-por-ureaplasma-parv-d7ec52ee 2026-03-26 https://revespquimioterapia.com/articulo/tincion-de-gram-de-los-hemocultivos-de-un-paciente-5198df76 2026-03-26 https://revespquimioterapia.com/articulo/severe-mucor-necrotizing-fasciitis-associated-to-d-74e8b90d 2026-03-26 https://revespquimioterapia.com/articulo/overview-of-virus-and-cancer-relationships-positio-3611afb7 2026-03-26 https://revespquimioterapia.com/articulo/actividad-del-voriconazol-sobre-levaduras-aisladas-66d466bd 2026-03-26 https://revespquimioterapia.com/articulo/celulitis-abscesificada-por-streptococcus-pneumoni-6890e728 2026-03-26 https://revespquimioterapia.com/articulo/tendremos-nuevos-antibioticos-1ba21a59 2026-03-26 https://revespquimioterapia.com/articulo/metodologia-de-la-investigacion-una-garantia-para--67e82cfe 2026-03-26 https://revespquimioterapia.com/articulo/anidulafungina-23c49c55 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-de-meningitis-encefalitis-en-uci-con-s-a8433d3e 2026-03-26 https://revespquimioterapia.com/articulo/efecto-antipseudomonico-de-los-macrolidos-experien-3171a6e9 2026-03-26 https://revespquimioterapia.com/articulo/air-pollution-and-health-prevention-a-document-of--95abbba5 2026-03-26 https://revespquimioterapia.com/articulo/optimized-identification-of-microorganisms-directl-b40f4bdc 2026-03-26 https://revespquimioterapia.com/articulo/dalbavancin-treatment-of-methicillin-susceptible-s-14db6f5c 2026-03-26 https://revespquimioterapia.com/articulo/disseminated-aspergillosis-in-an-immunocompetent-p-e61f3332 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-de-serotipos-causantes-de-enfermedad-n-8b8af3e6 2026-03-26 https://revespquimioterapia.com/articulo/terapia-antimicrobiana-y-medicina-basada-en-la-evi-3ce0be31 2026-03-26 https://revespquimioterapia.com/articulo/la-vacunacion-frente-al-neumococo-en-adultos-7c376a76 2026-03-26 https://revespquimioterapia.com/articulo/impacto-del-virus-gripal-tipo-b-y-divergencia-con--6bcba288 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-spanish-public-health-measures-on-emerge-4129dfae 2026-03-26 https://revespquimioterapia.com/articulo/definiendo-nuevos-escenarios-terapeuticos-para-ori-135d6d43 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-en-enterobacterias-uropatogenas-produ-781d0a7e 2026-03-26 https://revespquimioterapia.com/articulo/is-mycobacterium-shimoidei-an-under-recognized-cau-2b728355 2026-03-26 https://revespquimioterapia.com/articulo/factores-predictivos-de-neumonia-en-pacientes-infe-4d000494 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-y-utilidad-de-los-metodos-e-test-r-y-ne-22fbc040 2026-03-26 https://revespquimioterapia.com/articulo/dalbavancina-como-tratamiento-antibiotico-supresor-261529a4 2026-03-26 https://revespquimioterapia.com/articulo/useful-independent-factors-for-distinguish-infecti-391eeaf3 2026-03-26 https://revespquimioterapia.com/articulo/epidemiologia-y-clinica-de-las-infecciones-y-colon-cb9ed428 2026-03-26 https://revespquimioterapia.com/articulo/clinical-features-and-outcomes-of-aspiration-pneum-649e4db1 2026-03-26 https://revespquimioterapia.com/articulo/peritonitis-primaria-por-streptococcus-pyogenes-eabf26b7 2026-03-26 https://revespquimioterapia.com/articulo/vulnerability-to-sars-cov-2-infection-and-disease--575d1d7f 2026-03-26 https://revespquimioterapia.com/articulo/tendencia-de-sensibilidad-de-los-patogenos-bacteri-a7b37caa 2026-03-26 https://revespquimioterapia.com/articulo/impacto-de-la-bacteriemia-por-staphylococcus-aureu-0ea3aa99 2026-03-26 https://revespquimioterapia.com/articulo/comparacion-entre-el-sistema-phoenix-y-metodos-bas-a771865d 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-de-los-serotipos-de-salmonella-spp-y-su--f69fd3c6 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-en-mycobacterium-tuberculosis-durante--37513aad 2026-03-26 https://revespquimioterapia.com/articulo/recommendations-for-the-diagnosis-and-treatment-of-0f9cafa6 2026-03-26 https://revespquimioterapia.com/articulo/aplicabilidad-de-las-nuevas-tecnicas-de-diagnostic-7b9c1079 2026-03-26 https://revespquimioterapia.com/articulo/the-situation-of-infection-in-the-elderly-in-spain-906af93b 2026-03-26 https://revespquimioterapia.com/articulo/osteoarticular-tuberculosis-of-the-hip-and-soft-ti-cbd9da87 2026-03-26 https://revespquimioterapia.com/articulo/distribucion-de-los-patrones-de-sensibilidad-de-es-a410fa1f 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemias-por-burkholderia-cepacia-analisis-pro-2a905c8d 2026-03-26 https://revespquimioterapia.com/articulo/aislamientos-de-turicella-otitidis-en-exudados-oti-26c560bd 2026-03-26 https://revespquimioterapia.com/articulo/prognostic-value-of-static-and-dynamic-biomarkers--6fd707e1 2026-03-26 https://revespquimioterapia.com/articulo/secondary-infections-in-mechanically-ventilated-pa-8e2b96b4 2026-03-26 https://revespquimioterapia.com/articulo/progression-of-subclinical-cardiovascular-disease--3314cc17 2026-03-26 https://revespquimioterapia.com/articulo/importancia-de-la-autopsia-forense-en-el-diagnosti-5d4dafd3 2026-03-26 https://revespquimioterapia.com/articulo/bacteroides-mobilizable-and-conjugative-genetic-el-81817dec 2026-03-26 https://revespquimioterapia.com/articulo/controversies-in-the-management-of-esbl-producing--5ad687a3 2026-03-26 https://revespquimioterapia.com/articulo/antibioterapia-profilactica-en-la-artroplastia-de--ad27d97f 2026-03-26 https://revespquimioterapia.com/articulo/a-rare-case-of-pleural-infection-due-to-propioniba-8ff2350d 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-antibiotico-empirico-inicial-de-la-neu-230ee8d3 2026-03-26 https://revespquimioterapia.com/articulo/es-util-la-estratificacion-de-la-sensibilidad-anti-9c46a10a 2026-03-26 https://revespquimioterapia.com/articulo/determination-of-a-cutoff-value-for-medication-reg-e3df5fc5 2026-03-26 https://revespquimioterapia.com/articulo/meningococcal-meningitis-in-spain-in-the-horizon-2-9d058adb 2026-03-26 https://revespquimioterapia.com/articulo/cefditoren-pivoxilo-una-nueva-cefalosporina-oral-p-6871ebe2 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-linezolid-en-combinacion-con-81f5ec1d 2026-03-26 https://revespquimioterapia.com/articulo/peritonitis-caused-by-blastomonas-natatoria-in-a-p-fc6e4b5e 2026-03-26 https://revespquimioterapia.com/articulo/aislamiento-de-turicella-otitidis-en-el-contexto-d-65604f40 2026-03-26 https://revespquimioterapia.com/articulo/new-variants-of-sars-cov-2-e0981add 2026-03-26 https://revespquimioterapia.com/articulo/sindrome-de-cola-de-caballo-en-paciente-vih-0571d5fe 2026-03-26 https://revespquimioterapia.com/articulo/why-not-revising-tinidazole-as-potential-treatment-985fadf0 2026-03-26 https://revespquimioterapia.com/articulo/historical-evolution-of-the-diseases-caused-by-non-b3d10cc1 2026-03-26 https://revespquimioterapia.com/articulo/mycoplasma-genitalium-en-atencion-primaria-prevale-b92faa68 2026-03-26 https://revespquimioterapia.com/articulo/introduction-of-a-complementary-screening-system-f-1ff65edf 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-emergente-por-moraxella-osloensis-a-prop-327f991d 2026-03-26 https://revespquimioterapia.com/articulo/aumento-de-las-infecciones-por-virus-del-herpes-si-1dc754bc 2026-03-26 https://revespquimioterapia.com/articulo/ulcera-gastrica-por-citomegalovirus-en-paciente-co-36b465d4 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-infecciones-causadas-por-enterobact-49426b3d 2026-03-26 https://revespquimioterapia.com/articulo/infecciones-profundas-por-gardnerella-vaginalis-en-d30074ee 2026-03-26 https://revespquimioterapia.com/articulo/reverse-transcriptase-and-protease-inhibitors-muta-47d46562 2026-03-26 https://revespquimioterapia.com/articulo/variabilidad-entre-areas-sanitarias-en-el-consumo--9529ae9d 2026-03-26 https://revespquimioterapia.com/articulo/enfermedad-pelvica-inflamatoria-por-streptococcus--1d75ed93 2026-03-26 https://revespquimioterapia.com/articulo/treatment-of-clostridioides-difficile-infection-fr-4eb221f9 2026-03-26 https://revespquimioterapia.com/articulo/el-regreso-al-futuro-10-anos-despues-e9ec97e7 2026-03-26 https://revespquimioterapia.com/articulo/patogenos-hospitalarios-multirresistentes-0cf04328 2026-03-26 https://revespquimioterapia.com/articulo/rapida-adquisicion-de-resistencia-in-vitro-al-erta-b1d60897 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-de-gripe-confirmada-microbiologicament-500de7af 2026-03-26 https://revespquimioterapia.com/articulo/actualizacion-terapeutica-en-la-hepatitis-c-a9b72575 2026-03-26 https://revespquimioterapia.com/articulo/update-on-management-of-invasive-candidiasis-7dc74b9f 2026-03-26 https://revespquimioterapia.com/articulo/fascitis-necrotizante-y-sindrome-del-shock-toxico--8e9bf237 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-1-55-56-b4cb4d6d 2026-03-26 https://revespquimioterapia.com/articulo/el-codigo-postal-como-codigo-de-barras-de-las-resi-80442cae 2026-03-26 https://revespquimioterapia.com/articulo/vigilancia-de-la-resistencia-a-los-antibioticos-en-9e0758ea 2026-03-26 https://revespquimioterapia.com/articulo/betalactamasas-de-espectro-extendido-en-aumento-b442e54d 2026-03-26 https://revespquimioterapia.com/articulo/la-produccion-cientifica-espanola-en-antimicrobian-6ece1783 2026-03-26 https://revespquimioterapia.com/articulo/a-case-of-otitis-externa-caused-by-non-01-non-0139-77ede2a4 2026-03-26 https://revespquimioterapia.com/articulo/es-posible-la-curacion-de-la-infeccion-vih-aec93895 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-linezolid-moxifloxacino-levo-46664b7b 2026-03-26 https://revespquimioterapia.com/articulo/indicaciones-clinicas-de-la-monitorizacion-de-azol-1d3a03f9 2026-03-26 https://revespquimioterapia.com/articulo/booster-or-additional-vaccination-doses-in-patient-9a891d08 2026-03-26 https://revespquimioterapia.com/articulo/profilaxis-antibiotica-en-la-ecocardiografia-trans-77b43cfc 2026-03-26 https://revespquimioterapia.com/articulo/evolution-de-extractos-de-esponjas-marinas-como-nu-fddebd03 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-con-voriconazol-de-las-infecciones-fun-9e81a4b4 2026-03-26 https://revespquimioterapia.com/articulo/context-and-relevance-of-antimicrobial-resistance-in-gram-negative-bacilli-29983 2026-03-26 https://revespquimioterapia.com/articulo/ams-1785242526-269369 2026-03-26 https://revespquimioterapia.com/articulo/aneurisma-micotico-de-aorta-abdominal-por-listeria-d3facaf7 2026-03-26 https://revespquimioterapia.com/articulo/mecanismos-de-resistencia-a-combinaciones-de-betal-b7fea9ba 2026-03-26 https://revespquimioterapia.com/articulo/secondary-lumbosacral-echinococcosis-as-presumptiv-ff17ea37 2026-03-26 https://revespquimioterapia.com/articulo/herpes-zoster-complicated-with-aseptic-meningitis--59b9f465 2026-03-26 https://revespquimioterapia.com/articulo/colonial-architecture-and-growth-dynamics-of-staph-3a169f31 2026-03-26 https://revespquimioterapia.com/articulo/eficacia-efectividad-y-seguridad-de-la-vacuna-anti-c60a241d 2026-03-26 https://revespquimioterapia.com/articulo/capnocytophaga-canimorsus-como-causa-de-sepsis-y-m-9a0f3649 2026-03-26 https://revespquimioterapia.com/articulo/tercer-documento-de-consenso-sobre-el-uso-de-antim-7811f42d 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-de-la-resistencia-primaria-de-helicoba-212dbc0e 2026-03-26 https://revespquimioterapia.com/articulo/nuevos-modelos-predictivos-de-bacteriemia-en-el-se-62bc0120 2026-03-26 https://revespquimioterapia.com/articulo/empleo-de-antibioticos-en-veterinaria-c7377943 2026-03-26 https://revespquimioterapia.com/articulo/human-intestinal-microbiome-role-in-health-and-dis-7c30b9a6 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-inhibidores-de-betalactamasas-frente--20d262d3 2026-03-26 https://revespquimioterapia.com/articulo/factores-a-considerar-en-el-analisis-de-la-prescri-ab3d414b 2026-03-26 https://revespquimioterapia.com/articulo/comparacion-de-tres-metodos-genotipicos-para-la-de-afa3e901 2026-03-26 https://revespquimioterapia.com/articulo/meropenem-otras-indicaciones-meningitis-sepsis-pie-8d107ad6 2026-03-26 https://revespquimioterapia.com/articulo/experiancia-clinica-con-meropenem-en-el-tratamient-3b4a2a65 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-metodos-fenotipicos-para-la-deteccio-df3c561f 2026-03-26 https://revespquimioterapia.com/articulo/covid-19-en-pacientes-espanoles-e-inmigrantes-en-u-6c02662c 2026-03-26 https://revespquimioterapia.com/articulo/descripcion-de-una-supresion-en-el-gen-blatem-b65f4695 2026-03-26 https://revespquimioterapia.com/articulo/shigelosis-atendidas-en-el-servicio-de-urgencias-d-091a58fe 2026-03-26 https://revespquimioterapia.com/articulo/consumo-de-antibioticos-en-jovenes-espanoles-d6c6e920 2026-03-26 https://revespquimioterapia.com/articulo/reactivacion-del-sindrome-periodico-asociado-a-cri-ac1b7327 2026-03-26 https://revespquimioterapia.com/articulo/estudio-multicentrico-nacional-de-la-actividad-in--b80eb492 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-suppl-2-9-12-aecfe782 2026-03-26 https://revespquimioterapia.com/articulo/revision-exploratoria-sobre-series-de-casos-de-cor-6e27351a 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-prevalencia-de-la-infeccion-urinaria-en-ee0c9277 2026-03-26 https://revespquimioterapia.com/articulo/mesa-redonda-1-valoracion-in-vitro-de-los-antifung-1d683b93 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-neumococica-en-pacientes-adultos-de-un-fa984291 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-sepsis-flow-chip-a-novelty-fast-microbio-ca1ff4c1 2026-03-26 https://revespquimioterapia.com/articulo/first-clinical-isolate-in-europe-of-clindamycin-re-87c38485 2026-03-26 https://revespquimioterapia.com/articulo/poder-pronostico-de-mortalidad-a-corto-plazo-del-r-bf253173 2026-03-26 https://revespquimioterapia.com/articulo/direct-hemoperfusion-with-polymyxin-b-immobilized--d789792c 2026-03-26 https://revespquimioterapia.com/articulo/absceso-por-clostridium-perfringens-en-usuario-de--4736460b 2026-03-26 https://revespquimioterapia.com/articulo/documento-de-consenso-sobre-tratamiento-antimicrob-f5e743ea 2026-03-26 https://revespquimioterapia.com/articulo/otitis-externa-por-turicella-otitidis-a-proposito--5e1dff6a 2026-03-26 https://revespquimioterapia.com/articulo/mesa-redonda-4-mecanismos-moleculares-de-resistenc-441676da 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-de-marcapasos-por-mycobacterium-neoaurum-7252d71b 2026-03-26 https://revespquimioterapia.com/articulo/economic-burden-of-skin-and-skin-structure-infecti-47ded602 2026-03-26 https://revespquimioterapia.com/articulo/current-aspects-in-sepsis-approach-turning-things--f3b223d9 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-la-sensibilidad-de-streptococcus-pneumo-6d7e777d 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemias-por-staphylococcus-coagulasa-negativa-abeccb68 2026-03-26 https://revespquimioterapia.com/articulo/piperacilina-utilizacion-en-un-hospital-general-217512c2 2026-03-26 https://revespquimioterapia.com/articulo/impacto-de-la-vacunacion-neumococica-de-polisacari-ac0976d9 2026-03-26 https://revespquimioterapia.com/articulo/impacto-ecologico-del-tratamiento-antibiotico-de-l-15b3c998 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-4-226-227-4e411d18 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-temporal-de-las-variantes-de-sars-cov-2--991cf347 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-de-la-amfotericina-b-liposomal-para-la-pr-566d1f36 2026-03-26 https://revespquimioterapia.com/articulo/limitations-of-currently-available-chagas-disease--9c022c8b 2026-03-26 https://revespquimioterapia.com/articulo/microorganismos-aislados-de-muestras-de-orina-proc-6f54acf4 2026-03-26 https://revespquimioterapia.com/articulo/determinacion-de-la-concentracion-preventiva-de-mu-f0e8297c 2026-03-26 https://revespquimioterapia.com/articulo/quimioprofilaxis-en-cirugia-46262d3d 2026-03-26 https://revespquimioterapia.com/articulo/afectacion-articular-y-muscular-secundaria-a-levof-03cf1e64 2026-03-26 https://revespquimioterapia.com/articulo/decreased-painful-visual-acuity-corynebacterium-ma-70c24e3f 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemias-por-staphylococcus-coagulasa-negativa-0008436b 2026-03-26 https://revespquimioterapia.com/articulo/nino-con-lesiones-en-pestanas-en-el-medio-rural-92e2a7bd 2026-03-26 https://revespquimioterapia.com/articulo/fosfomycin-in-the-pediatric-setting-evidence-and-p-17d813ae 2026-03-26 https://revespquimioterapia.com/articulo/el-cateter-periferico-el-gran-olvidado-de-la-infec-bd94b0ab 2026-03-26 https://revespquimioterapia.com/articulo/postantifungal-effect-of-anidulafungin-against-can-384c211c 2026-03-26 https://revespquimioterapia.com/articulo/situacion-epidemiologica-de-la-tuberculosis-en-la--0d888151 2026-03-26 https://revespquimioterapia.com/articulo/staphylococcus-aureus-resistente-a-la-meticilina-p-7bb69819 2026-03-26 https://revespquimioterapia.com/articulo/comparacion-de-la-calidad-de-vida-en-personas-que--b21d015d 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-una-cohorte-de-pacientes-con-bacteriemi-425cccd5 2026-03-26 https://revespquimioterapia.com/articulo/perfil-de-sensibilidad-antifungica-in-vitro-de-sco-e3a01449 2026-03-26 https://revespquimioterapia.com/articulo/experiencia-de-micafungina-en-pacientes-con-tecnic-8208fe4a 2026-03-26 https://revespquimioterapia.com/articulo/possible-clinical-indications-of-ceftobiprole-f130de1f 2026-03-26 https://revespquimioterapia.com/articulo/guia-de-tratamiento-antimicrobiano-de-la-infeccion-556275ce 2026-03-26 https://revespquimioterapia.com/articulo/ajuste-posologico-de-linezolid-por-interaccion-con-929528ab 2026-03-26 https://revespquimioterapia.com/articulo/antimicrobial-stewardship-programs-in-emergency-de-a2bbe7f5 2026-03-26 https://revespquimioterapia.com/articulo/valoracion-del-interrogatorio-de-la-alergia-a-anti-7b9fb2a1 2026-03-26 https://revespquimioterapia.com/articulo/precision-diagnostica-de-la-procalcitonina-para-la-934a9d59 2026-03-26 https://revespquimioterapia.com/articulo/recomendaciones-del-tratamiento-antifungico-en-pac-9ab3355b 2026-03-26 https://revespquimioterapia.com/articulo/refractory-enterobius-vermicularis-infection-in-an-8ffa3989 2026-03-26 https://revespquimioterapia.com/articulo/rapid-ast-possibility-of-inferring-resistance-mech-27101b96 2026-03-26 https://revespquimioterapia.com/articulo/coste-de-la-infeccion-en-la-epoc-c3ef2e89 2026-03-26 https://revespquimioterapia.com/articulo/increased-severity-in-sars-cov-2-infection-of-mino-a3912b48 2026-03-26 https://revespquimioterapia.com/articulo/los-betalactamicos-en-la-clinica-practica-08b54add 2026-03-26 https://revespquimioterapia.com/articulo/aportacion-de-los-azoles-de-segunda-generacion-en--62ef8aa8 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-a-carbapenemes-por-metaloenzimas-en-ai-e4ff8d0a 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-antibiotico-empirico-inicial-de-la-neu-44cc05c1 2026-03-26 https://revespquimioterapia.com/articulo/metaanalisis-de-la-claritromicina-comparada-con-ot-76fae670 2026-03-26 https://revespquimioterapia.com/articulo/el-nacimiento-del-mayor-invento-del-siglo-xx-47fea3ed 2026-03-26 https://revespquimioterapia.com/articulo/fecal-microbiota-transplantation-for-recurrent-clo-303c2f46 2026-03-26 https://revespquimioterapia.com/articulo/errores-en-el-uso-de-antimicrobianos-la-epidemia-s-79bd1935 2026-03-26 https://revespquimioterapia.com/articulo/primer-brote-de-clostridioides-difficile-ribotipo--73393170 2026-03-26 https://revespquimioterapia.com/articulo/puntos-de-corte-farmacodinamicos-en-el-diseno-de-r-da9e8601 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-terapia-combinada-con-colist-ea4b1b95 2026-03-26 https://revespquimioterapia.com/articulo/analisis-de-la-demanda-de-deteccion-de-sars-cov-2--ce0e5efa 2026-03-26 https://revespquimioterapia.com/articulo/primer-aislamiento-clinico-de-mycobacterium-iranic-1eee30c1 2026-03-26 https://revespquimioterapia.com/articulo/analisis-farmacoeconomico-del-tratamiento-de-la-ba-e4fc2cce 2026-03-26 https://revespquimioterapia.com/articulo/rapid-techniques-for-therapeutic-optimization-diag-613e9ea1 2026-03-26 https://revespquimioterapia.com/articulo/meropenem-experiencia-clinica-en-el-paciente-neutr-ab3ace43 2026-03-26 https://revespquimioterapia.com/articulo/abscesos-intraperitoneales-por-eikenella-corrodens-7e60bc8d 2026-03-26 https://revespquimioterapia.com/articulo/vigilancia-de-la-evolucion-de-la-flora-comensal-y--19183331 2026-03-26 https://revespquimioterapia.com/articulo/impacto-de-la-cirugia-en-la-mortalidad-de-la-endoc-124b1a33 2026-03-26 https://revespquimioterapia.com/articulo/perspectivas-terapeuticas-actuales-de-la-sepsis-c86960f4 2026-03-26 https://revespquimioterapia.com/articulo/efecto-de-los-nuevos-antifungicos-en-la-etiologia--e4cb38b3 2026-03-26 https://revespquimioterapia.com/articulo/analisis-mediante-curvas-roc-de-los-factores-predi-5a679ea7 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-de-staphylococcus-aureus-portadores-de-d8e44f8c 2026-03-26 https://revespquimioterapia.com/articulo/staphylococcus-aureus-infections-and-factors-assoc-73ccff7d 2026-03-26 https://revespquimioterapia.com/articulo/cambio-en-la-dosificacion-de-colistimetato-sodico--a1dc2324 2026-03-26 https://revespquimioterapia.com/articulo/guidelines-for-the-management-of-community-acquire-84308945 2026-03-26 https://revespquimioterapia.com/articulo/risk-of-severe-covid-in-solid-organ-transplant-rec-c9fa67b8 2026-03-26 https://revespquimioterapia.com/articulo/casos-de-hidatidosis-en-el-departamento-de-salud-2-f9c8bb24 2026-03-26 https://revespquimioterapia.com/articulo/osteomielitis-polimicrobiana-en-extremidad-de-la-m-5feb423e 2026-03-26 https://revespquimioterapia.com/articulo/correlacion-entre-las-pruebas-de-sensibilidad-in-v-00dbf106 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-antibiotica-en-cepas-clinicas-de-salmo-36eef7f0 2026-03-26 https://revespquimioterapia.com/articulo/neumonia-neumococica-en-pacientes-con-infeccion-po-07da149d 2026-03-26 https://revespquimioterapia.com/articulo/programas-de-optimizacion-del-uso-de-antimicrobian-301f1b8a 2026-03-26 https://revespquimioterapia.com/articulo/antimicrobial-susceptibility-of-gram-negative-orga-3bb91bed 2026-03-26 https://revespquimioterapia.com/articulo/therapeutic-approach-in-the-critically-ill-patient-with-suspected-multidrug-resistance 2026-03-26 https://revespquimioterapia.com/articulo/criterios-de-sensibilidad-a-los-azoles-94b9ac95 2026-03-26 https://revespquimioterapia.com/articulo/epidemiologia-molecular-de-salmonella-typhimurium--dbb778e4 2026-03-26 https://revespquimioterapia.com/articulo/development-of-a-web-application-for-recording-bac-95acf5cd 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-liposomal-amphotericin-b-on-renal-functi-ad16bc49 2026-03-26 https://revespquimioterapia.com/articulo/advantages-and-disadvantages-of-maintaining-the-ma-0d6829ac 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-a-antimicrobianos-de-los-microorganism-4f0cc565 2026-03-26 https://revespquimioterapia.com/articulo/monitoring-the-antimicrobial-susceptibility-of-gra-5c90da6b 2026-03-26 https://revespquimioterapia.com/articulo/invasion-of-solid-culture-media-a-widespread-pheno-af739b85 2026-03-26 https://revespquimioterapia.com/articulo/current-status-in-outpatient-parenteral-antimicrob-8b87a2f2 2026-03-26 https://revespquimioterapia.com/articulo/bordetella-trematum-como-agente-colonizador-en-ulc-88c1a19f 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-de-herida-por-leptotrichia-goodfellowii--5ed62d80 2026-03-26 https://revespquimioterapia.com/articulo/the-role-of-fosfomycin-in-osteoarticular-infection-ba1dda03 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-oral-hospitalario-de-las-infecciones-d-012c4c58 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-la-actividad-investigadora-en-microb-ce1af2bc 2026-03-26 https://revespquimioterapia.com/articulo/is-it-reasonable-to-perform-fecal-microbiota-trans-d43fd647 2026-03-26 https://revespquimioterapia.com/articulo/cepa-de-escherichia-coli-resistente-a-cefalosporin-56616a10 2026-03-26 https://revespquimioterapia.com/articulo/cambios-en-la-epidemiologia-de-las-gastroenteritis-30a46542 2026-03-26 https://revespquimioterapia.com/articulo/seroprevalence-of-measles-mumps-rubella-and-varice-516c7292 2026-03-26 https://revespquimioterapia.com/articulo/neisseria-meningitidis-mas-alla-de-la-afectacion-d-9201b3af 2026-03-26 https://revespquimioterapia.com/articulo/dosis-unica-diaria-de-aminoglucosidos-2a03da42 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-de-la-region-medial-de-la-pro-adrenomodul-aad21f75 2026-03-26 https://revespquimioterapia.com/articulo/relacion-entre-estructura-y-funcion-en-los-azoles-f8327429 2026-03-26 https://revespquimioterapia.com/articulo/uveitis-complicada-por-scedosporium-apiospermum-se-b3079673 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-prolongado-con-dalbavancina-en-infecci-42ca459d 2026-03-26 https://revespquimioterapia.com/articulo/pacientes-con-inmunizacion-frente-a-sars-cov-2-que-4b833612 2026-03-26 https://revespquimioterapia.com/articulo/hipertension-arterial-no-diagnosticada-en-paciente-8a0ed352 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-de-protesis-articular-por-pseudomonas-st-f5114161 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-one-year-of-pandemic-on-spanish-intensiv-084fda87 2026-03-26 https://revespquimioterapia.com/articulo/biomarkers-of-fungal-infection-expert-opinion-on-t-d62bbef7 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-in-vitro-de-hongos-dematiaceos-a-los--0f8e744d 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-de-protesis-articular-por-clostridioides-1891c16d 2026-03-26 https://revespquimioterapia.com/articulo/vacunacion-y-profilaxis-postexposicion-en-personal-f46c937e 2026-03-26 https://revespquimioterapia.com/articulo/afectacion-hepatica-en-la-listeriosis-considere-un-d3496651 2026-03-26 https://revespquimioterapia.com/articulo/antibiotic-selection-in-the-treatment-of-acute-inv-8c6d26de 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-de-piel-y-partes-blandas-por-streptococc-0a40d73e 2026-03-26 https://revespquimioterapia.com/articulo/covid-19-on-the-threshold-of-the-fifth-year-the-si-789abb32 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-los-antifungicos-en-levaduras-negra-cc897c07 2026-03-26 https://revespquimioterapia.com/articulo/baloxavir-marboxil-un-potente-inhibidor-de-la-endo-666b9b77 2026-03-26 https://revespquimioterapia.com/articulo/artritis-septica-aguda-de-cadera-por-salmonella-en-f50d6f7f 2026-03-26 https://revespquimioterapia.com/articulo/prevencion-de-la-enfermedad-neumococica-invasiva-e-3c174033 2026-03-26 https://revespquimioterapia.com/articulo/revision-y-perspectivas-actuales-de-la-endocarditi-cadec9ef 2026-03-26 https://revespquimioterapia.com/articulo/eumicetomas-por-fusarium-oxysporum-y-madurella-myc-20c885e5 2026-03-26 https://revespquimioterapia.com/articulo/los-medicos-que-disponen-de-pruebas-rapidas-dismin-a8fb704f 2026-03-26 https://revespquimioterapia.com/articulo/baricitinib-en-el-tratamiento-de-infeccion-por-sar-89d459f9 2026-03-26 https://revespquimioterapia.com/articulo/detection-of-bacterial-pathogens-in-sterile-fluids-896bfa8e 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-cutanea-por-bacillus-licheniformis-82c7a8be 2026-03-26 https://revespquimioterapia.com/articulo/update-on-the-use-of-direct-acting-antiviral-agent-b12f6ad2 2026-03-26 https://revespquimioterapia.com/articulo/meningitis-bacteriana-por-streptococcus-pyogenes-e3eb6659 2026-03-26 https://revespquimioterapia.com/articulo/influencia-de-la-protocolizacion-razonada-y-consen-90ae4946 2026-03-26 https://revespquimioterapia.com/articulo/genesis-de-un-virus-pandemico-h1n1-a0083c27 2026-03-26 https://revespquimioterapia.com/articulo/h-erpes-zoster-y-neuralgia-postherpetica-ventajas--3c9d0a93 2026-03-26 https://revespquimioterapia.com/articulo/the-situation-and-management-of-clostridium-diffic-ea5b1d65 2026-03-26 https://revespquimioterapia.com/articulo/strategies-for-the-management-of-invasive-fungal-i-788fcbe7 2026-03-26 https://revespquimioterapia.com/articulo/factors-associated-with-development-of-nephrotoxic-92e00f64 2026-03-26 https://revespquimioterapia.com/articulo/resistance-to-hiv-integrase-strand-transfer-inhibi-c0012b67 2026-03-26 https://revespquimioterapia.com/articulo/una-vacuna-inactivada-para-la-inmunizacion-primari-b4ebad27 2026-03-26 https://revespquimioterapia.com/articulo/influence-of-pharmacist-intervention-based-on-cmo--8ef87eba 2026-03-26 https://revespquimioterapia.com/articulo/retratamiento-con-interferon-mas-ribavirina-en-pac-3eba5a90 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-serologico-de-un-brote-epidemico-de-ne-6e54ec2e 2026-03-26 https://revespquimioterapia.com/articulo/hepatitis-b-fulminante-como-consecuencia-de-reacti-1927b681 2026-03-26 https://revespquimioterapia.com/articulo/antifungicos-la-nueva-frontera-3d166157 2026-03-26 https://revespquimioterapia.com/articulo/efficacy-and-safety-of-outpatient-parenteral-antib-8185ccb9 2026-03-26 https://revespquimioterapia.com/articulo/vacuna-frente-al-covid-19-b3df093c 2026-03-26 https://revespquimioterapia.com/articulo/actividad-fagocitica-y-bactericida-de-los-leucocit-07b30d02 2026-03-26 https://revespquimioterapia.com/articulo/viral-load-in-spanish-hiv-patients-trends-since-th-61b562ec 2026-03-26 https://revespquimioterapia.com/articulo/limitaciones-del-ensayo-xpert-mtb-rif-r-en-el-diag-8c0feab7 2026-03-26 https://revespquimioterapia.com/articulo/consideraciones-sobre-la-infeccion-neumococica-ped-1acc00d7 2026-03-26 https://revespquimioterapia.com/articulo/safety-and-tolerability-of-ceftobiprole-b7d62149 2026-03-26 https://revespquimioterapia.com/articulo/unresolved-issues-in-the-diagnosis-of-catheter-rel-1fd70da3 2026-03-26 https://revespquimioterapia.com/articulo/a-case-report-of-multiple-abscess-co-infected-with-c749e93d 2026-03-26 https://revespquimioterapia.com/articulo/nuevas-vacunas-antineumococicas-mas-alla-del-neumo-6243d317 2026-03-26 https://revespquimioterapia.com/articulo/description-of-carbapenemase-producing-enterobacte-573889fe 2026-03-26 https://revespquimioterapia.com/articulo/variabilidad-en-la-prescripcion-de-antibioticos-en-46bbc183 2026-03-26 https://revespquimioterapia.com/articulo/traqueobronquitis-por-elizabethkingia-meningosepti-e3e159ed 2026-03-26 https://revespquimioterapia.com/articulo/seguridad-de-las-vacunas-antigripales-en-grupos-de-7496e190 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-fungica-en-hematologia-bcae7561 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-la-sensibilidad-in-vitro-de-levaduras-p-77f7bd7c 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-vaccination-on-the-epidemiology-and-prog-4b20deaf 2026-03-26 https://revespquimioterapia.com/articulo/unresolved-issues-in-the-epidemiology-and-diagnosi-b3ab595a 2026-03-26 https://revespquimioterapia.com/articulo/comparacion-de-dos-metodos-para-la-recuperacion-de-9c4c3a34 2026-03-26 https://revespquimioterapia.com/articulo/interferon-free-treatments-in-patients-with-hepati-d82e3dc5 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-los-antimicrobianos-de-micobacteria-0b5842ce 2026-03-26 https://revespquimioterapia.com/articulo/highlights-in-solid-transplant-infectious-diseases-cef635c2 2026-03-26 https://revespquimioterapia.com/articulo/eleccion-de-vacuna-antigripal-en-personas-mayores--6b9e60cf 2026-03-26 https://revespquimioterapia.com/articulo/la-utilidad-clinica-de-los-derivados-triazolicos-e-a8144634 2026-03-26 https://revespquimioterapia.com/articulo/wound-infection-caused-by-pasteurella-canis-and-ne-45385bbd 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-las-infecciones-relacionadas-con-pr-8182860f 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-los-antimicrobianos-de-enterococcus-1c5a318e 2026-03-26 https://revespquimioterapia.com/articulo/proyecto-uriscam-evaluacion-multicentrica-del-cito-7244d492 2026-03-26 https://revespquimioterapia.com/articulo/resultado-falso-negativo-en-diversas-pcr-multiplex-b4b76151 2026-03-26 https://revespquimioterapia.com/articulo/cryptococcal-infection-in-renal-transplant-two-cas-130ae51f 2026-03-26 https://revespquimioterapia.com/articulo/liposomal-formulations-of-amphotericin-b-differenc-21681a37 2026-03-26 https://revespquimioterapia.com/articulo/absceso-hepatico-amebiano-en-paciente-procedente-d-575c8d84 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-de-origen-urinario-por-lactobacillus-d-183c257e 2026-03-26 https://revespquimioterapia.com/articulo/diagnostic-and-therapeutic-approach-to-pulmonary-i-2b727602 2026-03-26 https://revespquimioterapia.com/articulo/estudio-comparativo-de-ingresos-por-covid-19-entre-83e84af5 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-del-hemocultivo-en-la-infeccion-del-tract-96c71d99 2026-03-26 https://revespquimioterapia.com/articulo/eventos-adversos-relacionados-con-la-medicacion-en-00958dfa 2026-03-26 https://revespquimioterapia.com/articulo/atencion-a-los-cambios-6039b846 2026-03-26 https://revespquimioterapia.com/articulo/la-aviumosis-como-infeccion-emergente-y-su-quimiot-eaf7f3e2 2026-03-26 https://revespquimioterapia.com/articulo/diagnostic-accuracy-of-combining-c-reactive-protei-862e8a57 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-de-la-resistencia-a-las-quinolonas-en-sa-9645cda3 2026-03-26 https://revespquimioterapia.com/articulo/actualizacion-en-patologia-infecciosa-2016-2d51c596 2026-03-26 https://revespquimioterapia.com/articulo/mucormicosis-pulmonar-por-cunninghamella-spp-en-pa-11e6b639 2026-03-26 https://revespquimioterapia.com/articulo/peritonitis-por-salmonella-serotipo-albany-en-paci-547e6f07 2026-03-26 https://revespquimioterapia.com/articulo/absceso-periamigdalino-producido-por-actinomyces-m-2e9cd1bd 2026-03-26 https://revespquimioterapia.com/articulo/economic-burden-of-recurrent-clostridioides-diffic-f3b0cbda 2026-03-26 https://revespquimioterapia.com/articulo/epidemiologia-de-la-fiebre-q-en-espana-2018-0163d35d 2026-03-26 https://revespquimioterapia.com/articulo/analisis-de-la-concordancia-del-tratamiento-antibi-20c2ec00 2026-03-26 https://revespquimioterapia.com/articulo/anemia-hemolitica-secundaria-a-rifampicina-en-paci-f822ed3b 2026-03-26 https://revespquimioterapia.com/articulo/estrategias-actuales-en-el-tratamiento-empirico-de-3b2d7d49 2026-03-26 https://revespquimioterapia.com/articulo/endoftalmitis-endogena-como-primera-manifestacion--3f0f3e9c 2026-03-26 https://revespquimioterapia.com/articulo/identificacion-y-sensibilidad-antifungica-in-vitro-625ba30d 2026-03-26 https://revespquimioterapia.com/articulo/carga-viral-y-antigenemia-de-citomegalovirus-en-la-6a2a5483 2026-03-26 https://revespquimioterapia.com/articulo/symposium-10-avances-en-vacunas-f4400091 2026-03-26 https://revespquimioterapia.com/articulo/es-la-cuantificacion-del-biofilm-un-elemento-difer-d42a825a 2026-03-26 https://revespquimioterapia.com/articulo/dalbavancin-was-effective-and-safe-after-one-year--fc84c1dd 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-e-infeccion-del-cateter-vascular-en-el-081ceb95 2026-03-26 https://revespquimioterapia.com/articulo/una-simple-celulitis-tras-podar-el-jardin-a-propos-270a2d85 2026-03-26 https://revespquimioterapia.com/articulo/a-systematic-review-on-extensively-drug-resistant--fda5a703 2026-03-26 https://revespquimioterapia.com/articulo/ertapenem-therapy-for-pneumonia-requiring-hospital-7200d1c4 2026-03-26 https://revespquimioterapia.com/articulo/betalactamasas-de-espectro-extendido-en-cepas-de-e-e1466319 2026-03-26 https://revespquimioterapia.com/articulo/respuesta-a-evolucion-de-la-cobertura-de-serotipos-f32c6cc5 2026-03-26 https://revespquimioterapia.com/articulo/periprosthetic-joint-infection-caused-by-haemophil-44ec482e 2026-03-26 https://revespquimioterapia.com/articulo/analisis-farmacoeconomico-del-tratamiento-de-la-ne-7950b4ab 2026-03-26 https://revespquimioterapia.com/articulo/absceso-cerebral-por-nocardia-en-paciente-diagnost-24d82a15 2026-03-26 https://revespquimioterapia.com/articulo/el-papel-de-la-reparacion-de-roturas-de-doble-cade-91b517e9 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-de-la-resistencia-antimicrobiana-y-morta-e8c805bb 2026-03-26 https://revespquimioterapia.com/articulo/treatment-of-infections-caused-by-carbapenemase-pr-638ca42d 2026-03-26 https://revespquimioterapia.com/articulo/top-ten-infections-in-onco-hematological-patients--e7e430c8 2026-03-26 https://revespquimioterapia.com/articulo/seguimiento-prospectivo-de-los-resultados-del-trat-62ca9c39 2026-03-26 https://revespquimioterapia.com/articulo/sospecha-de-artritis-bacteriana-en-paciente-vih-a5f4dfd3 2026-03-26 https://revespquimioterapia.com/articulo/endocarditis-infecciosa-por-kytococcus-schroeteri--f1badea0 2026-03-26 https://revespquimioterapia.com/articulo/in-vitro-activity-of-retapamulin-against-linezolid-40bfce2a 2026-03-26 https://revespquimioterapia.com/articulo/brote-de-salmonella-typhimurium-monofasica-asociad-83f86e37 2026-03-26 https://revespquimioterapia.com/articulo/epidemiologia-de-la-diseminacion-de-enterobacteria-dcb9913f 2026-03-26 https://revespquimioterapia.com/articulo/seroprevalencia-del-virus-de-la-hepatitis-e-en-pac-8b665fe3 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-diferencial-de-la-neumonia-en-los-tiem-af35f87e 2026-03-26 https://revespquimioterapia.com/articulo/experiencia-clinica-sobre-un-caso-de-osteomielitis-ffb4ecc3 2026-03-26 https://revespquimioterapia.com/articulo/vitamin-c-and-thiamine-for-the-treatment-of-refrac-4192e22a 2026-03-26 https://revespquimioterapia.com/articulo/what-happened-to-microbiological-diagnosis-in-2020-eb5ef6cd 2026-03-26 https://revespquimioterapia.com/articulo/vaccination-of-pregnant-women-in-the-valencian-com-e159f0d9 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-suppl-2-13-16-6bc31d70 2026-03-26 https://revespquimioterapia.com/articulo/comparacion-de-la-eficacia-de-quinupristina-dalfop-04159d9d 2026-03-26 https://revespquimioterapia.com/articulo/diarrea-asociada-a-helicobacter-pullorum-en-un-nin-8ed9251e 2026-03-26 https://revespquimioterapia.com/articulo/neutralizing-antibodies-for-sars-cov-2-infection-15071b9e 2026-03-26 https://revespquimioterapia.com/articulo/human-papillomavirus-in-the-region-of-la-ribera-va-02b0b816 2026-03-26 https://revespquimioterapia.com/articulo/efficacy-and-safety-of-caspofungin-in-critically-i-d07a4fe9 2026-03-26 https://revespquimioterapia.com/articulo/cytomegalovirus-reactivation-in-patients-diagnosed-98abf4af 2026-03-26 https://revespquimioterapia.com/articulo/decalogue-for-the-selection-of-oral-antibiotics-fo-8780db57 2026-03-26 https://revespquimioterapia.com/articulo/new-treatments-for-multidrug-resistant-non-ferment-3a20dd05 2026-03-26 https://revespquimioterapia.com/articulo/distintos-mecanismos-de-resistencia-asociados-a-in-7127d1aa 2026-03-26 https://revespquimioterapia.com/articulo/canaliculitis-por-mycobacterium-abscessus-subsp-ab-4ad52a12 2026-03-26 https://revespquimioterapia.com/articulo/real-life-use-of-remdesivir-in-hospitalized-patien-fc6ad2e6 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-2-131-133-4301cfb7 2026-03-26 https://revespquimioterapia.com/articulo/los-bacteriofagos-y-sus-productos-genicos-como-age-69d777bd 2026-03-26 https://revespquimioterapia.com/articulo/enfermedad-por-virus-ebola-una-vision-global-19cc08f5 2026-03-26 https://revespquimioterapia.com/articulo/aplicabilidad-de-los-parametros-pk-pd-de-los-antim-9e341de8 2026-03-26 https://revespquimioterapia.com/articulo/therapeutic-strategy-in-the-transplanted-patients-f8ed5505 2026-03-26 https://revespquimioterapia.com/articulo/usefulness-of-filmarray-meningitis-encephalitis-pa-9f793e36 2026-03-26 https://revespquimioterapia.com/articulo/marcadores-serologicos-de-gestantes-espanolas-e-in-d8fafd8b 2026-03-26 https://revespquimioterapia.com/articulo/meropenem-15-anos-de-eficacia-y-seguridad-a5ef8d1c 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-the-implementation-of-a-sepsis-code-prog-ed01af8f 2026-03-26 https://revespquimioterapia.com/articulo/situacion-de-la-cefalosporina-oral-de-tercera-gene-13287748 2026-03-26 https://revespquimioterapia.com/articulo/el-indice-cd64-como-marcador-de-infeccion-en-pacie-87d748b1 2026-03-26 https://revespquimioterapia.com/articulo/la-infeccion-congenita-por-citomegalovirus-es-mas--8c6160c9 2026-03-26 https://revespquimioterapia.com/articulo/neumonia-fatal-por-streptococcus-pyogenes-en-pacie-b5392951 2026-03-26 https://revespquimioterapia.com/articulo/absceso-cerebral-por-eikenella-corroden-s-como-com-cc2f6673 2026-03-26 https://revespquimioterapia.com/articulo/aspectos-epidemiologicos-y-de-manejo-clinico-relat-2958a6be 2026-03-26 https://revespquimioterapia.com/articulo/antimicrobial-susceptibility-trends-and-evolution--27746b3a 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-distintos-antimicrobianos-frente-a-st-01faad1e 2026-03-26 https://revespquimioterapia.com/articulo/descripcion-de-la-epidemia-estacional-por-gripe-b--4d9db73a 2026-03-26 https://revespquimioterapia.com/articulo/urinary-tract-infection-in-the-oldest-old-a-work-o-37b60f90 2026-03-26 https://revespquimioterapia.com/articulo/analisis-de-los-tratamientos-utilizados-en-las-inf-8d172065 2026-03-26 https://revespquimioterapia.com/articulo/highlights-from-9th-conference-on-hiv-science-from-822bac9a 2026-03-26 https://revespquimioterapia.com/articulo/estan-los-aspirantes-a-farmaceutico-interno-reside-dbb31cfe 2026-03-26 https://revespquimioterapia.com/articulo/fake-imported-tropical-diseases-a-retrospective-st-f7942eed 2026-03-26 https://revespquimioterapia.com/articulo/disminucion-de-la-actividad-bactericida-del-ciprof-801c7465 2026-03-26 https://revespquimioterapia.com/articulo/pleural-effusion-due-to-parvimonas-micra-a-case-re-d9e24438 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-del-metodo-de-difusion-en-disco-de-30-m-33a56a46 2026-03-26 https://revespquimioterapia.com/articulo/impact-and-control-of-the-covid-pandemic-in-an-eli-c91bf921 2026-03-26 https://revespquimioterapia.com/articulo/artritis-septica-por-pasteurella-multocida-5b0809c3 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-rescate-en-las-infecciones-graves-d-fdd0251c 2026-03-26 https://revespquimioterapia.com/articulo/candiduria-en-pacientes-hospitalizados-etiologia-s-2abb95fa 2026-03-26 https://revespquimioterapia.com/articulo/a-clinical-approach-to-assess-treatment-for-presum-0841c1ff 2026-03-26 https://revespquimioterapia.com/articulo/use-of-linezolid-in-critically-ill-patients-admitt-05a60d67 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-los-antibioticos-orales-frente-a-los--ada6ac84 2026-03-26 https://revespquimioterapia.com/articulo/codigo-sepsis-esquivando-la-mortalidad-en-un-hospi-ba76e82b 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-urinaria-por-shigella-dysenteriae-d18b177d 2026-03-26 https://revespquimioterapia.com/articulo/conocimiento-y-actitud-de-los-medicos-de-atencion--38413b0a 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-nocardiosis-pulmonar-diseminada-4dba75e7 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-del-genero-enterococcus-a-nuevos-anti-930d60b5 2026-03-26 https://revespquimioterapia.com/articulo/fenotipos-y-mecanismos-geneticos-de-resistencia-a--2a1fee56 2026-03-26 https://revespquimioterapia.com/articulo/prophylaxis-of-mould-infections-b5ae81db 2026-03-26 https://revespquimioterapia.com/articulo/espondilodiscitis-por-streptococcus-dysgalactiae-s-9f5addca 2026-03-26 https://revespquimioterapia.com/articulo/dalbavancin-as-consolidation-therapy-for-infective-f0690ccb 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-de-la-resistencia-a-los-antimicrobianos--f1ad490c 2026-03-26 https://revespquimioterapia.com/articulo/combination-antifungal-therapy-a-strategy-for-the--d212f69a 2026-03-26 https://revespquimioterapia.com/articulo/distribucion-del-genotipo-del-virus-de-la-hepatiti-c28705e0 2026-03-26 https://revespquimioterapia.com/articulo/fenotipos-y-mecanismos-de-resistencia-a-macrolidos-f91185c3 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-urinaria-por-lelliottia-amnigena-enterob-94238020 2026-03-26 https://revespquimioterapia.com/articulo/absceso-pancreatico-en-paciente-con-pancreatitis-a-fa6eeb04 2026-03-26 https://revespquimioterapia.com/articulo/consumo-de-antibioticos-en-la-poblacion-general-de-281105a7 2026-03-26 https://revespquimioterapia.com/articulo/concordancia-entre-la-prueba-de-la-tuberculina-y-e-7295b81f 2026-03-26 https://revespquimioterapia.com/articulo/epico-2-0-project-development-of-educational-thera-bec5f2a5 2026-03-26 https://revespquimioterapia.com/articulo/sars-cov-2-infection-presenting-as-acute-acalculou-a393fbe3 2026-03-26 https://revespquimioterapia.com/articulo/discordancia-en-los-resultados-de-sensibilidad-med-c15de157 2026-03-26 https://revespquimioterapia.com/articulo/bugs-hosts-and-icu-environment-countering-pan-resi-3cc39108 2026-03-26 https://revespquimioterapia.com/articulo/infecciones-asociadas-a-enterobacterias-productora-f90fdced 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-de-anticuerpos-frente-a-chlamydophila--7c5768cd 2026-03-26 https://revespquimioterapia.com/articulo/staphylococcus-aureus-resistentes-a-la-meticilina--22c3e2de 2026-03-26 https://revespquimioterapia.com/articulo/endocarditis-infecciosa-por-listeria-monocytogenes-93f47dcb 2026-03-26 https://revespquimioterapia.com/articulo/que-tratamiento-empirico-es-el-mas-adecuado-en-pac-ff627b95 2026-03-26 https://revespquimioterapia.com/articulo/treatment-of-infections-caused-by-multi-resistant--961be2b3 2026-03-26 https://revespquimioterapia.com/articulo/queratitis-por-moraxella-lacunata-a-proposito-de-u-a6680360 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-del-voriconazol-frente-a-levadu-94d466a5 2026-03-26 https://revespquimioterapia.com/articulo/puntos-de-corte-microbiologicos-y-farmacodinamicos-870375c7 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-posaconazol-fluconazol-itrac-259946b6 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-suppl-2-17-19-e3870413 2026-03-26 https://revespquimioterapia.com/articulo/symposium-4-quimioterapia-actual-de-la-tuberculosi-809a465f 2026-03-26 https://revespquimioterapia.com/articulo/efecto-postantibiotico-de-amoxicilina-acido-clavul-5c8cce0e 2026-03-26 https://revespquimioterapia.com/articulo/neumonia-por-burkholderia-cepacia-supone-la-cirros-d7fa7687 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-del-antigeno-galactomanano-y-la-pcr-en--59fde838 2026-03-26 https://revespquimioterapia.com/articulo/tasas-de-colonizacion-por-streptococcus-agalactiae-713598aa 2026-03-26 https://revespquimioterapia.com/articulo/efectos-no-antimicrobianos-de-las-tetraciclinas-18616efa 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-del-e-test-r-y-sus-condiciones-de-ensayo--863411f5 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemias-en-un-hospital-de-segundo-nivel-estud-f111aea1 2026-03-26 https://revespquimioterapia.com/articulo/manejo-de-la-candidiasis-invasiva-en-el-paciente-n-fa7b1032 2026-03-26 https://revespquimioterapia.com/articulo/shock-septico-y-empiema-por-pasteurella-multocida-a9229b76 2026-03-26 https://revespquimioterapia.com/articulo/infection-of-prosthetic-material-due-to-mycobacter-5a8c9d3b 2026-03-26 https://revespquimioterapia.com/articulo/la-importancia-de-las-redes-microbiologicas-en-el--2d2c329e 2026-03-26 https://revespquimioterapia.com/articulo/hacia-el-tratamiento-empirico-de-eleccion-en-las-i-98ae3d10 2026-03-26 https://revespquimioterapia.com/articulo/candida-bracarensis-an-emerging-yeast-involved-in--70ab3fac 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-la-diversidad-en-el-tratamiento-de-la-n-0cf46530 2026-03-26 https://revespquimioterapia.com/articulo/agentes-antibacterianos-en-el-cine-44b64b0a 2026-03-26 https://revespquimioterapia.com/articulo/manejo-de-la-pandemia-de-covid-19-en-hospitalizaci-497e23da 2026-03-26 https://revespquimioterapia.com/articulo/colistimetato-un-viejo-antimicrobiano-recuperado-p-895fe112 2026-03-26 https://revespquimioterapia.com/articulo/incidencia-y-sensibilidad-de-campylobacter-jejuni--b291ce74 2026-03-26 https://revespquimioterapia.com/articulo/azithromycin-and-moxifloxacin-resistance-determina-d7ed4b16 2026-03-26 https://revespquimioterapia.com/articulo/malignant-syphilis-in-hiv-negative-patient-treated-28b0c322 2026-03-26 https://revespquimioterapia.com/articulo/evolution-of-antimicrobial-susceptibility-patterns-ee2289d8 2026-03-26 https://revespquimioterapia.com/articulo/brote-de-tosferina-en-2024-¿nuevo-patrón-de-distribución-en-el-contagio-¿se-debería-replantear-el-refuerzo-de-dosis-en-la-vacunación 2026-03-26 https://revespquimioterapia.com/articulo/living-with-dogs-and-cats-is-it-a-risk-factor-for-community-acquired-methicillin-resistant-staphylococcus-aureus-skin-and-soft-tissue-infections-in-humans 2026-03-26 https://revespquimioterapia.com/articulo/epidemiological-characteristics-of-antimicrobial-use-in-primary-care-in-spain-a-nationwide-study 2026-03-26 https://revespquimioterapia.com/articulo/presencia-emergente-de-microorganismos-de-crecimiento-lento-en-urocultivos-analisis-clinico-y-microbiologico 2026-03-26 https://revespquimioterapia.com/articulo/repercusion-del-aumento-de-la-periodicidad-de-las-reuniones-en-las-que-el-equipo-del-programa-de-optimizacion-del-uso-de-antimicrobianos-realizo-auditorias-no-impositivas-de-ayuda-a-la-prescripcion-en-el-consumo-de-antimicrobianos 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-precoz-de-un-caso-de-artritis-septica-gracias-al-biofire-joint-infection-panel 2026-03-26 https://revespquimioterapia.com/articulo/comparison-of-perceived-versus-actual-care-complexity-in-hiv-positive-patients-receiving-antiretroviral-treatment-the-stratpatient-study 2026-03-26 https://revespquimioterapia.com/articulo/mastitis-por-streptococcus-pneumoniae-presentación-de-3-casos-y-revisión-de-la-literatura 2026-03-26 https://revespquimioterapia.com/articulo/conjunctival-and-cutaneous-kaposis-sarcoma-as-the-first-manifestation-of-hiv-infection 2026-03-26 https://revespquimioterapia.com/articulo/acute-infectious-gastroenteritis-in-childhood-the-role-of-rapid-multiplex-molecular-syndromic-panels-in-diagnosis-and-clinical-management 2026-03-26 https://revespquimioterapia.com/articulo/analisis-de-la-concordancia-entre-la-estratificacion-teorica-y-real-en-pacientes-que-viven-con-la-infeccion-por-vih-atendidos-en-un-hospital-de-tercer-nivel 2026-03-26 https://revespquimioterapia.com/articulo/corioamnionitis-recurrente-por-citrobacter-koseri-presentacion-de-un-caso-y-revision-de-la-literatura 2026-03-26 https://revespquimioterapia.com/articulo/analisis-epidemiologico-clinico-y-diagnostico-de-un-brote-de-infeccion-por-parvovirus-b19-en-la-isla-de-mallorca 2026-03-26 https://revespquimioterapia.com/articulo/profilaxis-preexposicion-y-el-incremento-de-infecciones-de-transmision-sexual-seguridad-mal-entendida 2026-03-26 https://revespquimioterapia.com/articulo/mycobacterium-bovis-a-rare-causative-pathogen-of-multiple-pseudoaneurysms 2026-03-26 https://revespquimioterapia.com/articulo/factors-associated-with-adequate-quality-of-life-levels-in-hiv-patients-during-a-five-year-longitudinal-study 2026-03-26 https://revespquimioterapia.com/articulo/anemia-and-lower-limbs-edemas-in-a-patient-with-hiv-infection 2026-03-26 https://revespquimioterapia.com/articulo/candida-parapsilosis-resistente-a-azoles-en-unidades-de-criticos 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-sistemica-por-magnusiomyces-spp-en-pacientes-oncohematologicos 2026-03-26 https://revespquimioterapia.com/articulo/evaluation-of-the-microbiological-diagnostic-algorithm-for-clostridioides-difficile-infection-and-associated-clinical-factors-in-a-tertiary-care-hospital 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-pulmonar-en-paciente-con-adenocarcinoma-un-patogeno-poco-frecuente-en-liquido-pleural 2026-03-26 https://revespquimioterapia.com/articulo/delafloxacin-what-does-a-new-fluoroquinolone-offer 2026-03-26 https://revespquimioterapia.com/articulo/rezafungin-for-the-treatment-of-invasive-candidiasis-secondary-to-esophagogastric-anastomotic-leak-clinical-success-in-a-complex-situation 2026-03-26 https://revespquimioterapia.com/articulo/intravenous-non-specific-immunoglobulins-as-adjunctive-therapy-for-invasive-streptococcus-pyogenes-infection--an-eleven-year-retrospective-study 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-de-un-caso-de-endocarditis-infecciosa-atipica-valor-anadido-de-las-tecnicas-de-biologia-molecular 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-secundaria-a-pancolitis-por-campylobacter-jejuni-en-un-paciente-inmunocompetente 2026-03-26 https://revespquimioterapia.com/articulo/implementacion-de-la-clasificacion-aware-en-un-hospital-pediatrico-como-estrategia-de-mejora-de-la-calidad-de-la-prescripcion-de-antibioticos 2026-03-26 https://revespquimioterapia.com/articulo/usefulness-of-business-intelligence-to-guide-antimicrobial-treatment-decision-in-infections-by-infrequent-microorganism-such-as-bordetella-bronchiseptica 2026-03-26 https://revespquimioterapia.com/articulo/cutaneous-eruption-by-streptococcus-dysgalactiae-in-an-immunocompromised-patient-854145 2026-03-26 https://revespquimioterapia.com/articulo/uso-de-antibioticos-y-lactancia-materna-2d62e84f 2026-03-26 https://revespquimioterapia.com/articulo/tigeciclina-10-anos-de-historia-y-en-plena-vigenci-ecbb6611 2026-03-26 https://revespquimioterapia.com/articulo/actividad-bactericida-in-vitro-de-concentraciones--8066a7af 2026-03-26 https://revespquimioterapia.com/articulo/estudio-prospectivo-de-staphylococcus-aureus-con-s-86d49515 2026-03-26 https://revespquimioterapia.com/articulo/a-systematic-review-of-randomized-clinical-trials--cb938271 2026-03-26 https://revespquimioterapia.com/articulo/turicella-otitidis-central-venous-related-bacterem-9d6117b5 2026-03-26 https://revespquimioterapia.com/articulo/clinical-impact-of-rapid-antimicrobial-susceptibility-testing-in-patients-with-bacteremia-due-to-gram-negative-bacilli 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-de-antifungicos-de-especies-de-acremo-99eb9b05 2026-03-26 https://revespquimioterapia.com/articulo/patron-fenotipico-de-resistencia-a-betalactamicos--2ea7ac3b 2026-03-26 https://revespquimioterapia.com/articulo/deciphering-pharmacokinetics-and-pharmacodynamics--6ab9ce3b 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2012-25-3-224-225-44fecc62 2026-03-26 https://revespquimioterapia.com/articulo/application-of-pharmacokinetic-pharmacodynamic-ana-2fdc856a 2026-03-26 https://revespquimioterapia.com/articulo/new-microbiological-aspects-of-fosfomycin-ad47e173 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-de-91-cepas-de-streptococcus-pneumoni-7a6285bf 2026-03-26 https://revespquimioterapia.com/articulo/integrones-nueva-causa-de-resistencia-a-antibiotic-c1e7cfde 2026-03-26 https://revespquimioterapia.com/articulo/sexually-transmitted-infections-in-spain-current-s-b282ae00 2026-03-26 https://revespquimioterapia.com/articulo/meningitis-por-salmonella-enterica-13cbde16 2026-03-26 https://revespquimioterapia.com/articulo/adecuacion-de-las-prescripciones-antimicrobianas-r-fe1d7cb0 2026-03-26 https://revespquimioterapia.com/articulo/dalbavancin-for-treating-prosthetic-joint-infectio-1c1f1d43 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-la-sensibilidad-de-citomegalovirus-a-ga-0e5a51cc 2026-03-26 https://revespquimioterapia.com/articulo/prosthetic-hip-joint-infection-caused-by-campyloba-cac5ce97 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2009-22-suppl-1-32-62e95e07 2026-03-26 https://revespquimioterapia.com/articulo/characterization-of-daptomycin-non-susceptible-ent-ec6377a7 2026-03-26 https://revespquimioterapia.com/articulo/eficacia-terapeutica-modelos-animales-y-farmacodin-5380c34a 2026-03-26 https://revespquimioterapia.com/articulo/pyelonephritis-in-pregnancy-how-adequate-is-empiri-4ecdc125 2026-03-26 https://revespquimioterapia.com/articulo/chlamydia-pneumoniae-su-asociacion-con-el-asma-y-l-3f4b655e 2026-03-26 https://revespquimioterapia.com/articulo/an-unexpected-pathogen-in-the-amniotic-fluid-of-a--fb13d923 2026-03-26 https://revespquimioterapia.com/articulo/bacteriocin-production-by-clinical-staphylococcus--f475e0a9 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-6-338-339-fa68084e 2026-03-26 https://revespquimioterapia.com/articulo/in-vitro-activity-of-cefiderocol-and-other-newly-a-15c4cdfe 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-6-336-337-c6d1f649 2026-03-26 https://revespquimioterapia.com/articulo/equilibrio-ecologico-y-alteracion-en-la-microflora-69a56f81 2026-03-26 https://revespquimioterapia.com/articulo/safety-of-fluoroquinolones-b442ee7f 2026-03-26 https://revespquimioterapia.com/articulo/determinacion-mediante-el-sistema-sensititre-r-de--f71cf098 2026-03-26 https://revespquimioterapia.com/articulo/antibiotic-use-in-barcelona-in-2023-in-primary-car-f51daddf 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-resistencia-a-betalactamicos-de-haemoph-e6432f7c 2026-03-26 https://revespquimioterapia.com/articulo/ceftazidime-avibactam-ee19386e 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-de-parechovirus-humanos-en-muestras-resp-baa31b4d 2026-03-26 https://revespquimioterapia.com/articulo/erupcion-mucocutanea-infecciosa-reactiva-rime-en-p-e1f13987 2026-03-26 https://revespquimioterapia.com/articulo/use-of-noninvasive-measurement-of-the-indocyanine--add1c987 2026-03-26 https://revespquimioterapia.com/articulo/significacion-clinica-de-las-resistencias-bacteria-fc392473 2026-03-26 https://revespquimioterapia.com/articulo/gripe-y-eventos-cardiorrespiratorios-una-revision--a9cfaf33 2026-03-26 https://revespquimioterapia.com/articulo/usefulness-of-monocyte-distribution-width-mdw-as-a-158c6bcf 2026-03-26 https://revespquimioterapia.com/articulo/transferencia-genica-trans-gram-el-caso-de-las-bet-5fdbf47e 2026-03-26 https://revespquimioterapia.com/articulo/bacteremic-pneumococcal-pneumonia-arrhythmogenic-d-255c710d 2026-03-26 https://revespquimioterapia.com/articulo/nocardiosis-diseminada-d7791d48 2026-03-26 https://revespquimioterapia.com/articulo/aspiration-pneumonia-d8bfc896 2026-03-26 https://revespquimioterapia.com/articulo/resistencias-de-escherichia-coli-a-amoxicilina-y-c-089b813d 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-al-alta-y-causas-de-mortalidad-de-paci-18976f4a 2026-03-26 https://revespquimioterapia.com/articulo/ceftobripole-experience-in-staphylococcal-bacterem-369d9e05 2026-03-26 https://revespquimioterapia.com/articulo/carta-al-director-dd7329e6 2026-03-26 https://revespquimioterapia.com/articulo/estudio-multicentrico-de-variabilidad-e-idoneidad--df3f631a 2026-03-26 https://revespquimioterapia.com/articulo/vigilancia-de-la-gripe-mediante-diagnostico-molecu-6dfee5e8 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-de-las-micosis-invasoras-deteccion-de--4fcce8eb 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-clinica-de-test-rapidos-para-el-diagnosti-f95a0101 2026-03-26 https://revespquimioterapia.com/articulo/transformacion-genetica-de-neisseria-meningitidis--df8cbccb 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-y-tratamiento-de-las-rinosinusitis-agu-d62ff26b 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-dos-tecnicas-fenotipicas-y-un-panel--bcd4c355 2026-03-26 https://revespquimioterapia.com/articulo/change-in-klebsiella-pneumoniae-susceptibility-pro-c2921426 2026-03-26 https://revespquimioterapia.com/articulo/association-of-nirmatrelvir-ritonavir-and-remdesiv-3fc57bc3 2026-03-26 https://revespquimioterapia.com/articulo/comparison-of-amplisens-r-hcv-genotype-frt-g-1-6-p-8327d473 2026-03-26 https://revespquimioterapia.com/articulo/neumonia-comunitaria-seleccion-del-tratamiento-emp-5801d06e 2026-03-26 https://revespquimioterapia.com/articulo/antimycobacterial-natural-products-an-opportunity--25640245 2026-03-26 https://revespquimioterapia.com/articulo/aneurisma-iliaco-solitario-y-test-fta-abs-positivo-d74d8b54 2026-03-26 https://revespquimioterapia.com/articulo/fatal-septic-shock-and-waterhouse-friderichsen-syn-bd47d13a 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemias-por-pseudomonas-aeruginosa-epidemiolo-2b526a66 2026-03-26 https://revespquimioterapia.com/articulo/report-of-38-cases-of-tracheobronchitis-in-non-imm-c7e241ce 2026-03-26 https://revespquimioterapia.com/articulo/antimicrobial-activity-of-ceftolozane-tazobactam-a-9613ff94 2026-03-26 https://revespquimioterapia.com/articulo/infective-endocarditis-on-prosthetic-valve-due-to--9e0d5add 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-de-aislamientos-faringeos-de-streptoc-810f94fc 2026-03-26 https://revespquimioterapia.com/articulo/consensus-document-on-treatment-of-infections-in-d-901790f0 2026-03-26 https://revespquimioterapia.com/articulo/rifampin-breakpoint-for-acinetobacter-baumannii-ba-69828fc1 2026-03-26 https://revespquimioterapia.com/articulo/actividad-fungicida-sobre-candida-albicans-de-una--8fe1d0b5 2026-03-26 https://revespquimioterapia.com/articulo/maintained-susceptibility-to-fosfomycin-in-extra-h-6ee3dc51 2026-03-26 https://revespquimioterapia.com/articulo/an-antimicrobial-stewardship-program-reduces-antim-b62eacfe 2026-03-26 https://revespquimioterapia.com/articulo/profilaxis-y-tratamiento-de-las-infecciones-fungic-2f29dbad 2026-03-26 https://revespquimioterapia.com/articulo/meropenem-aspectos-microbiologicos-bbecec85 2026-03-26 https://revespquimioterapia.com/articulo/estudio-comparativo-de-wider-e-test-y-microdilucio-d9a57fcb 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-suppl-2-3-5-fe9a0b1c 2026-03-26 https://revespquimioterapia.com/articulo/in-memoriam-8dc6b761 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-3-239-240-64f533c0 2026-03-26 https://revespquimioterapia.com/articulo/first-case-of-arcobacter-cryaerophilus-in-paediatr-64697412 2026-03-26 https://revespquimioterapia.com/articulo/microbioma-y-secuenciacion-masiva-f724895a 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-3-234-235-9e13c29f 2026-03-26 https://revespquimioterapia.com/articulo/pseudomonas-aeruginosa-resistencia-antimicrobiana--b1b94847 2026-03-26 https://revespquimioterapia.com/articulo/bacteremia-caused-by-clostridium-sporogenes-in-an--7f078e4b 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-trovafloxacino-en-238-patoge-34152c7c 2026-03-26 https://revespquimioterapia.com/articulo/high-level-of-medication-regimen-complexity-index--c4edb29d 2026-03-26 https://revespquimioterapia.com/articulo/patients-with-non-tuberculous-mycobacteria-in-resp-54026d68 2026-03-26 https://revespquimioterapia.com/articulo/clinical-characteristics-and-outcomes-of-1-331-pat-c8fed601 2026-03-26 https://revespquimioterapia.com/articulo/healthcare-associated-pneumonia-a-prospective-stud-3ac4cf76 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2019-32-suppl-2-73-79-2abc7d95 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2018-31-suppl-1-66-72-f2624790 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-3-229-230-8351bab2 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-penicilina-y-otros-13-antimicrobian-67cfbe9c 2026-03-26 https://revespquimioterapia.com/articulo/reunion-anual-de-la-seq-c09431e9 2026-03-26 https://revespquimioterapia.com/articulo/estudio-microbiologico-de-vulvovaginitis-en-ninas--9eabd7d0 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-fluconazol-voriconazol-y-pos-433cb432 2026-03-26 https://revespquimioterapia.com/articulo/pharmacokinetics-pharmacodynamics-and-tolerability-228bba0b 2026-03-26 https://revespquimioterapia.com/articulo/proteus-mirabilis-productor-de-ampc-plasmidica-en--675f0531 2026-03-26 https://revespquimioterapia.com/articulo/joint-infection-due-to-elizabethkingia-miricola-897464f0 2026-03-26 https://revespquimioterapia.com/articulo/acido-fusidico-8b34ce02 2026-03-26 https://revespquimioterapia.com/articulo/suburethral-abscess-in-young-woman-e0a158df 2026-03-26 https://revespquimioterapia.com/articulo/plantas-con-accion-antimicrobiana-5ab03fa5 2026-03-26 https://revespquimioterapia.com/articulo/epidemiologia-de-las-resistencias-genotipicas-del--c83b9f1e 2026-03-26 https://revespquimioterapia.com/articulo/ceftazidime-avibactam-1732cda8 2026-03-26 https://revespquimioterapia.com/articulo/community-acquired-pneumonia-similarities-and-diff-424db504 2026-03-26 https://revespquimioterapia.com/articulo/clinical-and-microbiologic-characteristics-of-pleu-ee8bf113 2026-03-26 https://revespquimioterapia.com/articulo/implementation-of-the-delayed-antibiotic-prescribi-30eff9cb 2026-03-26 https://revespquimioterapia.com/articulo/norovirus-infection-as-a-model-of-chronic-or-recur-046f615c 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-de-36-aislamientos-de-helicobacter-py-dfa7088d 2026-03-26 https://revespquimioterapia.com/articulo/strengths-and-weaknesses-of-computerized-clinical--3a14b4cc 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-antiterroviral-en-el-periodo-1996-2000-e4dc1f4f 2026-03-26 https://revespquimioterapia.com/articulo/eficacia-de-varias-pautas-de-tratamiento-empirico--260577bb 2026-03-26 https://revespquimioterapia.com/articulo/unusual-isolation-of-pseudoglutamicibacter-cummins-207c26da 2026-03-26 https://revespquimioterapia.com/articulo/is-the-universal-population-hepatitis-c-virus-scre-adbb3f28 2026-03-26 https://revespquimioterapia.com/articulo/seroprevalence-and-trends-of-htlv-1-2-among-blood--f8037aee 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-1-57-58-040d1b2d 2026-03-26 https://revespquimioterapia.com/articulo/pielonefritis-agudas-comunitarias-tratamiento-epid-7f637b25 2026-03-26 https://revespquimioterapia.com/articulo/asma-e-infeccion-factores-etiopatogenicos-y-tratam-b69d149a 2026-03-26 https://revespquimioterapia.com/articulo/implantacion-de-un-programa-de-optimizacion-y-uso--bc975ac4 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-vancomicina-teicoplanina-y-linezolid--1a1fe774 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-antifungicos-de-especies-de-scopula-eec11d35 2026-03-26 https://revespquimioterapia.com/articulo/serotipos-y-sensibilidad-antibiotica-de-streptococ-1fed115f 2026-03-26 https://revespquimioterapia.com/articulo/c-albicans-c-parapsilosis-and-c-tropicalis-invasiv-2bb0d2f4 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-ertapenem-y-otros-antimicrobianos-fre-2deaf400 2026-03-26 https://revespquimioterapia.com/articulo/congenital-tuberculosis-in-a-premature-newborn-62c9d59b 2026-03-26 https://revespquimioterapia.com/articulo/nuevos-patogenos-7a39fd21 2026-03-26 https://revespquimioterapia.com/articulo/pautas-de-tratamiento-antibiotico-empirico-de-las--1c137e43 2026-03-26 https://revespquimioterapia.com/articulo/symposium-2-nueva-referencia-en-el-tratamiento-ant-005429aa 2026-03-26 https://revespquimioterapia.com/articulo/perfil-de-seguridad-de-cefdioren-analisis-combinad-864e451f 2026-03-26 https://revespquimioterapia.com/articulo/could-mycoplasma-genitalium-be-involved-in-chronic-d9812bcf 2026-03-26 https://revespquimioterapia.com/articulo/antibacterial-spectrum-of-cefiderocol-ed2d4159 2026-03-26 https://revespquimioterapia.com/articulo/complicaciones-infecciosas-relacionadas-con-el-dre-dc061467 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-suppl-2-26-27-1b9406e7 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2021-34-suppl-1-81-89-ad33f6e7 2026-03-26 https://revespquimioterapia.com/articulo/a-systematic-literature-review-and-expert-consensu-d9166e1c 2026-03-26 https://revespquimioterapia.com/articulo/farmacoeconomia-y-antimicrobianos-8915f2ee 2026-03-26 https://revespquimioterapia.com/articulo/mycoplasma-genitalium-and-sexually-transmitted-inf-1715c97c 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-de-las-resistencias-del-genero-enterococ-65f15b76 2026-03-26 https://revespquimioterapia.com/articulo/perfil-farmacocinetico-farmacodinamico-del-cefdito-9658bf24 2026-03-26 https://revespquimioterapia.com/articulo/peritonitis-bacteriana-espontanea-por-listeria-mon-dde87ab7 2026-03-26 https://revespquimioterapia.com/articulo/eikenella-corrodens-y-antimicrobianos-orales-clasi-bc50bd0c 2026-03-26 https://revespquimioterapia.com/articulo/infective-endocarditis-treated-in-a-secondary-hosp-713b60a5 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-3-236-238-7cd65b18 2026-03-26 https://revespquimioterapia.com/articulo/clinical-experience-of-cefiderocol-4fc6418b 2026-03-26 https://revespquimioterapia.com/articulo/infecciones-respiratorias-etiologia-y-patrones-de--8f86bf1b 2026-03-26 https://revespquimioterapia.com/articulo/neisseria-meningitidis-bacteraemia-and-sars-cov-2--049290dc 2026-03-26 https://revespquimioterapia.com/articulo/prosthetic-joint-infections-due-to-methicillin-res-7ddf2dc8 2026-03-26 https://revespquimioterapia.com/articulo/ehrlich-y-el-concepto-de-bala-magica-16d04817 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-los-principales-antimicrobianos-emp-45872c83 2026-03-26 https://revespquimioterapia.com/articulo/debut-pediatrico-de-fascitis-necrotizante-08c57767 2026-03-26 https://revespquimioterapia.com/articulo/virus-de-la-inmunodeficiencia-humana-y-resistencia-4cede239 2026-03-26 https://revespquimioterapia.com/articulo/emergence-of-metallo-b-lactamases-in-acinetobacter-44cbb019 2026-03-26 https://revespquimioterapia.com/articulo/estudio-critico-del-perfil-del-consumidor-espanol--f5ad438e 2026-03-26 https://revespquimioterapia.com/articulo/the-microbiology-of-sepsis-is-more-than-the-applic-05ce4ad4 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-la-resistencia-primaria-de-mycobacteriu-b0dc5084 2026-03-26 https://revespquimioterapia.com/articulo/presion-antibiotica-desarrollo-de-resistencias-en--52ceface 2026-03-26 https://revespquimioterapia.com/articulo/perfil-de-aislamientos-bacterianos-y-sensibilidad--42f5acdd 2026-03-26 https://revespquimioterapia.com/articulo/bicitopenia-secundaria-a-infeccion-por-parvovirus--8284871d 2026-03-26 https://revespquimioterapia.com/articulo/efecto-de-los-antiinflamatorios-solos-y-asociados--9acd5a82 2026-03-26 https://revespquimioterapia.com/articulo/control-de-la-infeccion-por-trypanosoma-cruzi-enfe-7524ce16 2026-03-26 https://revespquimioterapia.com/articulo/correlacion-clinico-microbiologica-en-pacientes-tr-3a84fc23 2026-03-26 https://revespquimioterapia.com/articulo/new-trends-in-antifungal-treatment-what-is-coming--8e11a860 2026-03-26 https://revespquimioterapia.com/articulo/tienen-los-cetolidos-ventajas-reales-sobre-los-mac-55cf312d 2026-03-26 https://revespquimioterapia.com/articulo/revista-espanola-de-quimioterapia-una-nueva-singla-38997e90 2026-03-26 https://revespquimioterapia.com/articulo/estudio-multicentrico-de-resistencias-en-enterococ-59641a53 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-producida-por-enterocloster-aldenensis-ab6a43b9 2026-03-26 https://revespquimioterapia.com/articulo/a-clinically-relevant-reinterpretation-of-disk-approximation-testing-for-inducible-ampc-in-pseudomonas-aeruginosa 2026-03-26 https://revespquimioterapia.com/articulo/high-incidence-of-covid-19-at-nursing-homes-in-mad-a220952c 2026-03-26 https://revespquimioterapia.com/articulo/changes-in-bacterial-hospital-epidemiology-3fe8391c 2026-03-26 https://revespquimioterapia.com/articulo/aislamiento-de-pasteurella-dagmatis-tras-mordedura-9569e31c 2026-03-26 https://revespquimioterapia.com/articulo/the-magnificent-seven-seven-good-publications-in-i-b38bf7f7 2026-03-26 https://revespquimioterapia.com/articulo/ultima-hora-5f6801b0 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-costes-sanitarios-relacionados-con-e-95109437 2026-03-26 https://revespquimioterapia.com/articulo/comparison-of-two-methods-skipping-cell-lysis-and--4ff50f10 2026-03-26 https://revespquimioterapia.com/articulo/translocacion-bacteriana-un-mecanismo-de-infeccioe-e8053454 2026-03-26 https://revespquimioterapia.com/articulo/hepatitis-por-el-virus-delta-en-una-cohorte-de-pacientes-infectados-por-el-vih-en-guipuzcoa 2026-03-26 https://revespquimioterapia.com/articulo/recomendaciones-de-un-programa-de-optimizacion-de-tratamiento-antibiotico-sobre-la-duracion-del-tratamiento-antibiotico-eficacia-de-pautas-cortas-en-el-servicio-de-urgencias 2026-03-26 https://revespquimioterapia.com/articulo/factores-de-riesgo-asociados-a-inadecuacion-del-tratamiento-empirico-en-pacientes-con-sepsis-y-bacteremia-atendidos-en-un-servicio-de-urgencias 2026-03-26 https://revespquimioterapia.com/articulo/coexistencia-de-linfoma-primario-del-sistema-nervioso-central-y-toxoplasmosis-cerebral-en-una-paciente-con-infección-por-vih-avanzada-y-serología-negativa 2026-03-26 https://revespquimioterapia.com/articulo/programa-de-optimizacion-del-uso-de-antimicrobiano-ef8600fa 2026-03-26 https://revespquimioterapia.com/articulo/important-aspects-during-management-of-diabetic-fo-1445fd15 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-de-la-sensibilidad-antimicrobiana-en-ais-797da3dc 2026-03-26 https://revespquimioterapia.com/articulo/the-pharmacodynamic-bases-of-the-prescription-of-a-201a252b 2026-03-26 https://revespquimioterapia.com/articulo/current-diagnostic-approach-to-fungal-infection-in-the-critically-ill-patient 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-clinica-del-estudio-de-la-sensibilidad-al-c6450975 2026-03-26 https://revespquimioterapia.com/articulo/coste-del-tratamiento-antibiotico-empirico-en-paci-9fbee533 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-clinica-de-las-pruebas-de-sensibilidad-in-180c39cc 2026-03-26 https://revespquimioterapia.com/articulo/four-cases-of-bacteremia-caused-by-enterocloster-clostridioformis 2026-03-26 https://revespquimioterapia.com/articulo/towards-a-holistic-approach-to-pulmonary-infections-insights-from-the-sixth-annual-meeting-of-spanish-experts-2024 2026-03-26 https://revespquimioterapia.com/articulo/interaccion-de-linezolid-con-rifampicina-a-proposito-de-un-caso 2026-03-26 https://revespquimioterapia.com/articulo/antibioticoterapia-con-probioticos-87d224d5 2026-03-26 https://revespquimioterapia.com/articulo/queratoconjuntivitis-gonococica-en-el-adulto-una-e-ceb4a632 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-5-280-282-514b8c7d 2026-03-26 https://revespquimioterapia.com/articulo/seroconversion-a-igg4-en-un-paciente-con-brucelosi-0f4ab6b7 2026-03-26 https://revespquimioterapia.com/articulo/manejo-integral-del-paciente-con-exacerbacion-agud-d39c3fa3 2026-03-26 https://revespquimioterapia.com/articulo/comprehensive-approach-to-primary-immunodeficiencies-in-adulthood-recognition-and-diagnosis 2026-03-26 https://revespquimioterapia.com/articulo/therapeutic-optimization-against-bacteria-carrying-metalloenzymes-the-battle-for-class-b 2026-03-26 https://revespquimioterapia.com/articulo/incidence-of-surgical-site-infection-surveillance-in-hysterectomies-and-related-risk-factors-a-prospective-cohort-study 2026-03-26 https://revespquimioterapia.com/articulo/trends-in-antifungal-use-characteristics-in-primary-care-in-spain-2019-to-2024-a-nationwide-study-244568 2026-03-26 https://revespquimioterapia.com/articulo/challenges-and-opportunities-in-the-management-of-severe-pneumonia-key-concepts-from-the-seventh-annual-meeting-of-spanish-experts-2025 2026-03-26 https://revespquimioterapia.com/articulo/pulmonary-nocardiosis-after-covid-19-infection-cas-86a7625d 2026-03-26 https://revespquimioterapia.com/articulo/azoles-profilacticos-o-terapeuticos-ba38579c 2026-03-26 https://revespquimioterapia.com/articulo/tocilizumab-reduces-the-risk-of-icu-admission-and--22620679 2026-03-26 https://revespquimioterapia.com/articulo/comorbidities-of-primary-care-patients-with-covid--86f9c6b6 2026-03-26 https://revespquimioterapia.com/articulo/miasis-por-calliphora-sobre-pioderma-gangrenoso-654b66f7 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-la-neumonia-por-legionella-con-azit-9ef6e189 2026-03-26 https://revespquimioterapia.com/articulo/in-vitro-activity-of-imipenem-relebactam-against-g-731e61ea 2026-03-26 https://revespquimioterapia.com/articulo/some-impressions-of-the-content-of-the-san-francis-3f8790bd 2026-03-26 https://revespquimioterapia.com/articulo/penetracion-de-los-antibioticos-en-los-polimorfonu-02c2c81c 2026-03-26 https://revespquimioterapia.com/articulo/eravacycline-from-broad-spectrum-coverage-to-novel-clinical-applications 2026-03-26 https://revespquimioterapia.com/articulo/associations-between-high-risk-human-papillomavirus-genotypes-evidence-of-hpv16-predominance-as-a-monoinfection-and-its-no-stronger-link-with-high-grade-lesions--519563 2026-03-26 https://revespquimioterapia.com/articulo/neutropenia-probable-secundaria-al-tratamiento-con-rifampicina 2026-03-26 https://revespquimioterapia.com/articulo/elevada-tasa-de-resistencia-a-macrolidos-y-fluoroq-bae52cd5 2026-03-26 https://revespquimioterapia.com/articulo/introduction-edb9fac1 2026-03-26 https://revespquimioterapia.com/articulo/comparacion-entre-cinco-tecnicas-de-pcr-para-el-di-b6b7af16 2026-03-26 https://revespquimioterapia.com/articulo/a-combination-of-tigecycline-colistin-and-meropene-d5ea1c70 2026-03-26 https://revespquimioterapia.com/articulo/usefulness-of-biomarkers-on-infection-management-w-2c1c3eb7 2026-03-26 https://revespquimioterapia.com/articulo/antibioterapia-inhalada-y-dispositivos-de-inhalaci-16a9eae1 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-los-genes-de-resistencia-a-macrolidos-e-2c2c3373 2026-03-26 https://revespquimioterapia.com/articulo/neumonia-por-haemophilus-influenzae-estudio-de-una-925c5c8c 2026-03-26 https://revespquimioterapia.com/articulo/a-rapid-surveillance-of-pneumonia-in-hospitalized-patients-an-opportunity-for-intervention 2026-03-26 https://revespquimioterapia.com/articulo/hantavirus-infection-global-overview-and-current-situation-in-spain-270050 2026-03-26 https://revespquimioterapia.com/articulo/caracteristicas-epidemiologicas-de-pacientes-con-aislamientos-de-enterobacterales-productores-de-carbapenemasas-ndm-en-un-hospital-de-alta-complejidad 2026-03-26 https://revespquimioterapia.com/articulo/detection-of-a-blakpc-2-carrying-incp-6-plasmid-in-aeromonas-caviae-isolated-from-a-clinical-sample-in-a-spanish-hospital- 2026-03-26 https://revespquimioterapia.com/articulo/recomendaciones-para-la-prevencion-y-el-tratamiento-de-las-infecciones-respiratorias-en-adultos-mayores-institucionalizados 2026-03-26 https://revespquimioterapia.com/articulo/situation-and-questions-regarding-the-practice-of-blood-cultures-in-paediatric-patients-an-opinion-paper 2026-03-26 https://revespquimioterapia.com/articulo/classification-and-applicability-of-new-beta-lactamase-inhibitors 2026-03-26 https://revespquimioterapia.com/articulo/descripcion-clinica-y-epidemiologica-de-un-brote-g-7bd6c8c6 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-enterobacterias-productoras-de-car-d65b9e2c 2026-03-26 https://revespquimioterapia.com/articulo/concerning-the-presumptive-identification-of-candi-63ce6a9e 2026-03-26 https://revespquimioterapia.com/articulo/steroid-therapy-and-antiviral-treatment-in-sarscov-eede5cbd 2026-03-26 https://revespquimioterapia.com/articulo/sindrome-de-absceso-hepatico-asociado-a-colecistit-dc307113 2026-03-26 https://revespquimioterapia.com/articulo/repercusiones-en-el-hombre-del-consumo-de-antibiot-c9bf49e4 2026-03-26 https://revespquimioterapia.com/articulo/changes-in-tuberculosis-in-human-immunodeficiency--271d201d 2026-03-26 https://revespquimioterapia.com/articulo/comparacion-entre-penicilina-y-amoxicilina-acido-c-3b4b3e26 2026-03-26 https://revespquimioterapia.com/articulo/consumo-espanol-de-antibioticos-topicos-asociados--6f792691 2026-03-26 https://revespquimioterapia.com/articulo/profilaxis-antibiotica-en-cirurgia-situacion-y-uso-d061b266 2026-03-26 https://revespquimioterapia.com/articulo/conjuntivitis-primaria-por-neisseria-meningitidis-en-un-adulto-portador-de-lentes-de-contacto 2026-03-26 https://revespquimioterapia.com/articulo/xxv-aniversario-de-la-muerte-de-manolo-gomis 2026-03-26 https://revespquimioterapia.com/articulo/controversies-in-nosocomial-peritonitis 2026-03-26 https://revespquimioterapia.com/articulo/causes-and-consequences-of-undervaccination-in-adults 2026-03-26 https://revespquimioterapia.com/articulo/healthcare-resource-utilization-and-costs-associated-with-inadequate-initial-antibiotic-treatment-of-bacteraemia-produced-by-carbapenem-resistant-gram-negative-bacilli-crgnb-a-descriptive-observational-study-in-spanish-hospitals 2026-03-26 https://revespquimioterapia.com/articulo/fosfomycin-in-antimicrobial-stewardship-programs-de12ff3f 2026-03-26 https://revespquimioterapia.com/articulo/artritis-septica-de-rodilla-por-stenotrophomonas-m-3a61890c 2026-03-26 https://revespquimioterapia.com/articulo/relevancia-de-la-deteccion-del-antigeno-de-strepto-b4962cee 2026-03-26 https://revespquimioterapia.com/articulo/modelos-matematicos-en-el-estudio-de-la-resistenci-18dc63e2 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-de-co-infeccion-por-el-virus-herpes-simp-74568bf2 2026-03-26 https://revespquimioterapia.com/articulo/the-phh-1v-hipra-vaccine-a-new-tool-in-the-vaccina-d333f5ec 2026-03-26 https://revespquimioterapia.com/articulo/programa-de-optimizacion-de-antibioterapia-en-infe-136cdba2 2026-03-26 https://revespquimioterapia.com/articulo/htlv-1-infection-an-emerging-risk-pathogenesis-epi-e5185fff 2026-03-26 https://revespquimioterapia.com/articulo/fosfomycin-in-infections-caused-by-multidrug-resis-188265eb 2026-03-26 https://revespquimioterapia.com/articulo/desarrollo-de-una-formula-magistral-de-clofazimina-f7f82bf1 2026-03-26 https://revespquimioterapia.com/articulo/guia-clinica-para-la-evaluacion-y-el-tratamiento-d-2848922e 2026-03-26 https://revespquimioterapia.com/articulo/nuevas-estrategias-antiinfecciosas-interacciones-v-f0eaf1fc 2026-03-26 https://revespquimioterapia.com/articulo/consenso-sobre-la-vacunacion-anti-neumococica-en-e-d0455414 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemias-por-enterobacterias-productoras-de-be-e85f6fa1 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-a-quinolonas-en-salmonella-enterica-7b93e147 2026-03-26 https://revespquimioterapia.com/articulo/arcobacter-butzleri-and-intestinal-colonization-a942a870 2026-03-26 https://revespquimioterapia.com/articulo/patron-de-sensibilidad-a-antimicrobianos-en-uropat-14fcc5b5 2026-03-26 https://revespquimioterapia.com/articulo/identificacion-de-brucella-melitensis-como-ochroba-714ba61b 2026-03-26 https://revespquimioterapia.com/articulo/kikuchi-fujimoto-disease-a-rare-type-of-lymphadeno-ec65ac47 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-staphylococcus-aureus-de-origen-re-7c6f93b4 2026-03-26 https://revespquimioterapia.com/articulo/acute-zoonotic-total-knee-prosthetic-joint-infecti-0866448a 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-stenotrophomonas-maltophilia-estud-82c040e4 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-las-enfermedades-intestinales-causa-986ce297 2026-03-26 https://revespquimioterapia.com/articulo/morbidity-and-mortality-associated-with-primary-an-c8a93497 2026-03-26 https://revespquimioterapia.com/articulo/cuasiespecies-virales-y-su-implicacion-en-el-trata-bc534891 2026-03-26 https://revespquimioterapia.com/articulo/allplextm-ng-dr-seegene-utility-for-switching-oral-7bf18549 2026-03-26 https://revespquimioterapia.com/articulo/criterios-del-grupo-mensura-para-la-definicion-de--bed31ef1 2026-03-26 https://revespquimioterapia.com/articulo/ceftobiprole-medocaril-27d0c3bf 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-ertapenem-frente-a-cepas-bac-af4431da 2026-03-26 https://revespquimioterapia.com/articulo/mecanismos-de-resistencia-bacteriana-a-las-quinolo-977231f7 2026-03-26 https://revespquimioterapia.com/articulo/could-ceftaroline-be-an-alternative-therapy-for-li-eaaeb685 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-inmediato-o-tardio-con-imipenem-en-pac-f0f5430f 2026-03-26 https://revespquimioterapia.com/articulo/haemophilus-influenzae-no-capsulado-en-las-reagudi-7b2cbfd3 2026-03-26 https://revespquimioterapia.com/articulo/caracterizacion-de-los-genotipos-del-virus-de-la-h-ff7a9fc4 2026-03-26 https://revespquimioterapia.com/articulo/ceftobiprole-pharmacokinetics-and-pk-pd-profile-a21f0c7d 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-la-retinitis-por-citomegalovirus-en-08bb5331 2026-03-26 https://revespquimioterapia.com/articulo/adecuacion-del-uso-de-antibioticos-de-categoria-es-5a8cba0a 2026-03-26 https://revespquimioterapia.com/articulo/new-evidence-in-severe-pneumonia-meropenem-vaborba-45b833db 2026-03-26 https://revespquimioterapia.com/articulo/inhibicion-de-los-mecanismos-de-permeabilidad-y-bo-3ef3c227 2026-03-26 https://revespquimioterapia.com/articulo/ultima-hora-pag-229-1e042479 2026-03-26 https://revespquimioterapia.com/articulo/sepsis-por-yersinia-pseudotuberculosis-4a0c1bb7 2026-03-26 https://revespquimioterapia.com/articulo/genotypic-and-phenotypic-diversity-in-enterococcus-454f2591 2026-03-26 https://revespquimioterapia.com/articulo/fungal-corneal-abscess-caused-by-exophiala-dermati-74d4f657 2026-03-26 https://revespquimioterapia.com/articulo/monoterapia-con-inhibidores-de-la-proteasa-potenci-3a8f094a 2026-03-26 https://revespquimioterapia.com/articulo/se-pueden-o-deben-tratar-las-reagudizacionesdel-as-c6d17bd9 2026-03-26 https://revespquimioterapia.com/articulo/actividad-fungicida-y-efecto-paradojico-de-la-casp-5b1295b8 2026-03-26 https://revespquimioterapia.com/articulo/enfermedad-invasiva-por-streptococcus-pneumoniae-s-9ec201b3 2026-03-26 https://revespquimioterapia.com/articulo/debe-sustituir-cefminox-a-cefoxitina-en-las-infecc-6a6def9d 2026-03-26 https://revespquimioterapia.com/articulo/ceftaroline-in-severe-community-acquired-pneumonia-e1fb6b02 2026-03-26 https://revespquimioterapia.com/articulo/interactions-listed-in-the-paxlovid-fact-sheet-cla-b9a46bf7 2026-03-26 https://revespquimioterapia.com/articulo/criterios-de-introduccion-de-las-vacunas-en-los-ca-2ab90a79 2026-03-26 https://revespquimioterapia.com/articulo/importancia-clinica-de-los-azoles-en-la-terapia-an-cf943493 2026-03-26 https://revespquimioterapia.com/articulo/the-situation-of-vaccines-for-the-prevention-of-in-55fc448c 2026-03-26 https://revespquimioterapia.com/articulo/la-tigeciclina-el-primer-antibiotico-de-una-nueva--e61a374b 2026-03-26 https://revespquimioterapia.com/articulo/prevencion-de-la-infeccion-perinatal-por-estreptoc-ef9d5bc8 2026-03-26 https://revespquimioterapia.com/articulo/antifungal-prophylaxis-in-the-haematological-patie-a4bc0664 2026-03-26 https://revespquimioterapia.com/articulo/ertapenem-d38051db 2026-03-26 https://revespquimioterapia.com/articulo/prevencion-de-la-infeccion-neonatal-por-estreptoco-cedff6f8 2026-03-26 https://revespquimioterapia.com/articulo/infectious-endocarditis-caused-by-candida-glabrata-613a4de9 2026-03-26 https://revespquimioterapia.com/articulo/cefiderocol-summary-and-conclusions-50c9e488 2026-03-26 https://revespquimioterapia.com/articulo/resistance-of-bacteroides-isolates-recovered-among-721968c0 2026-03-26 https://revespquimioterapia.com/articulo/causas-que-justifican-el-cambio-del-tratamiento-an-1c9d90d8 2026-03-26 https://revespquimioterapia.com/articulo/situacion-actual-de-la-resistencia-de-la-pseudomon-c4137337 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-tratamiento-y-prevencion-de-la-infecci-299604a6 2026-03-26 https://revespquimioterapia.com/articulo/kingella-kingae-como-agente-causal-frecuente-de-ar-1eca4afd 2026-03-26 https://revespquimioterapia.com/articulo/cefepima-en-el-paciente-neutropenico-febril-8561dfe4 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-antibioticos-en-estreptococos-beta--8b3a88c0 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-a-las-asociaciones-de-betalactamicos-e-3d50fa9d 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-2-136-137-08e60fe1 2026-03-26 https://revespquimioterapia.com/articulo/comparison-of-culture-microscopic-smear-and-molecu-80e22d77 2026-03-26 https://revespquimioterapia.com/articulo/anfotericina-b-forma-liposomica-un-perfil-farmacoc-c464c992 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-rapido-de-un-caso-de-meningitis-posqui-70278ef7 2026-03-26 https://revespquimioterapia.com/articulo/caracteristicas-de-uso-y-calidad-en-la-prescripcio-d4fe937e 2026-03-26 https://revespquimioterapia.com/articulo/effectiveness-of-liposomal-amphotericin-b-in-patie-83bf4244 2026-03-26 https://revespquimioterapia.com/articulo/a-patient-with-a-rapidly-lethal-pneumonia-after-a--f5f0a197 2026-03-26 https://revespquimioterapia.com/articulo/la-tardia-emergencia-mediatica-de-la-vacuna-contra-dd0a5d54 2026-03-26 https://revespquimioterapia.com/articulo/update-in-infectious-diseases-2019-660b7add 2026-03-26 https://revespquimioterapia.com/articulo/clinical-interest-of-streptococcus-bovis-isolates--07282155 2026-03-26 https://revespquimioterapia.com/articulo/correction-antimicrobial-stewardship-in-patients-r-035d740e 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-de-mycobacterium-tuberculosis-en-un-ho-d5f3da49 2026-03-26 https://revespquimioterapia.com/articulo/reevaluacion-de-la-nistatina-en-la-profilaxis-y-el-e4a95151 2026-03-26 https://revespquimioterapia.com/articulo/relacion-entre-velocidad-de-sedimentacion-globular-67a75893 2026-03-26 https://revespquimioterapia.com/articulo/telitromicina-941111c0 2026-03-26 https://revespquimioterapia.com/articulo/etiologia-microbiana-de-la-prostatitis-cronica-bac-e6737d7a 2026-03-26 https://revespquimioterapia.com/articulo/aspergilosis-747882d9 2026-03-26 https://revespquimioterapia.com/articulo/response-to-the-importance-of-an-early-gastroenter-a21c94f3 2026-03-26 https://revespquimioterapia.com/articulo/mesa-redonda-2-diagnostico-microbiologico-de-la-ne-51853e2e 2026-03-26 https://revespquimioterapia.com/articulo/resistance-of-streptococcus-pneumoniae-isolated-fr-e8f1e625 2026-03-26 https://revespquimioterapia.com/articulo/stewardship-in-sepsis-22f52607 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-fungica-en-el-paciente-critico-papel-de--9f142cd0 2026-03-26 https://revespquimioterapia.com/articulo/actuacion-farmaceutica-en-el-control-de-la-duracio-057cd8eb 2026-03-26 https://revespquimioterapia.com/articulo/global-strategy-in-the-treatment-of-hiv-infection--12570297 2026-03-26 https://revespquimioterapia.com/articulo/update-on-the-management-of-febrile-neutropenia-in-2038b188 2026-03-26 https://revespquimioterapia.com/articulo/nosocomial-pneumonia-current-etiology-and-impact-o-5f6442f1 2026-03-26 https://revespquimioterapia.com/articulo/ultima-hora-pag-15-2529ed17 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-economica-de-intervenciones-en-enfermed-3b92c564 2026-03-26 https://revespquimioterapia.com/articulo/highlights-at-the-28th-congress-of-the-european-so-6d48342e 2026-03-26 https://revespquimioterapia.com/articulo/latent-tuberculosis-infection-approach-and-therape-f10d427e 2026-03-26 https://revespquimioterapia.com/articulo/revision-de-infecciones-por-actinotignum-schaalii--fcefccb8 2026-03-26 https://revespquimioterapia.com/articulo/a-rare-case-of-cardiac-alveolar-echinococcosis-wit-372e21ca 2026-03-26 https://revespquimioterapia.com/articulo/farmacoeconomia-de-la-infeccion-en-la-unidad-de-cu-08f187f3 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-antimicrobianos-de-cepas-de-staphyl-6ff4774b 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-la-sensibilidad-a-antimicrobianos-de-ce-2a57cfaf 2026-03-26 https://revespquimioterapia.com/articulo/highlights-in-asm-microbe-2017-new-orleans-d1ec84fc 2026-03-26 https://revespquimioterapia.com/articulo/actividad-comparativa-in-vitro-de-ertapenem-frente-40248388 2026-03-26 https://revespquimioterapia.com/articulo/prevencion-de-la-infeccion-perinatal-por-estreptoc-8b5e2121 2026-03-26 https://revespquimioterapia.com/articulo/biterapia-como-alternativa-de-tratamiento-en-los-p-42215791 2026-03-26 https://revespquimioterapia.com/articulo/motivos-de-introduccion-de-darunavir-en-un-regimen-3ced5530 2026-03-26 https://revespquimioterapia.com/articulo/top-ten-papers-in-infection-control-2015-2017-7e523b2e 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-libre-de-interferon-de-la-infeccion-po-10483962 2026-03-26 https://revespquimioterapia.com/articulo/importancia-de-los-resultados-de-los-hemocultivos--02c104ae 2026-03-26 https://revespquimioterapia.com/articulo/intraabdominal-candidiasis-in-surgical-icu-patient-081cefdf 2026-03-26 https://revespquimioterapia.com/articulo/colonizacion-cronica-por-bordetella-petrii-primer--f5f91420 2026-03-26 https://revespquimioterapia.com/articulo/absceso-esplenico-por-coprobacillus-catenaformis-a-14e67f21 2026-03-26 https://revespquimioterapia.com/articulo/utilizacion-del-e-test-para-determinar-la-activida-bc84d6fe 2026-03-26 https://revespquimioterapia.com/articulo/estudio-multicentrico-de-la-actividad-in-vitro-de--3dbcdc4a 2026-03-26 https://revespquimioterapia.com/articulo/guia-de-tratamiento-de-las-infecciones-de-piel-y-t-dc63de6b 2026-03-26 https://revespquimioterapia.com/articulo/papel-de-la-bacteriobilia-en-las-complicaciones-po-53b122ff 2026-03-26 https://revespquimioterapia.com/articulo/avances-en-vacunas-y-enfermedad-invasora-en-el-nin-5036fdea 2026-03-26 https://revespquimioterapia.com/articulo/control-y-prevencion-de-las-infecciones-nosocomial-b157b8ec 2026-03-26 https://revespquimioterapia.com/articulo/approach-to-covid-19-pandemic-management-in-madrid-2e1221e6 2026-03-26 https://revespquimioterapia.com/articulo/colistin-resistance-due-to-insertional-inactivatio-de01d3d9 2026-03-26 https://revespquimioterapia.com/articulo/aislamiento-de-moraxella-atlantae-en-la-valvula-na-00128760 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-the-covid-19-pandemic-on-the-mental-heal-c6f1a02b 2026-03-26 https://revespquimioterapia.com/articulo/demographic-clinical-and-microbiological-character-b7869f9d 2026-03-26 https://revespquimioterapia.com/articulo/enfermedad-de-whipple-con-presentacion-multiple-en-705d9ea4 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-mutaciones-que-confieren-resistencia-fdab821c 2026-03-26 https://revespquimioterapia.com/articulo/introduction-to-xiii-updating-course-of-antimicrob-3fc889e2 2026-03-26 https://revespquimioterapia.com/articulo/influencia-de-la-etnia-en-el-comportamiento-farmac-2072f7d8 2026-03-26 https://revespquimioterapia.com/articulo/endocarditis-infecciosa-por-tropheryma-whipplei-a--0493e0ba 2026-03-26 https://revespquimioterapia.com/articulo/pseudomonas-aeruginosa-estudio-multicentrico-en-13-2a8d6bb1 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-estreptococos-del-grupo-a-resultad-23a19270 2026-03-26 https://revespquimioterapia.com/articulo/sistemas-mdr-y-resistencia-a-los-antimicrobianos-f927d31b 2026-03-26 https://revespquimioterapia.com/articulo/j-barberan-lopez-9f2c8558 2026-03-26 https://revespquimioterapia.com/articulo/efecto-de-diferentes-antimicrobianos-a-concentraci-a319cb4b 2026-03-26 https://revespquimioterapia.com/articulo/modelizacion-matematica-de-la-propagacion-de-enfer-56b80dfb 2026-03-26 https://revespquimioterapia.com/articulo/antibacterianos-42f55664 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-de-hipertension-arterial-en-los-pacien-1fc6ac4a 2026-03-26 https://revespquimioterapia.com/articulo/usefulness-of-monitoring-linezolid-trough-serum-co-83d9f775 2026-03-26 https://revespquimioterapia.com/articulo/artritis-septica-de-rodilla-protesica-por-streptoc-10f3ec67 2026-03-26 https://revespquimioterapia.com/articulo/un-paciente-con-mal-de-pott-4dc0cfba 2026-03-26 https://revespquimioterapia.com/articulo/symposium-7-tratamiento-antifungico-de-las-infecci-9e917121 2026-03-26 https://revespquimioterapia.com/articulo/papel-de-daptomicina-en-el-tratamiento-empirico-y--0f8cfdeb 2026-03-26 https://revespquimioterapia.com/articulo/emergencia-de-streptococcus-agalactiae-con-resiste-a276c1de 2026-03-26 https://revespquimioterapia.com/articulo/encuesta-multicentrica-nacional-sobre-utilizacion--7f57766e 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-del-patron-de-sensibilidad-de-escherichi-52ef0c30 2026-03-26 https://revespquimioterapia.com/articulo/recommendations-for-use-of-antigenic-tests-in-the--2e64eb33 2026-03-26 https://revespquimioterapia.com/articulo/comprehensive-serological-strategy-for-the-diagnos-2ca154c0 2026-03-26 https://revespquimioterapia.com/articulo/treatment-of-invasive-fungal-infections-in-high-ri-0481c104 2026-03-26 https://revespquimioterapia.com/articulo/cobertura-de-la-vacuna-antineumococica-23-valente--382f0992 2026-03-26 https://revespquimioterapia.com/articulo/antifungicos-468d5632 2026-03-26 https://revespquimioterapia.com/articulo/highlights-at-the-27th-congress-of-the-european-so-78d5c861 2026-03-26 https://revespquimioterapia.com/articulo/acumulacion-y-expulsion-de-quinolonas-por-aislamie-f84ba39a 2026-03-26 https://revespquimioterapia.com/articulo/descriptivo-de-hafnia-alvei-aisladas-en-coproculti-9ff799da 2026-03-26 https://revespquimioterapia.com/articulo/los-abscesos-del-musculo-digastrico-psoas-o-iliops-10bf3003 2026-03-26 https://revespquimioterapia.com/articulo/cefditoren-en-las-infecciones-de-vias-respiratoria-70d93c76 2026-03-26 https://revespquimioterapia.com/articulo/outpatient-parenteral-antimicrobial-therapy-for-in-85f37286 2026-03-26 https://revespquimioterapia.com/articulo/status-of-herpes-zoster-and-herpes-zoster-vaccines-5cda0b93 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-a-antimicrobianos-en-salmonella-no-typ-a8b2d2c8 2026-03-26 https://revespquimioterapia.com/articulo/long-term-outcome-of-acute-prosthetic-joint-infect-c9bd6583 2026-03-26 https://revespquimioterapia.com/articulo/neumonia-por-legionella-macrolidos-o-quinolonas-3fe05c79 2026-03-26 https://revespquimioterapia.com/articulo/analisis-bibliometrico-de-la-revista-espanola-de-q-a6776ddf 2026-03-26 https://revespquimioterapia.com/articulo/actuacion-farmaceutica-en-el-control-de-la-duracio-9352a511 2026-03-26 https://revespquimioterapia.com/articulo/situacion-actual-de-la-infeccion-por-staphylococcu-652ff4a2 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-la-linezolida-en-aislamiento-df03d052 2026-03-26 https://revespquimioterapia.com/articulo/neumonia-adquirida-en-la-comunidad-en-los-servicio-1cafa558 2026-03-26 https://revespquimioterapia.com/articulo/efficacy-of-early-use-of-remdesivir-a-systematic-r-a9579497 2026-03-26 https://revespquimioterapia.com/articulo/highlights-in-hiv-2022-2024 2026-03-26 https://revespquimioterapia.com/articulo/therapeutic-management-of-health-care-associated-pneumonia 2026-03-26 https://revespquimioterapia.com/articulo/introduction-to-xiv-updating-course-of-antimicrobials-and-infectious-diseases 2026-03-26 https://revespquimioterapia.com/articulo/syndromic-platforms-in-the-management-of-infection-in-the-critically-ill-patient-test-indication-and-diagnostic-interpretation 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-individualizada-del-riesgo-de-infeccion-5d29fb71 2026-03-26 https://revespquimioterapia.com/articulo/clinical-study-types-and-guidance-for-their-correc-48df12af 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-las-infecciones-del-tracto-urinario-por-cbb5f239 2026-03-26 https://revespquimioterapia.com/articulo/neumonia-secundaria-por-bordetella-hinzii-en-pacie-796a3784 2026-03-26 https://revespquimioterapia.com/articulo/information-on-nosocomial-infections-in-the-mainst-208fefc2 2026-03-26 https://revespquimioterapia.com/articulo/effectiveness-of-cell-culture-based-influenza-vacc-ba70c56e 2026-03-26 https://revespquimioterapia.com/articulo/mycoplasma-y-ureaplasma-spp-en-la-practica-clinica-5f7db537 2026-03-26 https://revespquimioterapia.com/articulo/factores-de-riesgo-de-colonizacion-por-enterobacte-89d3ac46 2026-03-26 https://revespquimioterapia.com/articulo/gramnegativos-infrecuentes-como-agentes-etiologico-0c09df8a 2026-03-26 https://revespquimioterapia.com/articulo/una-vision-historica-socio-cultural-y-literaria-de-15390771 2026-03-26 https://revespquimioterapia.com/articulo/queratitis-fungica-por-colletotrichum-gloeosporioi-c459891d 2026-03-26 https://revespquimioterapia.com/articulo/breast-abscess-due-to-trueperella-bernardiae-and-a-4eb8e17f 2026-03-26 https://revespquimioterapia.com/articulo/sindrome-de-austrian-una-rara-manifestacion-de-la--c104cee7 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-the-use-of-antibiotics-on-the-clinical-r-47688830 2026-03-26 https://revespquimioterapia.com/articulo/a-practice-based-observational-study-identifying-f-79bf1564 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-la-validez-del-ag-panbio-covid19-de--ef05052a 2026-03-26 https://revespquimioterapia.com/articulo/las-pandemias-de-la-gripe-lecciones-aprendidas-e5f41c51 2026-03-26 https://revespquimioterapia.com/articulo/mecanismos-de-patogenicidad-y-adaptabilidad-humana-fb25ad3d 2026-03-26 https://revespquimioterapia.com/articulo/a-man-from-morocco-and-chronic-hip-pain-e880c58f 2026-03-26 https://revespquimioterapia.com/articulo/balanopostitis-por-facklamia-hominis-en-pediatria-f58d7a0d 2026-03-26 https://revespquimioterapia.com/articulo/update-on-bimervax-r-immunogenicity-amplitude-insi-a61476ac 2026-03-26 https://revespquimioterapia.com/articulo/tuberculosis-in-spain-an-opinion-paper-3645a832 2026-03-26 https://revespquimioterapia.com/articulo/heterorresistencia-y-tolerancia-a-glucopeptidos-en-87dd806f 2026-03-26 https://revespquimioterapia.com/articulo/eficacia-y-seguridad-de-la-vacunacion-antigripal-p-d80e499c 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-por-candida-parapsilosis-en-paciente-con-c14c6748 2026-03-26 https://revespquimioterapia.com/articulo/emergence-of-daptomycin-resistant-enterococcus-fae-eaa7fb05 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-de-la-resistencia-a-la-meticilina-de-sta-703c405c 2026-03-26 https://revespquimioterapia.com/articulo/herbaspirillum-huttiense-pneumonia-in-a-patient-wi-3ac88d1d 2026-03-26 https://revespquimioterapia.com/articulo/ulcera-ocular-por-moraxella-nonliquefaciens-b94aeb27 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-del-parametro-bact-info-del-citometro-d-458acd15 2026-03-26 https://revespquimioterapia.com/articulo/presentacion-15ad675f 2026-03-26 https://revespquimioterapia.com/articulo/la-gripe-todos-debemos-vacunarnos-ad41e3ea 2026-03-26 https://revespquimioterapia.com/articulo/la-importancia-de-un-diagnostico-precoz-tinea-capi-87572617 2026-03-26 https://revespquimioterapia.com/articulo/nosocomial-meningitis-caused-by-esbl-and-oxa-48-pr-3464be55 2026-03-26 https://revespquimioterapia.com/articulo/lesiones-en-diana-y-fiebre-un-microorganismo-inesp-697c1271 2026-03-26 https://revespquimioterapia.com/articulo/profilaxis-y-tratamiento-de-la-infeccion-fungica-i-03c9da94 2026-03-26 https://revespquimioterapia.com/articulo/la-jerga-de-los-antimicrobianos-eb7f72de 2026-03-26 https://revespquimioterapia.com/articulo/pautas-de-tratamiento-antibiotico-empirico-de-las--3e472f51 2026-03-26 https://revespquimioterapia.com/articulo/instrucciones-a-los-autores-25162307 2026-03-26 https://revespquimioterapia.com/articulo/micosis-pulmonar-cronica-por-paracoccidioides-bras-90ab35f2 2026-03-26 https://revespquimioterapia.com/articulo/impacto-de-la-covid-19-en-el-diagnostico-tardio-de-4d811844 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-de-paludismo-en-un-hospital-regional-c-6213985f 2026-03-26 https://revespquimioterapia.com/articulo/penetracion-en-liquido-cefalorraquideo-y-uso-de-ce-c3fc9232 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-de-uropatogenos-inusuales-durante-un-per-64300171 2026-03-26 https://revespquimioterapia.com/articulo/case-collection-study-of-the-safety-of-ambisome-in-1094a606 2026-03-26 https://revespquimioterapia.com/articulo/caracteristicas-sociodemograficas-y-factores-de-ri-e88e233f 2026-03-26 https://revespquimioterapia.com/articulo/micofenolato-como-ahorrador-de-corticoides-en-paci-c95b1a8d 2026-03-26 https://revespquimioterapia.com/articulo/levofloxacino-en-el-tratamiento-de-infecciones-nos-836a4695 2026-03-26 https://revespquimioterapia.com/articulo/incremento-de-infecciones-respiratorias-agudas-gra-54d22299 2026-03-26 https://revespquimioterapia.com/articulo/aspectos-epidemiologicos-de-la-resistencia-de-esch-775319c0 2026-03-26 https://revespquimioterapia.com/articulo/infective-endocarditis-in-a-patient-with-metastati-c651b238 2026-03-26 https://revespquimioterapia.com/articulo/integrase-strand-transfer-inhibitors-resistance-as-1ddd9a47 2026-03-26 https://revespquimioterapia.com/articulo/almacenamiento-de-antibioticos-en-los-hogares-espa-11f1c76c 2026-03-26 https://revespquimioterapia.com/articulo/staphylococcus-aureus-bacteremia-in-a-secondary-le-eab79841 2026-03-26 https://revespquimioterapia.com/articulo/descriptivo-de-los-casos-de-citomegalovirus-congen-33975c0f 2026-03-26 https://revespquimioterapia.com/articulo/resistencias-bacterianas-y-un-nuevo-antibiotico-la-a82acedf 2026-03-26 https://revespquimioterapia.com/articulo/should-we-leave-the-paper-currency-a-microbiologic-8b5a0be1 2026-03-26 https://revespquimioterapia.com/articulo/variables-clinicas-y-farmacologicas-de-pacientes-n-23b0ad3e 2026-03-26 https://revespquimioterapia.com/articulo/optimizacion-de-la-dosis-de-meropenem-en-infeccion-e0636373 2026-03-26 https://revespquimioterapia.com/articulo/meningitis-bacteriana-por-streptococcus-gallolytic-4d6770b8 2026-03-26 https://revespquimioterapia.com/articulo/john-donne-spanish-doctors-and-the-epidemic-typhus-4e60eab0 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-antimicrobiana-de-cepas-hipurato-nega-9431b618 2026-03-26 https://revespquimioterapia.com/articulo/papel-de-cefditoreno-en-el-tratamiento-de-las-infe-4f517d11 2026-03-26 https://revespquimioterapia.com/articulo/putative-secondary-structure-at-5-utr-as-a-potenti-15a1563c 2026-03-26 https://revespquimioterapia.com/articulo/postoperative-soft-tissue-infection-due-to-multidr-c53d0340 2026-03-26 https://revespquimioterapia.com/articulo/exploring-therapeutic-options-for-mild-diabetic-re-13d8a61c 2026-03-26 https://revespquimioterapia.com/articulo/streptobacillus-moniliformis-diferencias-in-vivo-e-4c384c9c 2026-03-26 https://revespquimioterapia.com/articulo/current-management-of-cmv-infection-in-cancer-pati-84b66883 2026-03-26 https://revespquimioterapia.com/articulo/microbiota-biliar-en-pacientes-colecistectomizados-ffb0047f 2026-03-26 https://revespquimioterapia.com/articulo/sondas-de-gastrostomia-indicaciones-y-complicacion-cba7d6f0 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-antibiotico-oral-de-la-exacerbacion-de-acd67c2e 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-a-la-penicilina-y-la-eritromicina-de-s-009f684a 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-moraxella-spp-revision-de-casos-pe-c4cc1135 2026-03-26 https://revespquimioterapia.com/articulo/de-la-lisozima-a-la-penicilina-un-camino-tan-compl-b0052ce9 2026-03-26 https://revespquimioterapia.com/articulo/repercusion-en-los-pacientes-de-las-resistencias-d-8e65c661 2026-03-26 https://revespquimioterapia.com/articulo/hepatitis-c-nuevos-diagnosticos-y-seroconversiones-5981f26c 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-urinaria-asociada-a-delftia-acidovorans-1f295434 2026-03-26 https://revespquimioterapia.com/articulo/infecciones-por-hongos-filamentosos-en-el-paciente-12750dde 2026-03-26 https://revespquimioterapia.com/articulo/dalbavancin-as-long-term-treatment-in-corynebacter-1c29e4df 2026-03-26 https://revespquimioterapia.com/articulo/fiebre-paratifoidea-dos-meses-despues-de-un-viaje--975a72bd 2026-03-26 https://revespquimioterapia.com/articulo/abordaje-de-la-candidemia-y-la-candidiasis-invasiv-7c395e7f 2026-03-26 https://revespquimioterapia.com/articulo/neck-infection-after-allogenic-hematopoietic-proge-8f1d6aa1 2026-03-26 https://revespquimioterapia.com/articulo/sepsis-por-pseudocitrobacter-anthropi-en-un-pacien-deeee5e8 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-1-52-54-ad7fffac 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-de-infeccion-por-sars-cov-2-durante-la-8feac898 2026-03-26 https://revespquimioterapia.com/articulo/management-of-hyperinflammation-in-covid-19-patien-01beb6a6 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-y-tratamiento-de-las-infecciones-por-g-e13be93c 2026-03-26 https://revespquimioterapia.com/articulo/mapa-de-la-atencion-a-las-infecciones-de-transmisi-9b0f6fe4 2026-03-26 https://revespquimioterapia.com/articulo/reacciones-adversas-asociadas-a-la-vacunacion-en-p-f6e8dc03 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-5-286-287-14810fb6 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-del-virus-de-epstein-barr-en-ulceras-gen-57738b6a 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-microbiologico-de-la-tuberculosis-20-a-efcca6b4 2026-03-26 https://revespquimioterapia.com/articulo/epoc-y-colonizacion-bacteriana-implicaciones-terap-8e89d2f7 2026-03-26 https://revespquimioterapia.com/articulo/recomendaciones-para-la-atencion-del-paciente-con--a3bd86af 2026-03-26 https://revespquimioterapia.com/articulo/in-vitro-study-of-synergy-of-ampicillin-with-ceftr-85248ecf 2026-03-26 https://revespquimioterapia.com/articulo/impacto-de-las-medidas-higienicas-y-de-distanciami-b4290330 2026-03-26 https://revespquimioterapia.com/articulo/dual-therapy-with-raltegravir-plus-a-fixed-dose-co-c1b2db87 2026-03-26 https://revespquimioterapia.com/articulo/la-herramienta-de-microsoft-r-power-bi-para-la-pre-5a67e173 2026-03-26 https://revespquimioterapia.com/articulo/farmacodinamia-y-metodos-de-administracion-de-farm-2c698541 2026-03-26 https://revespquimioterapia.com/articulo/mechanisms-of-resistance-to-daptomycin-in-staphylo-0e643dc7 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-de-aislamientos-clinicos-de-pseudomon-b95d3bf5 2026-03-26 https://revespquimioterapia.com/articulo/broncoespasmo-y-flushing-tras-la-vacunacion-con-ne-731d14f8 2026-03-26 https://revespquimioterapia.com/articulo/woman-with-necrotising-granulomatous-lymphadenitis-a9be7a97 2026-03-26 https://revespquimioterapia.com/articulo/sonication-did-not-provide-reliability-to-maki-tec-b6e6bad3 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-4-224-225-87daace6 2026-03-26 https://revespquimioterapia.com/articulo/actualizacion-en-patologia-infecciosa-2015-a8fd3adf 2026-03-26 https://revespquimioterapia.com/articulo/clinical-management-of-cuti-ciai-and-habp-vabp-att-898f458e 2026-03-26 https://revespquimioterapia.com/articulo/otitis-media-cronica-supurativa-por-mycobacterium--fb54f4d2 2026-03-26 https://revespquimioterapia.com/articulo/utilizacion-de-la-historia-digital-de-salud-y-la-a-1ba08458 2026-03-26 https://revespquimioterapia.com/articulo/antifungal-activity-of-posaconazole-against-candid-fd85b056 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-las-infecciones-por-bartonella-spp-ce0c3590 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-un-metodo-rapido-para-la-deteccion-d-95606fc5 2026-03-26 https://revespquimioterapia.com/articulo/estado-actual-de-la-sensibilidad-de-stenotrophomon-c134cf30 2026-03-26 https://revespquimioterapia.com/articulo/emerging-infectious-diseases-streptococcus-suis-me-2ce74bf4 2026-03-26 https://revespquimioterapia.com/articulo/coexistencia-de-linfoma-primario-del-sistema-nervioso-central-y-toxoplasmosis-cerebral-en-una-paciente-con-infeccion-por-vih-avanzada-y-serologia-negativa 2026-03-26 https://revespquimioterapia.com/articulo/1760445934919x784128786701221900 2026-03-26 https://revespquimioterapia.com/articulo/1751273998254x385728945802706940 2026-03-26 https://revespquimioterapia.com/articulo/vacuna-antigripal-trivalente-de-alta-dosis-segurid-b4fe8eed 2026-03-26 https://revespquimioterapia.com/articulo/the-importance-of-prevalence-and-pre-test-probabil-bd658df1 2026-03-26 https://revespquimioterapia.com/articulo/typing-and-antimicrobial-susceptibility-of-134-nei-31af93fc 2026-03-26 https://revespquimioterapia.com/articulo/a-case-report-rediscovering-tuberculostatics-drugs-16511825 2026-03-26 https://revespquimioterapia.com/articulo/evaluation-of-a-lateral-flow-immunoassay-to-detect-bcb1c11e 2026-03-26 https://revespquimioterapia.com/articulo/consenso-sobre-la-vacunacion-frente-a-la-gripe-en--e91cee11 2026-03-26 https://revespquimioterapia.com/articulo/estado-actual-y-perspectivas-en-el-tratamiento-ant-10e3c416 2026-03-26 https://revespquimioterapia.com/articulo/aumento-significativo-de-la-resistencia-a-fosfomic-8251075a 2026-03-26 https://revespquimioterapia.com/articulo/antivirales-en-la-prevencion-de-la-gripe-ba3774f5 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-la-resistencia-antibiotica-de-escher-83dec229 2026-03-26 https://revespquimioterapia.com/articulo/paciente-con-alergia-a-medicamentos-antituberculos-dcce6470 2026-03-26 https://revespquimioterapia.com/articulo/use-of-ceftaroline-in-complex-central-nervous-syst-4d7caa73 2026-03-26 https://revespquimioterapia.com/articulo/conjuntivitis-por-capnocytophaga-ochracea-en-un-ne-6d663bb8 2026-03-26 https://revespquimioterapia.com/articulo/repercusion-de-la-vacuna-contra-el-neumococo-en-la-8ac645c6 2026-03-26 https://revespquimioterapia.com/articulo/valoracion-de-una-tecnica-de-pcr-multiple-en-el-di-56caa5dc 2026-03-26 https://revespquimioterapia.com/articulo/caracteristicas-clinicas-pronostico-y-factores-aso-0e3bdae1 2026-03-26 https://revespquimioterapia.com/articulo/analisis-mediante-curvas-roc-de-los-factores-predi-c0f0c3c2 2026-03-26 https://revespquimioterapia.com/articulo/prevencion-de-un-brote-de-acinetobacter-baumannii--fb2d55ff 2026-03-26 https://revespquimioterapia.com/articulo/caracterizacion-fenotipica-de-la-resistencia-a-eri-41dec455 2026-03-26 https://revespquimioterapia.com/articulo/identifying-the-most-important-data-for-research-i-c97fc717 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-la-adecuacion-al-protocolo-de-profil-8d4912d5 2026-03-26 https://revespquimioterapia.com/articulo/guia-del-hospital-universitario-la-fe-para-la-prof-c8b243e8 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-de-staphylococcus-aureus-aislados-de--54b2e4c6 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-y-tipificacion-mediante-biologia-molecul-adfb2ce8 2026-03-26 https://revespquimioterapia.com/articulo/eficacia-en-vida-real-del-cambio-a-bictegravir-emt-303beb93 2026-03-26 https://revespquimioterapia.com/articulo/impacto-economico-y-sanitario-de-la-utilizacion-de-b8b225c6 2026-03-26 https://revespquimioterapia.com/articulo/chronic-obstructive-pulmonary-disease-copd-in-spai-7c644298 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-una-prueba-rapida-para-la-deteccion--4c6c764d 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-del-citometro-de-flujo-sysmex-uf-1000i--c3620c30 2026-03-26 https://revespquimioterapia.com/articulo/a-proposito-de-dos-casos-de-thelaziosis-ocular-hum-7a7ea36f 2026-03-26 https://revespquimioterapia.com/articulo/neumonia-bilateral-en-un-paciente-con-un-sindrome--2b45b8cb 2026-03-26 https://revespquimioterapia.com/articulo/dalbavancin-as-a-treatment-option-for-rothia-aeria-e0bdb14a 2026-03-26 https://revespquimioterapia.com/articulo/recomendaciones-del-tratamiento-antimicrobiano-en--07c6f424 2026-03-26 https://revespquimioterapia.com/articulo/-0bd3da6b 2026-03-26 https://revespquimioterapia.com/articulo/la-terapia-antiinfecciosa-nace-con-un-color-el-mal-42ccd516 2026-03-26 https://revespquimioterapia.com/articulo/is-it-possible-to-extrapolate-the-rates-of-resista-3a0860aa 2026-03-26 https://revespquimioterapia.com/articulo/salmonella-enterica-con-fenotipo-no-clasico-de-res-5b38e40d 2026-03-26 https://revespquimioterapia.com/articulo/aumento-de-staphylococcus-aureus-resistente-a-meti-f4065688 2026-03-26 https://revespquimioterapia.com/articulo/documento-de-consenso-para-la-implantacion-y-desar-6d2eefa5 2026-03-26 https://revespquimioterapia.com/articulo/actions-and-attitudes-on-the-immunized-patients-ag-e1cec03e 2026-03-26 https://revespquimioterapia.com/articulo/seroprevalencia-de-anticuerpos-frente-al-virus-del-22594ec2 2026-03-26 https://revespquimioterapia.com/articulo/antimicrobianos-en-atencion-primaria-una-vision-gl-6e2cf532 2026-03-26 https://revespquimioterapia.com/articulo/utilizacion-hospitalaria-de-levofloxacino-b2edece8 2026-03-26 https://revespquimioterapia.com/articulo/la-nueva-reglamentacion-sobre-ensayos-clinicos-mul-b5fd9d54 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-staphylococcus-aureus-en-el-hospit-5d67395e 2026-03-26 https://revespquimioterapia.com/articulo/vision-microbiologica-de-la-cavidad-anoftalmica-ac85df3b 2026-03-26 https://revespquimioterapia.com/articulo/influencia-de-la-protocolizacion-del-tratamiento-i-7cbc144f 2026-03-26 https://revespquimioterapia.com/articulo/central-nervous-system-infections-in-immunocomprom-cee33360 2026-03-26 https://revespquimioterapia.com/articulo/prevalence-of-anal-infection-by-human-papillomavir-6f09b65e 2026-03-26 https://revespquimioterapia.com/articulo/vacuna-antigripal-trivalente-de-alta-dosis-eficaci-d462fd37 2026-03-26 https://revespquimioterapia.com/articulo/first-isolation-of-skermanella-aerolata-from-a-hum-a1ac0039 2026-03-26 https://revespquimioterapia.com/articulo/gangrena-de-fournier-estudio-de-12-pacientes-y-rev-7affeb73 2026-03-26 https://revespquimioterapia.com/articulo/desarrollo-de-un-modelo-predictivo-para-mortalidad-6808eb8d 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemias-fatales-por-campylobacter-fetus-y-cam-430fd794 2026-03-26 https://revespquimioterapia.com/articulo/infection-in-the-process-of-organ-donation-3f8f6ad4 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-imipenem-y-meropenem-sobre-cepas-de-a-b3058a88 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-urinaria-por-acinetobacter-dijkshoorniae-0c7a2d26 2026-03-26 https://revespquimioterapia.com/articulo/estudio-epidemiologico-sobre-el-impacto-de-la-vacu-d249b8ad 2026-03-26 https://revespquimioterapia.com/articulo/contribucion-de-la-farmacodinamia-en-la-eleccion-d-8d1ac931 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-5-283-285-e382f589 2026-03-26 https://revespquimioterapia.com/articulo/impacto-del-sars-cov-2-en-el-diagnostico-de-bacter-412bbec3 2026-03-26 https://revespquimioterapia.com/articulo/otomastoiditis-tuberculosa-a-proposito-de-un-caso-d00ebb29 2026-03-26 https://revespquimioterapia.com/articulo/trascendencia-del-uso-de-una-tecnica-de-reaccion-e-84871d72 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-secundaria-a-procesos-odontologicos-pe-7e0e94d1 2026-03-26 https://revespquimioterapia.com/articulo/doctor-my-patient-has-cdi-and-should-continue-to-r-41374db8 2026-03-26 https://revespquimioterapia.com/articulo/ceftolozane-tazobactam-when-how-and-why-using-it-1131c388 2026-03-26 https://revespquimioterapia.com/articulo/recommendations-on-the-use-of-azole-antifungals-in-62c9659f 2026-03-26 https://revespquimioterapia.com/articulo/time-to-decision-in-sepsis-e29ad7b4 2026-03-26 https://revespquimioterapia.com/articulo/rendimiento-del-ensayo-de-amplificacion-mediada-po-c49fc9de 2026-03-26 https://revespquimioterapia.com/articulo/primoinfeccion-por-el-virus-epstein-barr-entre-los-76a46842 2026-03-26 https://revespquimioterapia.com/articulo/vaccination-strategies-against-sars-cov-2-general--48f543be 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-de-enterobacterias-portadoras-de-carbape-1c8d54fe 2026-03-26 https://revespquimioterapia.com/articulo/prevalence-of-genital-mycoplasma-and-response-to-e-ad0c143d 2026-03-26 https://revespquimioterapia.com/articulo/continuous-infusion-of-antibiotics-using-elastomer-6017d2ea 2026-03-26 https://revespquimioterapia.com/articulo/practical-approach-to-the-management-of-catheter-r-c2b4ef0c 2026-03-26 https://revespquimioterapia.com/articulo/use-of-clinical-vignettes-to-screen-general-practi-1a64642f 2026-03-26 https://revespquimioterapia.com/articulo/streptococcus-pneumoniae-resistencia-antibiotica-y-b62b0728 2026-03-26 https://revespquimioterapia.com/articulo/lessons-from-covid-19-for-future-disasters-an-opin-710f143a 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-1-59-61-cd1461db 2026-03-26 https://revespquimioterapia.com/articulo/relacion-entre-la-sensibilidad-de-pseudomonas-aeru-a948dd08 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-4-228-229-d9bad791 2026-03-26 https://revespquimioterapia.com/articulo/validez-y-utilidad-del-rae-cmbd-en-el-estudio-de-l-4ff7b78f 2026-03-26 https://revespquimioterapia.com/articulo/use-of-micafungin-as-antifungal-prophylaxis-in-pat-face3f5d 2026-03-26 https://revespquimioterapia.com/articulo/insights-for-covid-19-in-2023-e95aeddf 2026-03-26 https://revespquimioterapia.com/articulo/seroprevalence-of-toxoplasma-gondii-infection-in-p-3855dbfd 2026-03-26 https://revespquimioterapia.com/articulo/activity-of-imipenem-relebactam-against-enterobact-418d354e 2026-03-26 https://revespquimioterapia.com/articulo/nefritis-focal-aguda-bilateral-por-enterococcus-fa-83db5989 2026-03-26 https://revespquimioterapia.com/articulo/sarcoma-de-kaposi-parasitado-por-leishmania-en-pac-2d311e25 2026-03-26 https://revespquimioterapia.com/articulo/nuevos-antibioticos-activos-frente-a-grampositivos-1a66c9fd 2026-03-26 https://revespquimioterapia.com/articulo/probioticos-4d2cf77e 2026-03-26 https://revespquimioterapia.com/articulo/first-clinical-isolation-report-of-shewanella-alga-19995b83 2026-03-26 https://revespquimioterapia.com/articulo/use-of-fidaxomicin-through-a-nasogastric-tube-for--2f760a52 2026-03-26 https://revespquimioterapia.com/articulo/antivirales-3a0c14c1 2026-03-26 https://revespquimioterapia.com/articulo/streptococcus-agalactiae-prevencion-y-desarrollo-d-5763f2a3 2026-03-26 https://revespquimioterapia.com/articulo/tecnicas-microbiologicas-eb0ca45f 2026-03-26 https://revespquimioterapia.com/articulo/actividad-comparativa-de-doripenem-meropenem-e-imi-974064a8 2026-03-26 https://revespquimioterapia.com/articulo/activity-of-ertapenem-and-ceftriaxone-in-the-eradi-d21c1917 2026-03-26 https://revespquimioterapia.com/articulo/consideraciones-microbiologicas-y-terapeuticas-de--feb55d27 2026-03-26 https://revespquimioterapia.com/articulo/significance-of-lower-respiratory-tract-cultures-y-f582d182 2026-03-26 https://revespquimioterapia.com/articulo/los-linajes-victoria-y-yamagata-de-los-virus-gripa-bdcd1bdb 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-por-helicobacter-pylori-en-la-poblacion--adc87f31 2026-03-26 https://revespquimioterapia.com/articulo/new-materials-and-complications-of-prostheses-in-h-978159b1 2026-03-26 https://revespquimioterapia.com/articulo/introduction-to-third-pneumonia-national-meeting-n-20448ab6 2026-03-26 https://revespquimioterapia.com/articulo/peritonitis-por-clostridium-baratii-en-paciente-ci-8d8e95ba 2026-03-26 https://revespquimioterapia.com/articulo/aceptabilidad-de-la-vacuna-contra-el-vph-en-estudi-066bac91 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemias-en-geriatria-epidemiologia-y-factores-e9cf031e 2026-03-26 https://revespquimioterapia.com/articulo/celulitis-tras-mordedura-de-gato-e777b5d9 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-solobacterium-moorei-en-paciente-c-2fa028cd 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-de-la-resistencia-a-betalactamicos-en--dcaacfb5 2026-03-26 https://revespquimioterapia.com/articulo/influencia-de-los-antiinflamatorios-en-la-acumulac-9124ee0e 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-antibioticos-betalactamicos--6e52f57f 2026-03-26 https://revespquimioterapia.com/articulo/comportamiento-de-los-medicos-de-atencion-primaria-b1565003 2026-03-26 https://revespquimioterapia.com/articulo/potenciales-biomarcadores-predictores-de-mortalida-8e5b5ca5 2026-03-26 https://revespquimioterapia.com/articulo/impacto-del-consumo-de-antibioticos-de-uso-topico--656c430b 2026-03-26 https://revespquimioterapia.com/articulo/neumonia-por-neisseria-meningitidis-descripcion-de-84f630af 2026-03-26 https://revespquimioterapia.com/articulo/diagnostic-and-prognostic-value-of-time-to-positiv-ca066888 2026-03-26 https://revespquimioterapia.com/articulo/ceftaroline-fosamil-clinical-experience-after-23-m-5dbf2703 2026-03-26 https://revespquimioterapia.com/articulo/control-precoz-del-foco-de-infeccion-en-los-pacien-a2c48c40 2026-03-26 https://revespquimioterapia.com/articulo/prospective-comparison-of-severity-scores-for-pred-791da0b1 2026-03-26 https://revespquimioterapia.com/articulo/interleukin-il-1-b-il-6-and-tumor-necrosis-factor--34daddb4 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-the-covid-19-pandemic-community-and-hosp-afb07371 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-suppl-2-20-22-da5629e5 2026-03-26 https://revespquimioterapia.com/articulo/piperacilina-tazobactam-estudio-comparativo-de-la--c364f920 2026-03-26 https://revespquimioterapia.com/articulo/el-consumo-de-antimicrobianos-en-espana-un-problem-66533c24 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-del-modelo-5mpb-toledo-para-predecir-bact-3c06c3d6 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-un-test-rapido-inmunocromatografico--d58baaa8 2026-03-26 https://revespquimioterapia.com/articulo/optimization-of-antimicrobial-treatment-in-sepsis-98a1f133 2026-03-26 https://revespquimioterapia.com/articulo/fosfomicina-460cc55c 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-streptococcus-pyogenes-a-los-macrolid-2953ca31 2026-03-26 https://revespquimioterapia.com/articulo/duracion-del-tratamiento-antibiotico-8c8ed2b4 2026-03-26 https://revespquimioterapia.com/articulo/symposium-8-telitromicina-primer-cetolido-en-la-mo-961a0bb3 2026-03-26 https://revespquimioterapia.com/articulo/influencia-de-la-fase-preanalitica-en-la-cuantific-654f7813 2026-03-26 https://revespquimioterapia.com/articulo/asociacion-entre-integrones-de-clase-1-con-resiste-e9b1eca0 2026-03-26 https://revespquimioterapia.com/articulo/antiparasitarios-revision-de-los-farmacos-utiles-e-7c2a3d7f 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-an-antimicrobial-stewardship-program-on--006a77bb 2026-03-26 https://revespquimioterapia.com/articulo/antimicrobial-resistance-in-gram-negative-bacilli--9f35e1ee 2026-03-26 https://revespquimioterapia.com/articulo/what-are-the-most-relevant-publications-in-clinica-b93b01cb 2026-03-26 https://revespquimioterapia.com/articulo/the-role-of-viral-diagnostic-tests-in-respiratory--60f85dde 2026-03-26 https://revespquimioterapia.com/articulo/evaluation-questionnaire-cbfe5291 2026-03-26 https://revespquimioterapia.com/articulo/descripcion-de-un-brote-de-triquinosis-en-la-provi-f357d452 2026-03-26 https://revespquimioterapia.com/articulo/documento-de-consenso-sobre-quimioprofilaxis-quiru-7177ad14 2026-03-26 https://revespquimioterapia.com/articulo/simulacion-de-la-propagacion-de-un-brote-por-acine-47b28f7a 2026-03-26 https://revespquimioterapia.com/articulo/analisis-de-la-pervivencia-difusion-y-productivida-db2acda3 2026-03-26 https://revespquimioterapia.com/articulo/the-role-of-hospital-emergency-departments-in-iden-62b9648b 2026-03-26 https://revespquimioterapia.com/articulo/staphylococcus-aureus-sensible-a-cloxacilina-con-c-a9b0fa1a 2026-03-26 https://revespquimioterapia.com/articulo/pk-pd-y-desarrollo-de-nuevas-formas-farmaceuticas-214c6ac9 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-cefpodoxima-y-otros-betalactamicos-or-50ca7125 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-de-la-resistencia-genotipica-a-los-far-f1fe0e0f 2026-03-26 https://revespquimioterapia.com/articulo/prevalence-and-risk-factors-for-meticillin-resista-b11cbef6 2026-03-26 https://revespquimioterapia.com/articulo/analisis-de-la-incidencia-y-epidemiologia-de-las-i-c43135b9 2026-03-26 https://revespquimioterapia.com/articulo/vigilancia-de-la-sensibilidad-a-antimicrobianos-de-ef8e5564 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-diferentes-genes-en-la-deteccion-por-46143d01 2026-03-26 https://revespquimioterapia.com/articulo/variabilidad-del-consumo-de-antibioticos-en-una-re-8e72c07d 2026-03-26 https://revespquimioterapia.com/articulo/nirmatrelvir-ritonavir-como-posible-tratamiento-de-48ab7719 2026-03-26 https://revespquimioterapia.com/articulo/por-que-vacunar-a-ninos-frente-a-la-gripe-b69081db 2026-03-26 https://revespquimioterapia.com/articulo/recomendaciones-de-un-panel-de-expertos-sobre-la-u-5b9d9306 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-en-staphylococcus-aureus-ahora-a-la-va-d4214782 2026-03-26 https://revespquimioterapia.com/articulo/experiencia-clinica-con-tigeciclina-en-el-tratamie-38111fb2 2026-03-26 https://revespquimioterapia.com/articulo/bases-y-nuevas-perspectivas-del-uso-racional-de-lo-a9eeddc5 2026-03-26 https://revespquimioterapia.com/articulo/capacidad-del-qsofa1-lactato-para-predecir-mortali-77a1edba 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-de-la-incidencia-de-pacientes-con-coloni-fed34526 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-klebsiella-pneumoniae-productora-d-2c73a116 2026-03-26 https://revespquimioterapia.com/articulo/estabilidad-de-los-betalactamicos-en-los-discos-y--0dac0a9c 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-del-consumo-de-antibioticos-en-la-atenc-9966686a 2026-03-26 https://revespquimioterapia.com/articulo/piomiositis-glutea-con-absceso-del-obturador-inter-3a5419c7 2026-03-26 https://revespquimioterapia.com/articulo/effect-of-the-administration-of-a-probiotic-with-a-2a85842f 2026-03-26 https://revespquimioterapia.com/articulo/patron-serologico-anomalo-de-reactivacion-del-viru-fbe76f2a 2026-03-26 https://revespquimioterapia.com/articulo/el-despertar-de-la-era-antibiotica-ec781c61 2026-03-26 https://revespquimioterapia.com/articulo/caracteristicas-de-la-bacteriemia-relacionada-con--b629b679 2026-03-26 https://revespquimioterapia.com/articulo/the-role-of-cefiderocol-in-clinical-practice-70f82383 2026-03-26 https://revespquimioterapia.com/articulo/experience-with-the-use-of-siltuximab-in-patients--6678a0a1 2026-03-26 https://revespquimioterapia.com/articulo/unusual-case-report-of-skin-infection-by-paenibaci-87d6b9da 2026-03-26 https://revespquimioterapia.com/articulo/variabilidad-en-la-sensibilidad-de-tigeciclina-fre-bd7f98f7 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-la-formacion-sobre-el-programa-de-op-27429f9d 2026-03-26 https://revespquimioterapia.com/articulo/models-for-bacteraemia-risk-prediction-clinical-im-a0b17539 2026-03-26 https://revespquimioterapia.com/articulo/reduction-in-diabetic-amputations-over-15-years-in-21ca137f 2026-03-26 https://revespquimioterapia.com/articulo/variabilidad-geografica-de-la-prescripcion-de-anti-894ebb4c 2026-03-26 https://revespquimioterapia.com/articulo/la-estreptomicina-como-farmaco-de-segunda-linea-en-50ea4361 2026-03-26 https://revespquimioterapia.com/articulo/es-la-farmacodinamica-una-herramienta-util-para-la-f7d1b95c 2026-03-26 https://revespquimioterapia.com/articulo/factores-de-riesgo-y-evolucion-clinica-de-las-infe-01683794 2026-03-26 https://revespquimioterapia.com/articulo/nuevas-opciones-terapeuticas-para-el-tratamiento-d-106e31fc 2026-03-26 https://revespquimioterapia.com/articulo/estado-actual-del-tratamiento-farmacologico-de-la--c5a1adc0 2026-03-26 https://revespquimioterapia.com/articulo/antimicrobial-stewardship-in-patients-recently-tra-3a40c494 2026-03-26 https://revespquimioterapia.com/articulo/factores-predictivos-de-infeccion-por-el-virus-de--b059060d 2026-03-26 https://revespquimioterapia.com/articulo/in-silico-analysis-of-transferable-qepa-variants-a-87170eb4 2026-03-26 https://revespquimioterapia.com/articulo/factores-de-riesgo-y-pronostico-de-las-neumonias-n-6dc50206 2026-03-26 https://revespquimioterapia.com/articulo/mesa-redonda-3-criterios-actuales-en-el-diagnostic-4bb2442e 2026-03-26 https://revespquimioterapia.com/articulo/infecciones-en-pacientes-colonizados-con-bacterias-3b7bf208 2026-03-26 https://revespquimioterapia.com/articulo/recomendaciones-en-el-tratamiento-antibiotico-empi-ab1bc963 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-del-virus-respiratorio-sincitial-en-la-c-1e0be606 2026-03-26 https://revespquimioterapia.com/articulo/el-cumplimiento-del-tratamiento-antibiotico-en-la--552a1d3e 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-las-asociaciones-de-antifungicos-sist-2dbdb6ab 2026-03-26 https://revespquimioterapia.com/articulo/an-analysis-of-the-association-between-genotype-an-dfe4ef79 2026-03-26 https://revespquimioterapia.com/articulo/remdesivir-la-esperanza-antiviral-frente-al-sars-c-834e6901 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-1-50-51-dae3be80 2026-03-26 https://revespquimioterapia.com/articulo/reactivacion-de-neurocisticercosis-en-paciente-en--b7c1d9a1 2026-03-26 https://revespquimioterapia.com/articulo/fagoterapia-una-alternativa-a-la-antibioticoterapi-b8a57101 2026-03-26 https://revespquimioterapia.com/articulo/herpes-zoster-en-zona-perianal-y-perineal-en-pacie-8548e5fc 2026-03-26 https://revespquimioterapia.com/articulo/identification-of-curved-gram-negative-rods-by-mal-3682115b 2026-03-26 https://revespquimioterapia.com/articulo/absceso-de-psoas-asociado-a-infeccion-de-una-artro-8b6ddc00 2026-03-26 https://revespquimioterapia.com/articulo/velocidad-y-magnitud-de-actividad-bactericida-de-a-da481c7b 2026-03-26 https://revespquimioterapia.com/articulo/osteomielitis-esternal-y-mediastinitis-por-fusobac-7958f0ce 2026-03-26 https://revespquimioterapia.com/articulo/meropenem-experiencia-en-pediatria-5db7c89d 2026-03-26 https://revespquimioterapia.com/articulo/riesgo-de-sobreinfeccion-asociado-con-el-uso-de-an-778d7cb2 2026-03-26 https://revespquimioterapia.com/articulo/factor-de-impacto-y-calidad-de-las-publicaciones-c-b43a6251 2026-03-26 https://revespquimioterapia.com/articulo/segundo-estudio-multicentrico-de-la-sensibilidad-i-9b957d8e 2026-03-26 https://revespquimioterapia.com/articulo/direct-acting-antiviral-agents-in-patients-with-he-e21a24ad 2026-03-26 https://revespquimioterapia.com/articulo/effectiveness-and-safety-of-daclatasvir-sofosbuvir-8c1a42e5 2026-03-26 https://revespquimioterapia.com/articulo/neumonia-asociada-a-derrame-parapneumonico-en-paci-42132253 2026-03-26 https://revespquimioterapia.com/articulo/nirmatrelvir-mas-ritonavir-paxlovid-una-potente-co-5ba7395d 2026-03-26 https://revespquimioterapia.com/articulo/non-candida-isolates-from-blood-cultures-and-intra-c334cee1 2026-03-26 https://revespquimioterapia.com/articulo/role-of-hologic-r-panther-aptimatm-sars-cov-2-assa-1d6148a4 2026-03-26 https://revespquimioterapia.com/articulo/in-vitro-assessment-of-the-combined-effect-of-lete-51b20313 2026-03-26 https://revespquimioterapia.com/articulo/bezlotoxumab-in-the-treatment-of-clostridioides-di-ae0e3079 2026-03-26 https://revespquimioterapia.com/articulo/tres-claves-para-seleccionar-el-antibiotico-oral-a-89711ab5 2026-03-26 https://revespquimioterapia.com/articulo/pregnancies-in-perinatally-hiv-infected-women-anti-34dcdd3c 2026-03-26 https://revespquimioterapia.com/articulo/new-perspectives-for-reassessing-fosfomycin-applic-34d36752 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-la-variabilidad-en-la-sensibilidad-d-fd5f006b 2026-03-26 https://revespquimioterapia.com/articulo/la-infeccion-por-helicobacter-pylori-premio-nobel--4b3d8763 2026-03-26 https://revespquimioterapia.com/articulo/nuevos-antimicrobianos-frente-a-microorganismos-gr-b8aba4e4 2026-03-26 https://revespquimioterapia.com/articulo/estrategia-vacunal-para-la-prevencion-de-la-gripe-1d662ba1 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-helicobacter-cinaedi-en-paciente-i-c2e15533 2026-03-26 https://revespquimioterapia.com/articulo/recurrent-ventilator-associated-pneumonia-caused-b-e74e2a05 2026-03-26 https://revespquimioterapia.com/articulo/meningitis-aguda-por-streptococcus-agalactiae-en-u-fc7e3f57 2026-03-26 https://revespquimioterapia.com/articulo/usefulness-of-thoracic-ultrasound-for-diagnosis-an-f100e350 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-actynomices-oris-a0e4513e 2026-03-26 https://revespquimioterapia.com/articulo/del-genoma-de-un-patogeno-a-una-vacuna-efectiva-la-3d199109 2026-03-26 https://revespquimioterapia.com/articulo/compliance-with-preventive-measures-against-malari-07f4b1a1 2026-03-26 https://revespquimioterapia.com/articulo/importancia-clinica-de-los-azoles-en-la-terapia-an-76042fbe 2026-03-26 https://revespquimioterapia.com/articulo/instrucciones-a-los-autore-s-539e95c4 2026-03-26 https://revespquimioterapia.com/articulo/clarithromycin-plus-linezolid-as-a-sequential-ther-8ffa26fe 2026-03-26 https://revespquimioterapia.com/articulo/valoracion-de-dos-pruebas-inmunocromatograficas-pa-13b48933 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-temporal-de-la-terapia-antirretroviral-2-3e1e88fc 2026-03-26 https://revespquimioterapia.com/articulo/urgent-need-for-a-rapid-microbiological-diagnosis--b2f38fe3 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-staphylococcus-aureus-resistente-a-e46cbe1c 2026-03-26 https://revespquimioterapia.com/articulo/two-cases-of-prevotella-oris-causing-serious-pleur-4f43751a 2026-03-26 https://revespquimioterapia.com/articulo/corneal-abscess-caused-by-filobasidium-uniguttulat-064d167b 2026-03-26 https://revespquimioterapia.com/articulo/maraviroc-modifies-gut-microbiota-composition-in-a-dcf1fcb7 2026-03-26 https://revespquimioterapia.com/articulo/application-of-cmo-capacity-motivation-and-opportu-596568da 2026-03-26 https://revespquimioterapia.com/articulo/artritis-septica-por-neumococo-en-paciente-con-enf-8dafee36 2026-03-26 https://revespquimioterapia.com/articulo/coinfeccion-bacteriana-en-el-paciente-covid-19-cri-c1601db2 2026-03-26 https://revespquimioterapia.com/articulo/reduction-in-the-risk-of-progression-of-solid-orga-c6cfcfab 2026-03-26 https://revespquimioterapia.com/articulo/de-la-dosis-unica-a-las-formas-lipidicas-3377e29e 2026-03-26 https://revespquimioterapia.com/articulo/encuesta-multicentrica-nacional-sobre-el-manejo-de-7d61d8f6 2026-03-26 https://revespquimioterapia.com/articulo/estudio-multicentrico-nacional-de-la-actividad-in--b1bba165 2026-03-26 https://revespquimioterapia.com/articulo/identificacion-rapida-de-cocos-grampositivos-en-ca-9ac61b29 2026-03-26 https://revespquimioterapia.com/articulo/new-evidence-in-severe-pneumonia-imipenem-cilastat-8cbdf8d7 2026-03-26 https://revespquimioterapia.com/articulo/adenopatias-generalizadas-e-infeccion-diseminada-p-4c317ade 2026-03-26 https://revespquimioterapia.com/articulo/monitorizacion-farmacocinetica-de-isavuconazol-en--bdfb2eb1 2026-03-26 https://revespquimioterapia.com/articulo/myroides-odoratus-as-an-unusual-urinary-tract-infe-e9ba6187 2026-03-26 https://revespquimioterapia.com/articulo/influence-of-epidemiological-and-clinical-factors--89b730d5 2026-03-26 https://revespquimioterapia.com/articulo/el-nuevo-calendario-vacunal-oficial-del-adulto-no--70f44608 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemia-por-kluyvera-ascorbata-en-un-paciente--fca13af6 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-y-factores-de-riesgo-de-infeccion-por--1f906981 2026-03-26 https://revespquimioterapia.com/articulo/the-importance-of-an-early-gastroenteritis-diagnos-d3a1ee0f 2026-03-26 https://revespquimioterapia.com/articulo/comparison-two-blood-culture-bottles-for-the-recov-a4059103 2026-03-26 https://revespquimioterapia.com/articulo/a-5-year-study-of-bloodstream-infections-caused-by-be69f568 2026-03-26 https://revespquimioterapia.com/articulo/detection-and-genotyping-of-human-respiratory-viru-c1a35159 2026-03-26 https://revespquimioterapia.com/articulo/difusion-de-los-antibioticos-en-el-sistema-nervios-8c75f488 2026-03-26 https://revespquimioterapia.com/articulo/vulvovaginitis-por-streptococcus-pyogenes-en-mujer-c6ab2fcd 2026-03-26 https://revespquimioterapia.com/articulo/cerebellious-abscesses-caused-by-nocardia-farcinic-e99a6c73 2026-03-26 https://revespquimioterapia.com/articulo/analisis-del-uso-ambulatorio-de-antibioticos-en-lo-41a74bfe 2026-03-26 https://revespquimioterapia.com/articulo/importancia-de-los-centros-nacionales-de-gripe-en--f9b4ed26 2026-03-26 https://revespquimioterapia.com/articulo/efficacy-of-delafloxacin-alone-and-in-combination--b88f01fe 2026-03-26 https://revespquimioterapia.com/articulo/cambios-clinicos-y-terapeuticos-de-las-otitis-con--821c83ee 2026-03-26 https://revespquimioterapia.com/articulo/perspectivas-actuales-en-la-enfermedad-de-creutzfe-af7560b0 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-las-infecciones-urinarias-adquirida-be765611 2026-03-26 https://revespquimioterapia.com/articulo/evidencias-cientifica-y-concepcion-global-del-trat-ba4fd156 2026-03-26 https://revespquimioterapia.com/articulo/antifungicos-en-el-tratamiento-de-las-infecciones--7b6322b2 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-de-la-resistencia-a-quinolonas-y-betalac-4583acd6 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-a-los-macrolidos-en-streptococcus-pyog-72922e4b 2026-03-26 https://revespquimioterapia.com/articulo/el-tratamiento-de-las-enfermedades-infecciosas-en--5f3fab58 2026-03-26 https://revespquimioterapia.com/articulo/hemophagocytic-syndrome-in-patients-infected-with--80be968d 2026-03-26 https://revespquimioterapia.com/articulo/antivirales-antifungicos-y-antiprotozoarios-en-el--194d4e3d 2026-03-26 https://revespquimioterapia.com/articulo/listeria-monocytogenes-a-rare-cause-of-endophthalm-e3da0180 2026-03-26 https://revespquimioterapia.com/articulo/dinamica-estructural-de-colonias-biofilm-de-legion-597b7a79 2026-03-26 https://revespquimioterapia.com/articulo/optimizacion-de-la-actividad-bactericida-en-el-tra-97256aa1 2026-03-26 https://revespquimioterapia.com/articulo/osteomielitis-vertebral-por-actinomyces-reporte-de-61048658 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-urinaria-por-corynebacterium-jeikeium-y--3d41581e 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-la-furazolidona-y-la-nitrofu-2c680bd2 2026-03-26 https://revespquimioterapia.com/articulo/uso-de-dolutegravir-en-infeccion-aguda-por-vih-1-p-50f70330 2026-03-26 https://revespquimioterapia.com/articulo/peptidos-antibioticos-eucarioticos-reliquia-evolut-d8bce04c 2026-03-26 https://revespquimioterapia.com/articulo/la-tragedia-de-los-comunes-en-quimioterapia-antimi-aa56614a 2026-03-26 https://revespquimioterapia.com/articulo/sobre-el-segundo-documento-de-consenso-para-el-uso-fb580885 2026-03-26 https://revespquimioterapia.com/articulo/cutaneous-abscess-due-to-gordonia-bronchialis-case-00da64e7 2026-03-26 https://revespquimioterapia.com/articulo/influencia-de-la-protocolizacion-consensuada-en-el-9254df95 2026-03-26 https://revespquimioterapia.com/articulo/aspectos-microbiologicos-actuales-de-la-infeccion--306d6ae8 2026-03-26 https://revespquimioterapia.com/articulo/epidemiologia-de-la-enfermedad-asociada-a-clostrid-e5a248aa 2026-03-26 https://revespquimioterapia.com/articulo/update-in-infectious-diseases-2018-cb1370c5 2026-03-26 https://revespquimioterapia.com/articulo/adecuacion-a-las-recomendaciones-diagnosticas-en-p-2c28966b 2026-03-26 https://revespquimioterapia.com/articulo/recommendations-for-the-treatment-of-invasive-fung-ff2088ac 2026-03-26 https://revespquimioterapia.com/articulo/complicacion-infecciosa-poco-frecuente-tras-autoin-1d825a4a 2026-03-26 https://revespquimioterapia.com/articulo/peritonitis-por-moraxella-osloensis-a-proposito-de-6649d911 2026-03-26 https://revespquimioterapia.com/articulo/soft-tissue-infection-due-to-mycoplasma-hominis-96220426 2026-03-26 https://revespquimioterapia.com/articulo/profiles-and-clinical-management-of-hepatitis-c-pa-961ea7a7 2026-03-26 https://revespquimioterapia.com/articulo/infecciones-por-listeria-monocytogenes-b925058e 2026-03-26 https://revespquimioterapia.com/articulo/antibioterapia-para-el-siglo-xxi-antibacterianos-p-fac36c51 2026-03-26 https://revespquimioterapia.com/articulo/timing-in-antibiotic-therapy-when-and-how-to-start-a60c856f 2026-03-26 https://revespquimioterapia.com/articulo/valores-de-sensibilidad-in-vitro-al-aciclovir-y-al-3984a219 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-moxifloxacino-frente-a-patog-4a78ee9d 2026-03-26 https://revespquimioterapia.com/articulo/drug-resistant-bacteria-on-hands-of-healthcare-wor-1d3b9067 2026-03-26 https://revespquimioterapia.com/articulo/desfluoroquinolonas-frente-a-fluoroquinolonas-a0935b8e 2026-03-26 https://revespquimioterapia.com/articulo/clostridioides-difficile-infection-in-a-long-term--96166ba9 2026-03-26 https://revespquimioterapia.com/articulo/criptosporidiosis-en-paciente-inmunodeprimida-por--92dabf7e 2026-03-26 https://revespquimioterapia.com/articulo/clinical-characteristics-and-outcome-of-patients-w-e50c108f 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-2-140-141-92ffa778 2026-03-26 https://revespquimioterapia.com/articulo/sindrome-post-covid-un-documento-de-reflexion-y-op-02dc02dc 2026-03-26 https://revespquimioterapia.com/articulo/antimicrobial-resistance-and-one-health-65ebaa53 2026-03-26 https://revespquimioterapia.com/articulo/brain-abscesses-caused-by-anaerobic-microorganisms-5c84c9ef 2026-03-26 https://revespquimioterapia.com/articulo/seguridad-en-la-seleccion-del-tratamiento-antibiot-ce638c73 2026-03-26 https://revespquimioterapia.com/articulo/estado-actual-de-la-resistencia-multiple-a-farmaco-20b4769d 2026-03-26 https://revespquimioterapia.com/articulo/descripcion-de-la-gripe-b-en-las-epidemias-estacio-af1287d5 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-de-streptococcus-pyogenes-en-muestras-fa-20915eb4 2026-03-26 https://revespquimioterapia.com/articulo/caracteristicas-de-la-infeccion-por-helicobacter-p-8d957576 2026-03-26 https://revespquimioterapia.com/articulo/nuevos-avances-metodologicos-propuesta-de-algoritm-b5607baf 2026-03-26 https://revespquimioterapia.com/articulo/incidencia-de-nefrotoxicidad-inducida-por-colistin-529ec1e7 2026-03-26 https://revespquimioterapia.com/articulo/use-of-antibiotics-at-a-university-clinic-hospital-d0ade42a 2026-03-26 https://revespquimioterapia.com/articulo/the-spanish-flu-and-the-fiction-literature-681c6d2d 2026-03-26 https://revespquimioterapia.com/articulo/epidemiology-diagnosis-and-treatment-of-fungal-res-dc053598 2026-03-26 https://revespquimioterapia.com/articulo/beliefs-and-attitudes-about-deprescription-in-olde-e72a0c56 2026-03-26 https://revespquimioterapia.com/articulo/endocarditis-infecciosa-por-listeria-monocytogenes-04c7e4df 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-claritromicina-y-metronidazo-267806af 2026-03-26 https://revespquimioterapia.com/articulo/covid-19-and-acute-respiratory-distress-syndrome-i-2ccde036 2026-03-26 https://revespquimioterapia.com/articulo/temporary-hospitals-in-times-of-the-covid-pandemic-37e4d9dc 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-la-hepatitis-cronica-c-y-pruebas-de-5a9a5ff3 2026-03-26 https://revespquimioterapia.com/articulo/covid-19-impact-on-prescribing-and-antimicrobial-r-dc77332d 2026-03-26 https://revespquimioterapia.com/articulo/veinte-anos-de-anfotericina-b-liposomal-en-la-hist-556de3b0 2026-03-26 https://revespquimioterapia.com/articulo/a-young-patient-with-fever-after-heart-transplanta-0e679042 2026-03-26 https://revespquimioterapia.com/articulo/sars-cov-2-infection-in-solid-organ-transplant-rec-ee0253f3 2026-03-26 https://revespquimioterapia.com/articulo/misconceptions-of-spanish-general-practitioners-at-b833db19 2026-03-26 https://revespquimioterapia.com/articulo/practical-decalogue-in-the-management-of-sepsis-e400ddc3 2026-03-26 https://revespquimioterapia.com/articulo/clinically-important-pharmacokinetic-drug-drug-int-6b73741e 2026-03-26 https://revespquimioterapia.com/articulo/implicacion-de-los-genes-ermx-en-la-resistencia-a--f38c7d9d 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-a-las-quinolonas-en-aislamientos-de-es-fc8bd71c 2026-03-26 https://revespquimioterapia.com/articulo/side-effects-of-benznidazole-treatment-in-a-cohort-30927a3c 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-las-infecciones-relacionadas-con-ca-d40ed3e0 2026-03-26 https://revespquimioterapia.com/articulo/redlabra-a-spanish-network-of-microbiology-laborat-636a390d 2026-03-26 https://revespquimioterapia.com/articulo/interacciones-de-las-bacterias-y-el-antimicrobiano-ac42fbbf 2026-03-26 https://revespquimioterapia.com/articulo/deteccion-del-virus-respiratorio-sincitial-en-mues-3c6c8a13 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-utilizacion-en-practica-clinica-real-de-177a5131 2026-03-26 https://revespquimioterapia.com/articulo/covid-19-in-donation-and-transplant-f4307374 2026-03-26 https://revespquimioterapia.com/articulo/panorama-actual-de-la-ensenanza-de-la-medicina-tro-2383094a 2026-03-26 https://revespquimioterapia.com/articulo/inmunidad-frente-a-sars-cov-2-caminando-hacia-la-v-afd640ab 2026-03-26 https://revespquimioterapia.com/articulo/comportamiento-de-la-prueba-katex-en-el-cribado-y--b0acfa37 2026-03-26 https://revespquimioterapia.com/articulo/disenteria-bacteriemica-por-shigella-en-un-adulto-d050fbe3 2026-03-26 https://revespquimioterapia.com/articulo/coste-biologico-asociado-a-la-resistencia-a-la-fos-b524c003 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-del-tratamiento-de-la-sifilis-a-lo-largo-44807d38 2026-03-26 https://revespquimioterapia.com/articulo/nuevos-avances-terapeuticos-en-la-hepatitis-cronic-42d986f6 2026-03-26 https://revespquimioterapia.com/articulo/respuesta-a-profilaxis-post-exposicion-frente-vih--565575f3 2026-03-26 https://revespquimioterapia.com/articulo/antibiotic-selection-in-the-treatment-of-acute-inv-9a0786da 2026-03-26 https://revespquimioterapia.com/articulo/estudio-multicentrico-en-el-cono-sur-americano-de--95782035 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-ocho-fluoroquinolonasfrente--46c09cd6 2026-03-26 https://revespquimioterapia.com/articulo/endocarditis-por-kingella-kingae-en-un-paciente-ad-b023a5dc 2026-03-26 https://revespquimioterapia.com/articulo/valoracion-de-la-adherencia-al-tratamiento-antibio-29f5bddc 2026-03-26 https://revespquimioterapia.com/articulo/cobertura-vacunal-antigripal-en-el-cuerpo-militar--d16077b7 2026-03-26 https://revespquimioterapia.com/articulo/meropenem-experiencia-en-neumonia-nosocomial-cae5f09c 2026-03-26 https://revespquimioterapia.com/articulo/tuberculosis-cases-presenting-with-spontaneous-hem-80c3b501 2026-03-26 https://revespquimioterapia.com/articulo/cefditoren-versus-ceftazidime-in-inducer-substrate-44c48449 2026-03-26 https://revespquimioterapia.com/articulo/present-and-future-of-resistance-in-pseudomonas-ae-21249f09 2026-03-26 https://revespquimioterapia.com/articulo/inhibidores-de-la-bomba-de-protones-y-riesgo-de-in-a8855838 2026-03-26 https://revespquimioterapia.com/articulo/bacteremia-caused-by-eikenella-corrodens-in-a-pati-7764a67c 2026-03-26 https://revespquimioterapia.com/articulo/absceso-primario-de-psoas-por-brucella-melitensis--f212d98f 2026-03-26 https://revespquimioterapia.com/articulo/guillain-barre-syndrome-and-influenza-vaccines-cur-1d6c4e45 2026-03-26 https://revespquimioterapia.com/articulo/optimizacion-en-la-recuperacion-del-estreptococo-d-a96825fb 2026-03-26 https://revespquimioterapia.com/articulo/recommendations-for-the-prevention-of-healthcare-a-801427ff 2026-03-26 https://revespquimioterapia.com/articulo/hepatotoxicidad-por-antibioticos-actualizacion-en--dab9bbcb 2026-03-26 https://revespquimioterapia.com/articulo/tuberculosis-extremadamente-resistente-tratada-con-11537404 2026-03-26 https://revespquimioterapia.com/articulo/diferencias-en-el-uso-de-tigeciclina-entre-pacient-201179e4 2026-03-26 https://revespquimioterapia.com/articulo/antiviral-drugs-against-sars-cov-2-398e0ab2 2026-03-26 https://revespquimioterapia.com/articulo/cefditoreno-una-realidad-para-el-tratamiento-de-la-e2cfe748 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-por-candida-spp-sobre-protesis-articular-c1793e55 2026-03-26 https://revespquimioterapia.com/articulo/the-first-100-cases-of-covid-19-in-a-hospital-in-m-0ba6dce2 2026-03-26 https://revespquimioterapia.com/articulo/la-necesidad-de-implementar-biomarcadores-en-las-e-b5165ded 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-a-los-antimicrobianos-perfil-plasmidic-4f8ff3d7 2026-03-26 https://revespquimioterapia.com/articulo/parametros-farmacodinamicos-y-farmacocineticos-de--5f09a05f 2026-03-26 https://revespquimioterapia.com/articulo/clinical-experience-with-linezolid-for-the-treatme-fa89bb2e 2026-03-26 https://revespquimioterapia.com/articulo/infectious-postoperative-endophthalmitis-after-cat-755c888d 2026-03-26 https://revespquimioterapia.com/articulo/successful-management-of-remdesivir-extravasation-f025b340 2026-03-26 https://revespquimioterapia.com/articulo/efectividad-seguridad-e-impacto-economico-del-regi-2a3d2e68 2026-03-26 https://revespquimioterapia.com/articulo/past-and-future-of-hiv-infection-a-document-based--3c8bec87 2026-03-26 https://revespquimioterapia.com/articulo/estudio-microbiologico-de-los-casos-de-endoftalmit-67ee6ef5 2026-03-26 https://revespquimioterapia.com/articulo/cambios-en-la-resistencia-antibiotica-en-episodios-a0ce1d47 2026-03-26 https://revespquimioterapia.com/articulo/relevancia-del-tratamiento-antibiotico-empirico-en-cbfd2570 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-del-modelo-mpb-infurg-semes-para-predecir-ea9ebc57 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-del-acido-ascorbico-vitamina-c--eb174ecf 2026-03-26 https://revespquimioterapia.com/articulo/queratitis-por-nocardia-farcinica-en-paciente-inmu-daf5b21f 2026-03-26 https://revespquimioterapia.com/articulo/a-practice-based-observational-study-on-the-use-of-8b691ab4 2026-03-26 https://revespquimioterapia.com/articulo/uso-de-vacuna-frente-a-hepatitis-b-adyuvada-con-as-0f8d3858 2026-03-26 https://revespquimioterapia.com/articulo/meropenem-experiencia-en-infeccion-intraabdominal-a0bf9370 2026-03-26 https://revespquimioterapia.com/articulo/clinical-experience-in-the-treatment-of-covid-19-w-3ceff29d 2026-03-26 https://revespquimioterapia.com/articulo/cumplimiento-de-las-recomendaciones-internacionale-bf9aa660 2026-03-26 https://revespquimioterapia.com/articulo/influencia-de-la-confirmacion-microbiologica-en-la-47c45577 2026-03-26 https://revespquimioterapia.com/articulo/empirical-antifungal-treatment-a-valid-alternative-8a01d567 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-antimicrobiana-en-aislados-clinicos-de-2cb039a2 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-in-vitro-a-los-antibioticos-y-serotip-8f28b813 2026-03-26 https://revespquimioterapia.com/articulo/aislamientos-microbiologicos-en-pacientes-con-neut-5c129fdf 2026-03-26 https://revespquimioterapia.com/articulo/trend-in-the-use-of-topical-ocular-anti-infectives-c66e572d 2026-03-26 https://revespquimioterapia.com/articulo/sindromes-febriles-en-el-viajero-que-regresa-de-re-a890a3dc 2026-03-26 https://revespquimioterapia.com/articulo/grupo-bacteroides-fragilis-en-heces-humanas-no-dia-d434bce7 2026-03-26 https://revespquimioterapia.com/articulo/pk-pd-y-desarrollo-de-nuevas-formulaciones-en-el-c-abcaf9db 2026-03-26 https://revespquimioterapia.com/articulo/etiologia-de-las-infecciones-del-tracto-urinario-y-79089c39 2026-03-26 https://revespquimioterapia.com/articulo/candent-issues-in-pneumonia-reflections-from-the-f-417bd794 2026-03-26 https://revespquimioterapia.com/articulo/symposium-1-resistencia-en-infeccion-respiratoria--f7a7c402 2026-03-26 https://revespquimioterapia.com/articulo/interacciones-potenciales-de-los-antimicrobianos-e-09f1cec8 2026-03-26 https://revespquimioterapia.com/articulo/antibioticos-en-la-comunidad-valenciana-controland-b78b7757 2026-03-26 https://revespquimioterapia.com/articulo/peramivir-un-nuevo-y-potente-inhibidor-de-la-neura-0f0d9573 2026-03-26 https://revespquimioterapia.com/articulo/two-rare-cases-of-pleural-infection-due-to-prevote-92f405aa 2026-03-26 https://revespquimioterapia.com/articulo/precision-del-metodo-e-test-para-el-estudio-de-la--ac718c4f 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-antibiotica-de-haemophilus-spp-en-el--68238fa4 2026-03-26 https://revespquimioterapia.com/articulo/pharmacological-treatment-of-covid-19-an-opinion-p-ab42d113 2026-03-26 https://revespquimioterapia.com/articulo/30-de-octubre-de-1928-una-fecha-clave-en-el-diario-6dbfe632 2026-03-26 https://revespquimioterapia.com/articulo/difusion-y-farmacocinetica-de-antibioticos-en-el-g-2013bda4 2026-03-26 https://revespquimioterapia.com/articulo/actualizacion-en-la-infeccion-por-el-virus-ebola-1fb1c95d 2026-03-26 https://revespquimioterapia.com/articulo/prescripcion-de-antibioticos-y-cambios-en-las-resi-ff5b800e 2026-03-26 https://revespquimioterapia.com/articulo/a-rare-case-of-saprochaete-capitata-fungemia-in-a--64aaa6e6 2026-03-26 https://revespquimioterapia.com/articulo/estado-actual-de-las-vacunas-combinadas-5eacc423 2026-03-26 https://revespquimioterapia.com/articulo/adherencia-a-la-higiene-de-manos-con-soluciones-hi-e8a28674 2026-03-26 https://revespquimioterapia.com/articulo/farmacodinamia-de-los-betalactamicos-y-su-modifica-0e072f73 2026-03-26 https://revespquimioterapia.com/articulo/sindrome-hemofagocitico-por-leishmania-en-paciente-017db7e0 2026-03-26 https://revespquimioterapia.com/articulo/management-in-the-emergency-room-of-patients-requi-873ea523 2026-03-26 https://revespquimioterapia.com/articulo/ulcera-palmar-en-una-paciente-esplenectomizada-e221a109 2026-03-26 https://revespquimioterapia.com/articulo/podemos-pautar-tratamiento-empirico-para-infeccion-20606254 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-la-adherencia-a-la-higiene-de-manos--4b0aa388 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-colonizacion-del-tracto-genital-femenino-4c39d75c 2026-03-26 https://revespquimioterapia.com/articulo/importancia-de-la-cobertura-antimicrobiana-y-de-la-f47e7053 2026-03-26 https://revespquimioterapia.com/articulo/generacion-in-vitro-de-mutantes-de-klebsiella-pneu-59ca6eed 2026-03-26 https://revespquimioterapia.com/articulo/methicillin-resistant-staphylococcus-epidermidis-i-8da86953 2026-03-26 https://revespquimioterapia.com/articulo/long-term-persistence-effectiveness-safety-and-metabolic-impact-of-bictegravir-emtricitabine-tenofovir-alafenamide-fixed-dose-combination-in-people-living-with-hiv-in-the-bictarg-cohort-63955 2026-03-26 https://revespquimioterapia.com/articulo/underdiagnosed-brain-abscess-and-meningitis-caused-by-Parvimonas-micra-in-an-immunocompetent-host-an-idiopathic-case 2026-03-26 https://revespquimioterapia.com/articulo/baseline-survey-of-doravirine-resistance-among-pregnant-women-with-hiv 2026-03-26 https://revespquimioterapia.com/articulo/epidemiology-of-the-covid-19-pneumonia-in-a-group-of-hospitals-from-madrid--spain-during-the-full-period-of-the-state-of-alarm–-hm-cohort 2026-03-26 https://revespquimioterapia.com/articulo/effect-of-a-multifaceted-intervention-on-potentially-unnecessary-antibiotic-prescriptions-in-general-practice-out-of-hours-services-and-nursing-homes-in-spain 2026-03-26 https://revespquimioterapia.com/articulo/post-covid-19-tuberculosis-in-southeastern-spain-incidence-risk-factors-and-the-role-of-latent-tuberculosis-infection-screening-- 2026-03-26 https://revespquimioterapia.com/articulo/sospecha-de-síndrome-serotoninérgico-asociado-a-tedizolid-a-propósito-de-un-caso 2026-03-26 https://revespquimioterapia.com/articulo/impacto-de-un-comite-monografico-multidisciplinar-endocarditis-team-en-el-abordaje-y-evolucion-de-la-endocarditis-infecciosa-en-un-hospital-de-tercer-nivel 2026-03-26 https://revespquimioterapia.com/articulo/distribución-de-patotipos-de-escherichia-coli-diarreagénica-en-población-pediátrica-y-perfil-de-sensibilidad-antibiótica-en-el-área-de-salud-de-valladolid-oeste-asvao 2026-03-26 https://revespquimioterapia.com/articulo/endocarditis-infecciosa-causada-por-aggregatibacter-actinomycetemcomitans 2026-03-26 https://revespquimioterapia.com/articulo/use-of-a-rapid-detection-test-for-extended-spectrum-beta-lactamase-from-direct-blood-culture-an-antimicrobial-stewardship-tool-in-a-tertiary-hospital-in-spain 2026-03-26 https://revespquimioterapia.com/articulo/successful-rezafungin-treatment-of-an-azole-resistant-candida-parapsilosis-vascular-graft-infection 2026-03-26 https://revespquimioterapia.com/articulo/optimizing-compliance-with-latent-tuberculosis-infection-screening-among-kidney-transplant-recipients 2026-03-26 https://revespquimioterapia.com/articulo/capacidad-de-la-region-medial-de-la-proadrenomedulina-mr-proadm-para-predecir-mala-evolucion-clinica-y-estratificar-el-pronostico-en-los-pacientes-adultos-atendidos-en-urgencias-por-sospecha-de-infeccion 2026-03-26 https://revespquimioterapia.com/articulo/disseminated-histoplasmosis-with-bone-marrow-infiltration-in-a-newly-diagnosed-hiv-patient 2026-03-26 https://revespquimioterapia.com/articulo/effectiveness-and-safety-of-dual-therapy-with-co-packaged-dolutegravir-and-lamivudine-compared-to-triple-therapy-as-switching-strategy-in-clinical-practice 2026-03-26 https://revespquimioterapia.com/articulo/impacto-del-incremento-en-la-frecuencia-de-reuniones-del-equipo-del-programa-de-optimizacion-del-uso-de-antimicrobianos-sobre-los-indicadores-de-uso-hospitalario-de-antimicrobianos-basados-en-consumo 2026-03-26 https://revespquimioterapia.com/articulo/pseudoglutamicibacter-cumminsii-in-outpatient-samples-analysis-of-isolates-and-antimicrobial-susceptibility 2026-03-26 https://revespquimioterapia.com/articulo/kytococcus-schroeteri-pneumonia-in-an-immunocompromised-individual-a-case-report-and-review-of-the-literature 2026-03-26 https://revespquimioterapia.com/articulo/predictive-performance-of-weekly-rectal-surveillance-cultures-and-extra-rectal-colonization-for-carbapenem-resistant-enterobacterales-infections-in-a-resource-limited-icu-with-kpc-and-ndm-co-circulation 2026-03-26 https://revespquimioterapia.com/articulo/de-absceso-cutaneo-a-ventriculitis-por-staphylococcus-aureus-resistente-a-meticilina-productor-de-leucocidina-de-panton-valentine 2026-03-26 https://revespquimioterapia.com/articulo/the-icu-pharmacists-contribution-to-antimicrobial-optimization-through-routine-pharmacist-interventions 2026-03-26 https://revespquimioterapia.com/articulo/colonizacion-o-invasion-precoz-aspergilosis-diseminada-tras-aislamiento-bronquial-de-aspergillus-fumigatus-en-un-trasplantado-cardiaco 2026-03-26 https://revespquimioterapia.com/articulo/multiple-intracranial-infectious-aneurysms-in-a-case-of-endocarditis-Intravascular-management 2026-03-26 https://revespquimioterapia.com/articulo/candida-kefyrkluyveromyces-marxianus-infection-of-aortic-endograft 2026-03-26 https://revespquimioterapia.com/articulo/human-herpesvirus-type-7-and-bone-marrow-disorders-a-new-association-to-consider-in-relation-with-a-case-report 2026-03-26 https://revespquimioterapia.com/articulo/artritis-septica-pediatrica-por-staphylococcus-argenteus-50487 2026-03-26 https://revespquimioterapia.com/articulo/fracaso-virologico-precoz-con-cabotegravir-rilpivirina-de-accion-prolongada-descripcion-de-dos-casos 2026-03-26 https://revespquimioterapia.com/articulo/oportunidades-perdidas-en-la-deteccion-del-vih-experiencia-en-un-hospital-de-referencia 2026-03-26 https://revespquimioterapia.com/articulo/documento-de-opinion-de-expertos-para-la-mejora-de-7864265f 2026-03-26 https://revespquimioterapia.com/articulo/resistencia-a-las-quinolonas-de-streptococcus-pneu-84bc19f8 2026-03-26 https://revespquimioterapia.com/articulo/bartolinitis-por-streptococcus-pneumoniae-92501716 2026-03-26 https://revespquimioterapia.com/articulo/biofilm-prevention-concentration-of-clarithromycin-ab58c816 2026-03-26 https://revespquimioterapia.com/articulo/conocimientos-y-aptitudes-del-personal-sanitario-f-050a71cf 2026-03-26 https://revespquimioterapia.com/articulo/estudio-observacional-retrospectivo-de-persistenci-51bf0d3f 2026-03-26 https://revespquimioterapia.com/articulo/treatment-of-invasive-fungal-infections-in-high-ri-dec910b4 2026-03-26 https://revespquimioterapia.com/articulo/and-then-there-were-none-f98d762c 2026-03-26 https://revespquimioterapia.com/articulo/comparacion-de-distintas-estrategias-para-la-predi-783adcb1 2026-03-26 https://revespquimioterapia.com/articulo/otitis-media-tuberculosa-presentacion-de-un-caso-y-159c8e43 2026-03-26 https://revespquimioterapia.com/articulo/diseminacion-monoclonal-de-klebsiella-pneumoniae-p-d068a6f8 2026-03-26 https://revespquimioterapia.com/articulo/bacterial-osteomyelitis-microbiological-clinical-t-e776f543 2026-03-26 https://revespquimioterapia.com/articulo/investigacion-de-las-resistencias-a-antimicrobiano-92f29e76 2026-03-26 https://revespquimioterapia.com/articulo/a-two-hour-procedure-for-determining-the-susceptib-7405ce6e 2026-03-26 https://revespquimioterapia.com/articulo/erradicacion-de-achromobacter-spp-multiresistente--358e2401 2026-03-26 https://revespquimioterapia.com/articulo/oral-and-intravenous-fosfomycin-in-complicated-uri-096fc599 2026-03-26 https://revespquimioterapia.com/articulo/asociacion-de-los-genes-de-resistencia-a-antibios--c1b4aa2d 2026-03-26 https://revespquimioterapia.com/articulo/ventilation-support-in-sars-cov-2-pneumonia-strate-894743a1 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-antimicrobiana-de-bacterias-anaerobia-cc221534 2026-03-26 https://revespquimioterapia.com/articulo/mechanisms-of-action-and-antimicrobial-activity-of-95d17753 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-y-tratamiento-de-la-malaria-analisis-d-351e968e 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-las-resistencias-a-antibioticos-de-acin-acb37df9 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-tuberculosa-de-localizacion-infrecuente-3c26bcdf 2026-03-26 https://revespquimioterapia.com/articulo/daptomicina-un-antibiotico-reevaluado-229c578b 2026-03-26 https://revespquimioterapia.com/articulo/protection-of-enterococcus-faecalis-in-mixed-cultu-89c25b1e 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-sensibilidad-de-aislamientos-levadurifo-e86b9437 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-empirical-treatment-with-antifungal-agen-026fd5f8 2026-03-26 https://revespquimioterapia.com/articulo/pseudoaneurisma-micotico-carotideo-presentacion-de-dea470d5 2026-03-26 https://revespquimioterapia.com/articulo/meropenem-en-el-tratamiento-empirico-de-infeccione-652adbc5 2026-03-26 https://revespquimioterapia.com/articulo/cellulitis-due-to-pasteurella-stomatis-and-actinom-b8d05f2f 2026-03-26 https://revespquimioterapia.com/articulo/initial-clinical-outcomes-and-prognostic-variables-f0ab57a9 2026-03-26 https://revespquimioterapia.com/articulo/infradiagnostico-de-linfogranuloma-venereo-75027351 2026-03-26 https://revespquimioterapia.com/articulo/use-of-walkaway-microscan-system-colistin-well-whe-4dc43de2 2026-03-26 https://revespquimioterapia.com/articulo/achromobacter-xylosoxidans-bacteremia-clinical-and-92027dc2 2026-03-26 https://revespquimioterapia.com/articulo/mortality-among-methicillin-resistant-staphylococc-2fdfba1f 2026-03-26 https://revespquimioterapia.com/articulo/epidemiologia-y-etiologia-de-la-candidiasis-vagina-07c1d02f 2026-03-26 https://revespquimioterapia.com/articulo/infeccion-de-trasmision-sexual-vs-enfermedad-infla-7ae4fb3b 2026-03-26 https://revespquimioterapia.com/articulo/isolation-of-the-first-metallo-b-lactamase-produci-7b58fa4b 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-6-340-341-ef684916 2026-03-26 https://revespquimioterapia.com/articulo/inmunizacion-y-antimicrobianos-asociacion-de-efect-48991171 2026-03-26 https://revespquimioterapia.com/articulo/acinetobacter-multirresistencia-o-supervivencia-1be07cd1 2026-03-26 https://revespquimioterapia.com/articulo/identificacion-presuntiva-de-candida-albicans-basa-946d06d7 2026-03-26 https://revespquimioterapia.com/articulo/a-gil-e2a8fa30 2026-03-26 https://revespquimioterapia.com/articulo/dosificacion-de-cefazolina-prequirurgica-en-pacien-a773b450 2026-03-26 https://revespquimioterapia.com/articulo/consumo-de-antibioticos-sistemicos-en-valladolid-1-714769dd 2026-03-26 https://revespquimioterapia.com/articulo/absceso-en-psoas-secundario-a-infeccion-de-endopro-8202972b 2026-03-26 https://revespquimioterapia.com/articulo/estudio-comparativo-de-tres-pruebas-de-sensibilida-f760ec44 2026-03-26 https://revespquimioterapia.com/articulo/desarrollo-de-modelo-experimental-animal-de-perito-07f56537 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-antibiotica-de-cepas-de-corynebacteri-54327537 2026-03-26 https://revespquimioterapia.com/articulo/enfermedad-inflamatoria-pelvica-grave-respuesta-al-b690fd81 2026-03-26 https://revespquimioterapia.com/articulo/prevencion-de-las-infecciones-fungicas-de-origen-e-9bb2cb5e 2026-03-26 https://revespquimioterapia.com/articulo/association-between-antibiotic-pressure-and-the-ri-6f7e010c 2026-03-26 https://revespquimioterapia.com/articulo/antimicrobial-activity-of-ceftolozane-tazobactam-a-336da6b2 2026-03-26 https://revespquimioterapia.com/articulo/serotipos-y-sensibilidad-antibiotica-del-genero-sa-475ee358 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-de-los-serotipos-causantes-de-enfermedad-f1470ac6 2026-03-26 https://revespquimioterapia.com/articulo/metodologia-de-los-estudios-caso-control-en-la-epi-c99973f3 2026-03-26 https://revespquimioterapia.com/articulo/antifungicos-mecanismo-de-accion-en-celulas-de-lev-5d54d2e1 2026-03-26 https://revespquimioterapia.com/articulo/effectiveness-of-12-week-ledipasvir-sofosbuvir-and-1ccf670d 2026-03-26 https://revespquimioterapia.com/articulo/estudio-comparativo-de-dos-metodos-de-deteccion-fr-c9e820bb 2026-03-26 https://revespquimioterapia.com/articulo/shock-septico-secundario-a-elizabethkingia-meningo-96222f4a 2026-03-26 https://revespquimioterapia.com/articulo/situacion-de-las-resistencias-a-farmacos-de-mycoba-7c5204b7 2026-03-26 https://revespquimioterapia.com/articulo/nocardia-farcinica-isolated-meningitis-in-a-patien-581c3302 2026-03-26 https://revespquimioterapia.com/articulo/prevalence-of-prescription-of-the-top-10-drug-clas-b639f787 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-de-tres-test-inmunocromatograficos-pa-ecbdb545 2026-03-26 https://revespquimioterapia.com/articulo/aplicacion-del-documento-de-consenso-disponible-en-5a700df3 2026-03-26 https://revespquimioterapia.com/articulo/streptococcus-suis-tipo-2-patogeno-emergente-produ-52d8eb19 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-fluoroquinolonas-y-antibioti-a0d3ac7c 2026-03-26 https://revespquimioterapia.com/articulo/linezolid-more-efficacious-than-vancomycin-to-erad-7bb58e58 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-microbiologico-en-varones-revision-de--768d1d64 2026-03-26 https://revespquimioterapia.com/articulo/farmacos-biotecnologicos-y-quimioterapia-antiinfec-2f1243ae 2026-03-26 https://revespquimioterapia.com/articulo/altos-porcentajes-de-corresistencia-antimicrobiana-b8d7df8a 2026-03-26 https://revespquimioterapia.com/articulo/fe-de-erratas-79b466df 2026-03-26 https://revespquimioterapia.com/articulo/linezolid-en-el-tratamiento-de-infecciones-por-coc-8f538be7 2026-03-26 https://revespquimioterapia.com/articulo/investigacion-de-las-resistencias-a-antimicrobiano-4f3bc4dd 2026-03-26 https://revespquimioterapia.com/articulo/epidemiologia-y-forma-de-presentacion-clinica-de-l-fac0a96c 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-del-consumo-de-antimicrobianos-mediante-d5ec1c59 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-daptomicina-ciprofloxacino-clindamici-029cc05e 2026-03-26 https://revespquimioterapia.com/articulo/determinacion-de-la-sensibilidad-fa61f413 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-trovafloxacino-y-otros-diez-antimicro-18215eed 2026-03-26 https://revespquimioterapia.com/articulo/uncommon-adverse-events-of-intravesical-bacillus-c-146acf09 2026-03-26 https://revespquimioterapia.com/articulo/bacterias-problematicas-c8359b80 2026-03-26 https://revespquimioterapia.com/articulo/optic-neuritis-as-sign-presentation-of-acute-disse-6531f2a2 2026-03-26 https://revespquimioterapia.com/articulo/alto-porcentaje-de-resistencia-a-claritromicina-y--23b831b6 2026-03-26 https://revespquimioterapia.com/articulo/acinetobacter-baumanii-multirresistente-situacion--40364ff2 2026-03-26 https://revespquimioterapia.com/articulo/microbiological-and-epidemiological-features-of-re-8a60e018 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-3-243-244-975683fa 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-antimicrobianos-de-aislamientos-cli-2ba5e687 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-del-indice-de-complejidad-de-la-terapia--12868174 2026-03-26 https://revespquimioterapia.com/articulo/cefiderocol-a-new-antibiotic-against-multidrug-res-e15c3309 2026-03-26 https://revespquimioterapia.com/articulo/ceftobiprole-a-clinical-view-c7218e2c 2026-03-26 https://revespquimioterapia.com/articulo/b-lactams-susceptibility-of-escherichia-coli-isola-a7de3fe6 2026-03-26 https://revespquimioterapia.com/articulo/optimizacion-de-la-terapia-antibacteriana-mediante-dc30b30f 2026-03-26 https://revespquimioterapia.com/articulo/current-status-of-eskape-microorganisms-in-spain-e-830bd18e 2026-03-26 https://revespquimioterapia.com/articulo/estudio-prospectivo-y-comparativo-entre-cefuroxima-4ad68dc0 2026-03-26 https://revespquimioterapia.com/articulo/programa-de-asesoramiento-en-tratamiento-antibioti-408e596a 2026-03-26 https://revespquimioterapia.com/articulo/prescripcion-de-antibioticos-a-la-poblacion-pediat-51a0f800 2026-03-26 https://revespquimioterapia.com/articulo/estudio-prospectivo-y-comparativo-1994-1998-sobre--9267bb31 2026-03-26 https://revespquimioterapia.com/articulo/sepsis-y-bacteriemia-fe367fb3 2026-03-26 https://revespquimioterapia.com/articulo/epidemiology-and-prevalence-of-mutations-associate-f4c6fc2a 2026-03-26 https://revespquimioterapia.com/articulo/uso-de-antibioticos-de-primera-linea-6-anos-despue-fc9a921d 2026-03-26 https://revespquimioterapia.com/articulo/reflexiones-sobre-resistencia-bacteriana-5a9371a7 2026-03-26 https://revespquimioterapia.com/articulo/streptococcus-cristatus-an-infrequent-cause-of-bac-2e8b8fab 2026-03-26 https://revespquimioterapia.com/articulo/hidatidosis-aspectos-epidemiologicos-clinicos-diag-aaf363e7 2026-03-26 https://revespquimioterapia.com/articulo/current-treatment-of-nosocomial-pneumonia-and-vent-da353f03 2026-03-26 https://revespquimioterapia.com/articulo/equinocandinas-buscando-diferencias-el-ejemplo-de--bf9c68cb 2026-03-26 https://revespquimioterapia.com/articulo/osteomielitis-del-cuboides-por-mycobacterium-smegm-d8e91d6b 2026-03-26 https://revespquimioterapia.com/articulo/monocyte-distribution-width-mdw-as-an-infection-in-991ad584 2026-03-26 https://revespquimioterapia.com/articulo/infection-and-infectivity-utility-of-rapid-antigen-97e04993 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-5-278-279-bdd3da44 2026-03-26 https://revespquimioterapia.com/articulo/artritis-meningococica-primaria-b7d5c972 2026-03-26 https://revespquimioterapia.com/articulo/identification-of-anaerobiospirillum-succiniciprod-be40f71a 2026-03-26 https://revespquimioterapia.com/articulo/estudio-prospectivo-de-la-densidad-de-incidencia-d-84da8a2e 2026-03-26 https://revespquimioterapia.com/articulo/actividad-in-vitro-de-fluconazol-sobre-candida-par-f8e038a4 2026-03-26 https://revespquimioterapia.com/articulo/clindamycin-but-not-intravenous-immunoglobulins-re-2c809c3d 2026-03-26 https://revespquimioterapia.com/articulo/frequency-of-sero-positivity-in-household-members--7cc32dbf 2026-03-26 https://revespquimioterapia.com/articulo/dalbavancina-combinada-con-linezolid-en-infeccion--a542bc77 2026-03-26 https://revespquimioterapia.com/articulo/male-genitourinary-infections-by-corynebacterium-g-cb7776ea 2026-03-26 https://revespquimioterapia.com/articulo/actividad-del-itraconazol-frente-a-aislamientos-cl-87118c9e 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-3-231-233-20c00573 2026-03-26 https://revespquimioterapia.com/articulo/diagnostico-y-tratamiento-antimicrobiano-de-las-si-5fd7e4ca 2026-03-26 https://revespquimioterapia.com/articulo/bacteriemias-por-escherichia-coli-productor-de-bet-73545d5e 2026-03-26 https://revespquimioterapia.com/articulo/patron-de-aislamiento-bacteriano-y-sensibilidad-an-56cb8f34 2026-03-26 https://revespquimioterapia.com/articulo/highlights-on-bacterial-infections-in-id-week-2017-b2fe56d5 2026-03-26 https://revespquimioterapia.com/articulo/sindrome-de-stevens-johnson-asociado-a-vancomicina-06d7e579 2026-03-26 https://revespquimioterapia.com/articulo/quimica-combinatoria-en-biomedicina-una-nueva-estr-2a1dd0d7 2026-03-26 https://revespquimioterapia.com/articulo/macrolides-and-staphylococcal-biofilms-8ec6ac94 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-3-241-242-1f54af59 2026-03-26 https://revespquimioterapia.com/articulo/metaanalisis-de-la-claritromicina-comparada-con-ot-4f77c31d 2026-03-26 https://revespquimioterapia.com/articulo/effect-of-protein-binding-on-the-activity-of-voric-4ea186b0 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-suppl-2-6-8-fe69e9d3 2026-03-26 https://revespquimioterapia.com/articulo/identificacion-y-sensibilidad-rapida-de-cocos-gram-5b48a85f 2026-03-26 https://revespquimioterapia.com/articulo/patron-de-sensibilidad-de-aislamientos-clinicos-de-55a93c32 2026-03-26 https://revespquimioterapia.com/articulo/revision-sistematica-de-la-literatura-y-analisis-d-964f9247 2026-03-26 https://revespquimioterapia.com/articulo/clinical-practice-update-of-antifungal-prophylaxis-215df809 2026-03-26 https://revespquimioterapia.com/articulo/necesitamos-guias-de-tratamiento-para-infecciones--2b449ccd 2026-03-26 https://revespquimioterapia.com/articulo/vigilancia-activa-de-cepas-de-salmonella-enterica--0a58ecbd 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-de-campylobacter-jejuni-a-ocho-antibi-52e2452f 2026-03-26 https://revespquimioterapia.com/articulo/estudio-piloto-de-utilizacion-de-antifungicos-sist-b97d40f7 2026-03-26 https://revespquimioterapia.com/articulo/evolucion-del-sistema-phoenix-para-identificacion--30a7a557 2026-03-26 https://revespquimioterapia.com/articulo/antifungal-treatment-with-echinocandins-a-10-year--a53f41b0 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-la-respuesta-clinica-al-tratamiento-ant-ff98e3aa 2026-03-26 https://revespquimioterapia.com/articulo/exantema-postvacunal-en-paciente-con-enfermedad-re-e16885cb 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-21-antimicrobianos-destaphylococcus-56e124c7 2026-03-26 https://revespquimioterapia.com/articulo/plitidepsina-un-inhibidor-del-factor-de-elongacion-fe3902f0 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-y-resistencia-de-pseudomonas-aerugino-a7bfbd50 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-2-138-139-e7d45da6 2026-03-26 https://revespquimioterapia.com/articulo/symposium-5-manejo-antibiotico-de-la-infeccion-bac-641f703d 2026-03-26 https://revespquimioterapia.com/articulo/sindromes-clinicos-9354eefc 2026-03-26 https://revespquimioterapia.com/articulo/threat-of-preterm-labor-and-preterm-birth-in-the-p-b0f2f4ae 2026-03-26 https://revespquimioterapia.com/articulo/patrones-de-sensibilidad-a-antimicrobianos-de-ente-6245f076 2026-03-26 https://revespquimioterapia.com/articulo/resistencias-a-farmacos-en-mycobacterium-tuberculo-0cd52803 2026-03-26 https://revespquimioterapia.com/articulo/meningitis-por-streptococcus-salivarius-f5cbf3e1 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2017-30-2-134-135-abb7a97a 2026-03-26 https://revespquimioterapia.com/articulo/identificacion-rapida-de-mycobacterium-abscessus-e-3b935a84 2026-03-26 https://revespquimioterapia.com/articulo/susceptibilidad-a-antimicrobianos-y-tipificacion-m-0c44ee84 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-suppl-2-23-25-8c4e3e48 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-antibiotica-de-neisseria-gonorrhoeae--686f3d7b 2026-03-26 https://revespquimioterapia.com/articulo/rev-esp-quimioter-2016-29-suppl-2-28-31-2406837c 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-de-la-resistencia-a-piperacilina-tazobact-0d01b65f 2026-03-26 https://revespquimioterapia.com/articulo/mpox-global-outbreak-update-in-epidemiology-clinic-bf460e0b 2026-03-26 https://revespquimioterapia.com/articulo/epico-project-development-of-educational-recommend-63b3f13c 2026-03-26 https://revespquimioterapia.com/articulo/utilizacion-del-test-de-deteccion-de-antigeno-de-s-c6e18bff 2026-03-26 https://revespquimioterapia.com/articulo/identificacion-de-micobacterias-en-muestras-clinic-a14134c1 2026-03-26 https://revespquimioterapia.com/articulo/ziresovir-un-potente-inhibidor-selectivo-y-oral-de-la-proteina-de-fusion-f-del-virus-respiratorio-sincitial 2026-03-26 https://revespquimioterapia.com/articulo/risk-model-derivation-and-clinical-outcomes-in-covid-19-pneumonia-patients-discharged-from-the-emergency-department 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-antimicrobiana-de-uropatogenos-gramne-b267ba45 2026-03-26 https://revespquimioterapia.com/articulo/staphylococcus-haemolyticus-y-bacteriemias-dfe102fe 2026-03-26 https://revespquimioterapia.com/articulo/estudio-de-resistencia-antibiotica-del-genero-ente-8128f9ff 2026-03-26 https://revespquimioterapia.com/articulo/zoonosis-diptera-tipo-miasis-facultativa-furunculo-75f95f7e 2026-03-26 https://revespquimioterapia.com/articulo/multiple-liver-abscesses-in-crohn-s-disease-in-inf-844bf406 2026-03-26 https://revespquimioterapia.com/articulo/consideraciones-sobre-las-prescripciones-antimicro-ecfcf4be 2026-03-26 https://revespquimioterapia.com/articulo/factores-de-riesgo-en-bacteriemias-nosocomiales-se-d40ba0c2 2026-03-26 https://revespquimioterapia.com/articulo/serratia-marcescens-como-causa-de-endoftalmitis-ta-75351578 2026-03-26 https://revespquimioterapia.com/articulo/bacteriobilia-un-problema-sin-resolver-052768f2 2026-03-26 https://revespquimioterapia.com/articulo/treatment-guidelines-for-multidrug-resistant-gram--df083bbe 2026-03-26 https://revespquimioterapia.com/articulo/micromunidad-un-podcast-de-divulgacion-especializa-1b33d597 2026-03-26 https://revespquimioterapia.com/articulo/farmacodinamia-como-predictor-de-eficacia-la-visio-96d69eda 2026-03-26 https://revespquimioterapia.com/articulo/ventajas-y-desventajas-de-los-antifungicos-de-uso--91b84aea 2026-03-26 https://revespquimioterapia.com/articulo/ventilatory-support-and-corticosteroid-therapy-in--ae4d3710 2026-03-26 https://revespquimioterapia.com/articulo/efficacy-of-an-information-system-addressed-to-nur-d934b7eb 2026-03-26 https://revespquimioterapia.com/articulo/cavitary-pneumonia-and-empyema-thoracis-caused-by--00bf16f5 2026-03-26 https://revespquimioterapia.com/articulo/staphylococcus-epidermidis-resistente-a-linezolid--223c3eba 2026-03-26 https://revespquimioterapia.com/articulo/symposium-3-se-necesitan-nuevas-quinolonas-0b80fe56 2026-03-26 https://revespquimioterapia.com/articulo/nasal-swab-guided-deescalation-of-empirical-linezolid-in-respiratory-infections-at-a-secondary-level-hospital-quantification-of-quality-gaps-and-antimicrobial-stewardship-opportunities 2026-03-26 https://revespquimioterapia.com/articulo/guia-de-tratamiento-antimicrobiano-de-la-infeccion-ebc8880d 2026-03-26 https://revespquimioterapia.com/articulo/nirmatrelvir-ritonavir-as-a-possible-treatment-for-96e8f587 2026-03-26 https://revespquimioterapia.com/articulo/absceso-intrafascial-por-bacillus-cereus-2f8b27c0 2026-03-26 https://revespquimioterapia.com/articulo/la-vacunacion-tambien-es-cosa-de-adultos-viernes-1-7d8ebadb 2026-03-26 https://revespquimioterapia.com/articulo/evaluation-of-the-sensititre-yeast-one-microdiluti-90b83bff 2026-03-26 https://revespquimioterapia.com/articulo/eleccion-y-uso-de-las-pruebas-de-deteccion-de-resi-9b47a34b 2026-03-26 https://revespquimioterapia.com/articulo/ofloxacino-oral-versus-imipenem-cilastatina-intrav-4bd16758 2026-03-26 https://revespquimioterapia.com/articulo/role-of-molecular-diagnostics-in-the-clinical-mana-c9ad7087 2026-03-26 https://revespquimioterapia.com/articulo/analysis-of-respiratory-syncytial-virus-cases-at-hospital-clinico-san-carlos-in-madrid-during-2018-2025 2026-03-26 https://revespquimioterapia.com/articulo/legends-dogmas-presumptions-and-demystifications-in-antibiotic-therapy 2026-03-26 https://revespquimioterapia.com/articulo/new-evidence-in-the-management-of-cmv-infection-impact-on-prophylaxis-and-treatment 2026-03-26 https://revespquimioterapia.com/articulo/complicaciones-infecciosas-tras-terapia-intravesical-con-bacilo-de-calmette-guerin-serie-de-casos 2026-03-26 https://revespquimioterapia.com/articulo/diagnostic-and-therapeutic-approach-to-occupationa-cb3d12aa 2026-03-26 https://revespquimioterapia.com/articulo/new-definitions-of-susceptibility-categories-eucas-2efef5ca 2026-03-26 https://revespquimioterapia.com/articulo/diagnostic-stewardship-in-sepsis-minding-the-gap-from-the-microbiology-lab-to-ward 2026-03-26 https://revespquimioterapia.com/articulo/septic-arthritis-caused-by-bacteroides-thetaiotaom-c765dd75 2026-03-26 https://revespquimioterapia.com/articulo/evaluacion-de-los-criterios-de-seleccion-de-antimi-04846a0f 2026-03-26 https://revespquimioterapia.com/articulo/infecciones-nosocomiales-por-pseudomonas-aeruginos-c45de30c 2026-03-26 https://revespquimioterapia.com/articulo/impact-of-a-stewardship-program-on-bacteraemia-in--56dafecf 2026-03-26 https://revespquimioterapia.com/articulo/systemic-absorption-of-liposomal-inhaled-amikacin-in-the-treatment-of-resistant-mycobacterium-avium-beyond-expectations 2026-03-26 https://revespquimioterapia.com/articulo/usefulness-of-monocyte-distribution-width-mdw-in-enhancing-diagnostic-accuracy-of-infection-among-severely-ill-patients-presenting-to-the-emergency-department 2026-03-26 https://revespquimioterapia.com/articulo/asp-complex-redefining-antimicrobial-stewardship-to-improve-outcomes-in-high-risk-severe-infections-477185 2026-03-26 https://revespquimioterapia.com/articulo/efectos-del-itraconazol-y-el-fluconazol-sobre-el-m-0cf5664e 2026-03-26 https://revespquimioterapia.com/articulo/role-of-pneumocystis-jirovecii-in-patients-with-di-f1693176 2026-03-26 https://revespquimioterapia.com/articulo/actividad-de-las-nuevas-fluoroquinolonas-frente-a--360b7da5 2026-03-26 https://revespquimioterapia.com/articulo/cefiderocol-associated-chromaturia-a-secondary-side-effect-to-recognize 2026-03-26 https://revespquimioterapia.com/articulo/pneumococcal-vaccination-coverage-residential-care-unit-of-the-community-of-madrid 2026-03-26 https://revespquimioterapia.com/articulo/lung-abscess-in-a-migrant 2026-03-26 https://revespquimioterapia.com/articulo/mas-alla-del-sitio-de-puncion-discordancia-entre-lcr-ventricular-y-lumbar-en-meningitis-tuberculosa-pediatrica 2026-03-26 https://revespquimioterapia.com/articulo/diagnostic-accuracy-of-pct-il-6-and-mr-pro-adm-for-early-identification-of-sepsis-in-the-emergency-department 2026-03-26 https://revespquimioterapia.com/articulo/candidemias-nosocomiales-nuevos-retos-de-un-proble-b4fc5553 2026-03-26 https://revespquimioterapia.com/articulo/nosocomial-infection-following-video-assisted-thor-c20d74f3 2026-03-26 https://revespquimioterapia.com/articulo/visceral-leishmaniasis-in-a-multiple-sclerosis-patient-a-rare-complication-of-fingolimod-induced-lymphopenia 2026-03-26 https://revespquimioterapia.com/articulo/actualizacion-de-las-interacciones-farmacologicas--4f2e9570 2026-03-26 https://revespquimioterapia.com/articulo/identification-of-fungal-clinical-isolates-by-matr-95488c49 2026-03-26 https://revespquimioterapia.com/articulo/consumo-de-antifungicos-de-uso-topico-en-espana-0eef4b29 2026-03-26 https://revespquimioterapia.com/articulo/prevalencia-y-patrones-de-sensibilidad-de-escheric-d53706ba 2026-03-26 https://revespquimioterapia.com/articulo/quimioprofilaxis-en-meningitis-9ce1398c 2026-03-26 https://revespquimioterapia.com/articulo/la-depuracion-de-endotoxina-como-tratamiento-coady-87038f85 2026-03-26 https://revespquimioterapia.com/articulo/relevancia-de-los-polimorfismos-geneticos-en-la-neurotoxicidad-por-voriconazol-caso-clinico-en-paciente-pediatrico 2026-03-26 https://revespquimioterapia.com/articulo/zigomicetos-y-zigomicosis-en-la-era-de-las-nuevas--ffd30845 2026-03-26 https://revespquimioterapia.com/articulo/analisis-de-la-disminucion-de-la-sensibilidad-de-l-d19d93bc 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-a-fluconazol-e-itraconazol-en-aislami-616fd85b 2026-03-26 https://revespquimioterapia.com/articulo/tratamiento-de-la-infeccion-cronica-por-el-virus-d-cc1c93e2 2026-03-26 https://revespquimioterapia.com/articulo/adultos-jovenes-sanos-portadores-de-streptococcus--b1864e0e 2026-03-26 https://revespquimioterapia.com/articulo/implicaciones-clinicas-de-las-especies-del-genero--9b358aa9 2026-03-26 https://revespquimioterapia.com/articulo/corrigendum-to-a-rapid-surveillance-of-pneumonia-in-hospitalized-patients-an-opportunity-for-intervention--585154 2026-03-26 https://revespquimioterapia.com/articulo/evolution-of-postsurgical-mediastinitis-after-major-heart-surgery-mhs-in-the-last-12-years-are-we-improving 2026-03-26 https://revespquimioterapia.com/articulo/review-on-the-management-of-intra-abdominal-candidiasis 2026-03-26 https://revespquimioterapia.com/articulo/spontaneous-bacterial-peritonitis-due-to-brucella-species-versus-peritoneal-dialysis-related-peritonitis-a-systematic-review 2026-03-26 https://revespquimioterapia.com/articulo/antibiotic-therapy-in-febrile-neutropenia-in-haematological-patients-current-considerations-and-future-challenges 2026-03-26 https://revespquimioterapia.com/articulo/pulmonary-nocardiosis-a-case-report-6497912f 2026-03-26 https://revespquimioterapia.com/articulo/productos-naturales-con-actividad-antimicotico-f2f10b9c 2026-03-26 https://revespquimioterapia.com/articulo/infecciones-endovasculares-por-campylobacter-a-pro-5f4166a1 2026-03-26 https://revespquimioterapia.com/articulo/sensibilidad-antimicrobiana-de-cepas-de-vibrio-cho-8d0145fa 2026-03-26 https://revespquimioterapia.com/articulo/utilidad-de-maldi-tof-y-rep-pcr-frente-a-pfge-para-1ad9b5cb 2026-03-26 https://revespquimioterapia.com/articulo/descolonizacion-de-pacientes-portadores-de-staphyl-983a2606 2026-03-26 https://revespquimioterapia.com/articulo/respiratory-syncytial-virus-a-new-era-cff9c7ef 2026-03-26 https://revespquimioterapia.com/october-2026-volume-39-no5-892899 2026-03-26 https://revespquimioterapia.com/volume-39-suppl-1--452761 2026-03-16 https://revespquimioterapia.com/october-2026-volume-39-no-5-136578 2026-03-26 https://revespquimioterapia.com/december-2026-volume-39-no-6-994719 2026-06-15 https://revespquimioterapia.com/december-2026-volume-39-num-6-402986 2026-06-15 https://revespquimioterapia.com/ahead-of-print-869865 2026-07-21 https://revespquimioterapia.com/august-2026-volume-39-no-4-892360 2026-07-20 https://revespquimioterapia.com/june-2026-volume-39-no-3-430270 2026-07-08 https://revespquimioterapia.com/april-2026-volume-39-no-2-287298 2026-07-29 https://revespquimioterapia.com/1761041409488x141551002021003260 2026-07-29 https://revespquimioterapia.com/february-2025-vol-38-1-1-74-645945 2026-07-31 https://revespquimioterapia.com/1758098558883x905170666546004000 2026-06-13 https://revespquimioterapia.com/1750319940691x534176715279695900 2026-04-30 https://revespquimioterapia.com/1746614627772x647491529641295900 2026-03-16 https://revespquimioterapia.com/1743584258521x821390469114626000 2026-03-16 https://revespquimioterapia.com/1739202327500x498003495720845300 2026-03-16 https://revespquimioterapia.com/1735804957104x476457950806540300 2026-03-16 https://revespquimioterapia.com/february-2024-vol-37-1-1-120-842986 2026-07-31 https://revespquimioterapia.com/june-2024-vol-37-3-203-284-179038 2026-07-31 https://revespquimioterapia.com/october-2024-vol-37-5-369-437-554883 2026-07-31 https://revespquimioterapia.com/august-2024-vol-37-4-285-368-737708 2026-07-31 https://revespquimioterapia.com/april-2024-vol-37-2-121-202-669390 2026-07-31 https://revespquimioterapia.com/december-2024-vol-37-6-438-526-308650 2026-07-31 https://revespquimioterapia.com/october-2023-vol-36-5-444-551-608316 2026-07-31 https://revespquimioterapia.com/february-2023-vol-36-1-1-113-846787 2026-07-31 https://revespquimioterapia.com/april-2023-vol-36-2-114-222-163619 2026-07-31 https://revespquimioterapia.com/june-2023-vol-36-3-223-233-209888 2026-07-31 https://revespquimioterapia.com/december-2023-vol-36-6-552-660-765724 2026-07-31 https://revespquimioterapia.com/august-2023-vol-36-4-334-443-527370 2026-07-31 https://revespquimioterapia.com/november-2023-vol-36-suppl-1-1-76-989015 2026-07-31 https://revespquimioterapia.com/october-2022-vol-35-suppl-3-1-107-653582 2026-07-31 https://revespquimioterapia.com/october-2022-vol-35-5-421-508-765399 2026-07-31 https://revespquimioterapia.com/april-2022-vol-35-2-105-230-512502 2026-07-31 https://revespquimioterapia.com/april-2022-vol-35-suppl-1-1-122-836928 2026-07-31 https://revespquimioterapia.com/february-2022-vol-35-1-1-104-96606 2026-07-31 https://revespquimioterapia.com/september-2022-vol-35-suppl-2-1-47-775046 2026-07-31 https://revespquimioterapia.com/december-2022-vol-35-6-509-591-516457 2026-07-31 https://revespquimioterapia.com/august-2022-vol-35-4-307-420-565459 2026-07-31 https://revespquimioterapia.com/june-2022-vol-35-3-231-306-669540 2026-07-31 https://revespquimioterapia.com/december-2021-vol-34-6-525-688-698658 2026-07-31 https://revespquimioterapia.com/august-2021-vol-34-4-269-401-640281 2026-07-31 https://revespquimioterapia.com/september-2021-vol-34-suppl-1-1-89-452796 2026-07-31 https://revespquimioterapia.com/october-2021-vol-34-5-402-524-923406 2026-07-31 https://revespquimioterapia.com/june-2021-vol-34-3-169-268-230655 2026-07-31 https://revespquimioterapia.com/february-2021-vol-34-1-1-71-803370 2026-07-31 https://revespquimioterapia.com/april-2021-vol-34-2-72-168-91385 2026-07-31 https://revespquimioterapia.com/october-2020-vol-33-5-296-389-167488 2026-07-31 https://revespquimioterapia.com/december-2020-vol-33-6-390-484-704147 2026-07-31 https://revespquimioterapia.com/june-2020-vol-33-3-176-225-130351 2026-07-31 https://revespquimioterapia.com/february-2020-vol-33-1-1-86-643853 2026-07-31 https://revespquimioterapia.com/august-2020-vol-33-4-226-295-65869 2026-07-31 https://revespquimioterapia.com/april-2020-vol-33-2-87-175-798579 2026-07-31 https://revespquimioterapia.com/september-2019-vol-32-suppl-2-1-79-111961 2026-07-31 https://revespquimioterapia.com/february-2019-vol-32-1-1-97-555928 2026-07-31 https://revespquimioterapia.com/october-2019-vol-32-5-410-484-748350 2026-07-31 https://revespquimioterapia.com/april-2019-vol-32-2-98-207-497471 2026-07-31 https://revespquimioterapia.com/september-2019-vol-32-suppl-3-01-36-130990 2026-07-31 https://revespquimioterapia.com/june-2019-vol-32-3-208-287-766620 2026-07-31 https://revespquimioterapia.com/december-2019-vol-32-6-485-576-729375 2026-07-31 https://revespquimioterapia.com/may-2019-vol-32-suppl-1-1-66-528890 2026-07-31 https://revespquimioterapia.com/august-2019-vol-32-4-288-409-496458 2026-07-31 https://revespquimioterapia.com/april-2018-vol-31-2-101-202-264953 2026-07-31 https://revespquimioterapia.com/september-2018-vol-31-suppl-1-1-72-571561 2026-07-31 https://revespquimioterapia.com/october-2018-vol-31-5-386-484-192604 2026-07-31 https://revespquimioterapia.com/december-2018-vol-31-6-485-559-611246 2026-07-31 https://revespquimioterapia.com/august-2018-vol-31-4-298-385-592176 2026-07-31 https://revespquimioterapia.com/june-2018-vol-31-3-203-297-399456 2026-07-31 https://revespquimioterapia.com/february-2018-vol-31-1-1-100-562169 2026-07-31 https://revespquimioterapia.com/junio-2017-vol-30-3-169-244-988455 2026-07-31 https://revespquimioterapia.com/octubre-2017-vol-30-5-305-390-261419 2026-07-31 https://revespquimioterapia.com/december-2017-vol-30-6-391-484-232496 2026-07-31 https://revespquimioterapia.com/abril-2017-vol-30-2-79-168-463133 2026-07-31 https://revespquimioterapia.com/agosto-2017-vol-30-4-245-304-721957 2026-07-31 https://revespquimioterapia.com/febrero-2017-vol-30-1-1-78-344528 2026-07-31 https://revespquimioterapia.com/diciembre-2016-vol-29-suppl-2-1-31-749051 2026-07-31 https://revespquimioterapia.com/junio-2016-vol-29-3-113-174-328507 2026-07-31 https://revespquimioterapia.com/diciembre-2016-vol-29-6-288-344-825572 2026-07-31 https://revespquimioterapia.com/octubre-2016-vol-29-5-239-287-682453 2026-07-31 https://revespquimioterapia.com/septiembre-2016-vol-29-suppl-1-1-81-455405 2026-07-31 https://revespquimioterapia.com/agosto-2016-vol-29-4-175-238-278016 2026-07-31 https://revespquimioterapia.com/febrero-2016-vol-29-1-1-54-874255 2026-07-31 https://revespquimioterapia.com/abril-2016-vol-29-2-55-112-242258 2026-07-31 https://revespquimioterapia.com/diciembre-2015-vol-28-6-275-330-424057 2026-07-31 https://revespquimioterapia.com/junio-2015-vol-28-3-116-168-45062 2026-07-31 https://revespquimioterapia.com/septiembre-2015-vol-28-suppl-1-1-62-996954 2026-07-31 https://revespquimioterapia.com/agosto-2015-vol-28-4-169-224-844445 2026-07-31 https://revespquimioterapia.com/febrero-2015-vol-28-1-1-60-425202 2026-07-31 https://revespquimioterapia.com/abril-2015-vol-28-2-61-115-234523 2026-07-31 https://revespquimioterapia.com/octubre-2015-vol-28-5-225-274-702980 2026-07-31 https://revespquimioterapia.com/diciembre-2014-vol-27-4-230-280-495473 2026-07-31 https://revespquimioterapia.com/marzo-2014-vol-27-1-1-86-950762 2026-07-31 https://revespquimioterapia.com/junio-2014-vol-27-2-87-140-706096 2026-07-31 https://revespquimioterapia.com/septiembre-2014-vol-27-3-141-229-866351 2026-07-31 https://revespquimioterapia.com/marzo-2013-vol-26-1-1-80-653946 2026-07-31 https://revespquimioterapia.com/septiembre-2013-vol-26-3-189-286-378967 2026-07-31 https://revespquimioterapia.com/diciembre-2013-vol-26-4-287-386-671050 2026-07-31 https://revespquimioterapia.com/junio-2013-vol-26-2-81-188-215793 2026-07-31 https://revespquimioterapia.com/enero-2013-26-suppl-1-1-84-538925 2026-07-31 https://revespquimioterapia.com/diciembre-2012-vol-25-4-240-304-485159 2026-07-31 https://revespquimioterapia.com/junio-2012-vol-25-2-89-171-975829 2026-07-31 https://revespquimioterapia.com/septiembre-2012-vol-25-3-172-239-93536 2026-07-31 https://revespquimioterapia.com/marzo-2012-vol-25-1-1-88-458868 2026-07-31 https://revespquimioterapia.com/diciembre-2011-vol-24-4-173-270-175971 2026-07-31 https://revespquimioterapia.com/junio-2011-vol-24-2-57-116-708326 2026-07-31 https://revespquimioterapia.com/marzo-2011-vol-24-1-1-56-635110 2026-07-31 https://revespquimioterapia.com/septiembre-2011-vol-24-3-117-172-428275 2026-07-31 https://revespquimioterapia.com/septiembre-2010-vol-23-3-109-157-956899 2026-07-31 https://revespquimioterapia.com/julio-2010-vol-23-suppl-1-1-63-642670 2026-07-31 https://revespquimioterapia.com/marzo-2010-vol-23-1-1-52-335366 2026-07-31 https://revespquimioterapia.com/junio-2010-vol-23-2-53-108-553186 2026-07-31 https://revespquimioterapia.com/diciembre-2010-vol-23-4-158-218-103950 2026-07-31 https://revespquimioterapia.com/junio-2009-vol-22-2-57-116-596766 2026-07-31 https://revespquimioterapia.com/marzo-2009-vol-22-1-1-56-189633 2026-07-31 https://revespquimioterapia.com/diciembre-2009-vol-22-4-173-227-874826 2026-07-31 https://revespquimioterapia.com/septiembre-2009-vol-22-3-117-172-906800 2026-07-31 https://revespquimioterapia.com/noviembre-2009-vol-22-suppl-1-1-34-215228 2026-07-31 https://revespquimioterapia.com/extraordinario-2008-vol-21-spec-no1-1-34-207147 2026-07-31 https://revespquimioterapia.com/diciembre-2008-vol-21-4-203-260-883541 2026-07-31 https://revespquimioterapia.com/junio-2008-vol-21-2-83-142-200907 2026-07-31 https://revespquimioterapia.com/septiembre-2008-vol-21-3-143-202-874015 2026-07-31 https://revespquimioterapia.com/marzo-2008-vol-21-1-1-82-460486 2026-07-31 https://revespquimioterapia.com/diciembre-2007-438761 2026-07-31 https://revespquimioterapia.com/septiembre-2007-180911 2026-07-31 https://revespquimioterapia.com/junio-2007-845588 2026-07-31 https://revespquimioterapia.com/marzo-2007-656136 2026-07-31 https://revespquimioterapia.com/diciembre-2006-943077 2026-07-31 https://revespquimioterapia.com/junio-2006-554120 2026-07-31 https://revespquimioterapia.com/septiembre-2006-910350 2026-07-31 https://revespquimioterapia.com/marzo-2006-632740 2026-07-31 https://revespquimioterapia.com/septiembre-2005-981597 2026-07-31 https://revespquimioterapia.com/junio-2005-315496 2026-07-31 https://revespquimioterapia.com/marzo-2005-986327 2026-07-31 https://revespquimioterapia.com/diciembre-2005-447821 2026-07-31 https://revespquimioterapia.com/diciembre-2004-971393 2026-07-31 https://revespquimioterapia.com/septiembre-2004-961371 2026-07-31 https://revespquimioterapia.com/marzo-2004-170652 2026-07-31 https://revespquimioterapia.com/junio-2004-974399 2026-07-31 https://revespquimioterapia.com/diciembre-2003-800463 2026-07-31 https://revespquimioterapia.com/mayo-2003-682662 2026-07-31 https://revespquimioterapia.com/septiembre-2003-518209 2026-07-31 https://revespquimioterapia.com/marzo-2003-935702 2026-07-31 https://revespquimioterapia.com/junio-2003-590862 2026-07-31 https://revespquimioterapia.com/junio-2002-944829 2026-07-31 https://revespquimioterapia.com/diciembre-2002-383308 2026-07-31 https://revespquimioterapia.com/septiembre-2002-268482 2026-07-31 https://revespquimioterapia.com/marzo-2002-800390 2026-07-31 https://revespquimioterapia.com/junio-2001-241805 2026-07-31 https://revespquimioterapia.com/diciembre-2001-991128 2026-07-31 https://revespquimioterapia.com/septiembre-2001-343025 2026-07-31 https://revespquimioterapia.com/marzo-2001-434127 2026-07-31 https://revespquimioterapia.com/junio-2000-188818 2026-07-31 https://revespquimioterapia.com/marzo-2000-48425 2026-07-31 https://revespquimioterapia.com/diciembre-2000-378917 2026-07-31 https://revespquimioterapia.com/junio-1999-200976 2026-07-31 https://revespquimioterapia.com/septiembre-1999-297824 2026-07-31 https://revespquimioterapia.com/marzo-1999-239218 2026-07-31 https://revespquimioterapia.com/diciembre-1999-90069 2026-07-31 https://revespquimioterapia.com/junio-1998-775517 2026-07-31 https://revespquimioterapia.com/diciembre-1998-293411 2026-07-31 https://revespquimioterapia.com/septiembre-1998-575107 2026-07-31 https://revespquimioterapia.com/marzo-1998-912313 2026-07-31 https://revespquimioterapia.com/septiembre-1997-287694 2026-07-31 https://revespquimioterapia.com/diciembre-1997-303820 2026-07-31 https://revespquimioterapia.com/marzo-1997-37372 2026-07-31 https://revespquimioterapia.com/junio-1997-157751 2026-07-31 https://revespquimioterapia.com/diciembre-1996-247040 2026-07-31